OBO_ID (LABEL):	GO_0005739 (mitochondrion)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2396486	6/2008	S91-PMC2396486	['red circles indicate increased spots, blue circles indicate spots reduced in the average gel in dvd Animals.10.1371/journal.pone.0002383.t001\n\ncaption (table-wrap): table 1\nsummary of differentially Expressed protein spots in Nucleus Accumbens Tissue from Adult Dvd-deficient and control ratsfold changep valueproteinuniprot accession numbermowse scoremolecular weightph Calcium binding proteins 1.140.031calreticulin calrp18418114479664.33-1.250.050calbindin (Calretinin) calb2p47728156313844.94-1.180.045calbindin calb1p0717169299754.711.170.032hippocalcin hpcap8407679224134.87 General Cellular Metabolism proteins 1.470.026l-Lactate Dehydrogenase B Chain ldhbp42123119365895.701.230.004aldose reductase aldrp07943154357746.26-1.110.014crystallin, Mu crymq9qyu496335335.34-1.090.030malate dehydrogenase, Cytoplasmic mdhco8898969364606.16-1.350.030glycerol-3-Phosphate dehydrogenase [Nad+], Cytoplasmic gpdao35077141374286.16-1.170.043glutathione s-transferase p gstp1p0490678234246.89 Mitochondria Proteins -1.540.041hexokinase 1 hxk1p05708761023426.29-1.350.048dynamin 1-Like Protein dnm1lo35303106838566.64-1.120.046ubiquinol-Cytochrome-C Reductase Complex Core Protein 1, uqcr1q68fy0145528155.57-1.140.033isocitrate Dehydrogenase (Nad) Subunit Alpha, Mitochondrial idh3aq99na5113395886.471.160.037idh3aq99na5117..-1.370.011nadh Dehydrogenase 1 Alpha Subcomplex Subunit 10, nduaaq561s0219404687.64-1.100.039pyruvate dehydrogenase e1 component Subunit Beta, odpbp4943295389576.20-1.180.033voltage-Dependent Anion-Selective Channel Protein 2 vdac2p8115559317267.44 signal transduction and map-related proteins -1.280.007mitogen-Activated Protein Kinase 1 (Erk-2; Mapk 2) mk01p6308657412496.50-1.240.009serine/threonine-protein phosphatase 2a catalytic subunit beta Isoform pp2abp62716107355525.211.230.036guanine nucleotide-binding protein g(i)/g(s)/g(t) Subunit Beta 1 gbb1p5431164373535.60-1.150.031guanine nucleotide-binding protein g(i)/g(s)/g(t) subunit Beta 2 gbb2p5431374373075.60-1.240.029dynamin 1 dyn1p21575152958676.32-1.670.047thimet oligopeptidase mepdp24155112782645.54-1.220.006dihydropyrimidinase-Related Protein 2 (Drp-2; Crmp-2) dpyl2p47942101622395.951.170.038dpyl2p4794253..1.240.007dpyl2p4794285..-1.210.024syntaxin-Binding Protein 1 stxb1p6176591675266.49-1.250.036adenosylhomocysteinase sahhp1076093475076.071.310.013ras-Related Protein Rab-3C rab3cp6282464258565.101.140.003beta-synuclein syubq6375456144954.481.170.013myosin Light Polypeptide 6 myl6q6411954169644.46 proteins not otherwise classified 1.480.011eukaryotic initiation factor 4a-ii if4a2q5rki190463735.331.190.001glyceraldehyde-3-Phosphate dehydrogenase g3pp0479778358058.14-1.150.047adp-ribosylation factor 1 arf1p84079128206846.32\ningenuity pathway analysis identified two major networks; (a) Cellular Movement, Cellular Assembly and Organization, Cell Signaling; and (b) protein synthsis, rna post-transcriptional modification, cancer.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 100, 'animals'), ('GO_0010467', 'gene expression', 199, 'expressed'), ('UBERON_0001882', 'nucleus accumbens', 226, 'nucleus accumbens'), ('UBERON_0000479', 'tissue', 244, 'tissue'), ('UBERON_0007023', 'adult organism', 256, 'adult'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 262, 'DVD'), ('CHEBI_31341', 'calcium dihydroxide', 371, 'Calcium'), ('PR_000004968', 'calretinin', 461, 'calretinin'), ('GO_0007631', 'feeding behavior', 581, 'General'), ('GO_0044237', 'cellular metabolic process', 589, 'cellular metabolism'), ('CHEBI_24996', 'lactate', 629, 'lactate'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 629, 'lactate dehydrogenase B chain'), ('NCBITaxon_10088', 'Mus <genus>', 751, 'mu'), ('GO_0005737', 'cytoplasm', 807, 'cytoplasmic'), ('CHEBI_15588', '(R)-malate(2-)', 858, '-3-phosphate'), ('CHEBI_34739', 'equilenin', 886, 'NAD+],'), ('GO_0005737', 'cytoplasm', 893, 'cytoplasmic'), ('GO_0005739', 'mitochondrion', 988, 'Mitochondria'), ('PR_000010050', 'transcription factor MafG', 988, 'Mitochondria Proteins'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 1031, '1'), ('PR_000003930', 'methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial', 1073, '1-like protein'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 1130, '-cytochrome-c reductase complex core protein 1'), ('CHEBI_75050', 'chromogenic compound', 1131, 'cytochrome-c'), ('GO_0030128', 'clathrin coat of endocytic vesicle', 1141, '-c reductase complex core protein 1'), ('PR_000006279', 'death-associated protein-like 1', 1222, 'dehydrogenase ...'), ('CHEBI_13389', 'NAD', 1237, 'NAD'), ('PR_000001224', 'medium-wave-sensitive opsin', 1237, 'NAD ... subunit alpha'), ('GO_0005739', 'mitochondrion', 1257, 'mitochondrial'), ('PR_000006629', 'docking protein 2', 1334, 'dehydrogenase 1 alpha subcomplex subunit 10'), ('GO_0031105', 'septin complex', 1356, 'subcomplex'), ('PR_000015908', 'synaptotagmin-6', 1448, 'subunit beta'), ('PR_000004671', 'HMG box transcription factor BBX', 1500, '-dependent anion-selective channel protein 2'), ('CHEBI_22563', 'anion', 1511, 'anion'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 1630, '-activated protein kinase 1'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 1659, 'ERK-2'), ('PR_000010147', 'microtubule-associated protein 6', 1666, 'MAPK 2'), ('SO_0001060', 'sequence_variant', 1768, 'isoform'), ('PR_000013350', 'pregnancy-specific beta-1-glycoprotein 2', 1856, ') subunit beta 1'), ('PR_000004606', 'beta-1,4-galactosyltransferase 2', 1962, 'beta 2'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 2008, '1'), ('PR_000004806', 'bromodomain-containing protein 2', 2115, '-related protein 2'), ('PR_000006660', 'dipeptidyl peptidase 3', 2135, 'DRP-2'), ('PR_000005875', 'cysteine-rich protein 3', 2142, 'CRMP-2'), ('PR_000004806', 'bromodomain-containing protein 2', 2239, '-binding protein 1'), ('PR_000004759', 'Bloom syndrome protein', 2346, '-related protein'), ('PR_000013639', 'Ras-related protein Rab-7a', 2363, 'Rab-3C'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 2453, 'light polypeptide 6'), ('CHEBI_15588', '(R)-malate(2-)', 2618, '-3-phosphate'), ('GO_0001905', 'activation of membrane attack complex', 2786, 'Cellular Movement'), ('GO_0044277', 'cell wall disassembly', 2805, 'cellular assembly'), ('GO_0009566', 'fertilization', 2827, 'organization'), ('GO_0007267', 'cell-cell signaling', 2841, 'cell signaling')]
PMC2396486	6/2008	S107-PMC2396486	['in addition, six Mitochondrial proteins were down-regulated in dvd-deficient Rats (nduaa, Uqcr1, Odpb, Idh3A, Hkk1, Vdac2).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 17, 'mitochondrial'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 77, 'rats'), ('PR_000017120', 'ubiquinol-cytochrome-c reductase complex assembly factor 1', 90, 'UQCR1'), ('PR_000012044', 'oxysterol-binding protein 2', 97, 'ODPB'), ('PR_000008928', 'interferon omega-1', 103, 'IDH3A'), ('PR_000008609', 'hexokinase-2', 110, 'HKK1'), ('PR_000017279', 'testis-specific basic protein Y 1', 116, 'VDAC2')]
PMC2581757	11/2008	S165-PMC2581757	['Superoxide Generation also perpetuates oxidative stress and Lipid peroxidation through the oxidation of Mitochondrial Iron-Sulphur Clusters such as aconitase, which subsequently stimulate Membrane Phospholipid peroxidation by Alkoxyl Radicals [45].']	N/A	N/A	[('CHEBI_9358', 'Sumatrol', 0, 'Superoxide'), ('GO_0002552', 'serotonin secretion by mast cell', 0, 'Superoxide generation'), ('CHEBI_18059', 'lipid', 60, 'lipid'), ('GO_0005739', 'mitochondrion', 104, 'mitochondrial'), ('CHEBI_24870', 'ion', 118, 'iron'), ('CHEBI_26835', 'sulfur molecular entity', 123, 'sulphur clusters'), ('GO_0016020', 'membrane', 188, 'membrane'), ('CHEBI_16247', 'phospholipid', 197, 'phospholipid'), ('CHEBI_22333', 'alkylating agent', 226, 'alkoxyl'), ('CHEBI_26534', 'retinals', 234, 'radicals')]
PMC2671035	5/2009	S8-PMC2671035	['Mitochondrial Dna copy number was reduced by >50% in u-c versus u-u Mice ( p = 0.014).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('NCBITaxon_10088', 'Mus <genus>', 68, 'mice')]
PMC2671035	5/2009	S59-PMC2671035	['quantitative real-time pcr and Mitochondrial Dna copy number.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 31, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 31, 'mitochondrial DNA')]
PMC2671035	5/2009	S63-PMC2671035	['Mitochondrial Dna (mtdna) was quantitated in Epididymal Fat dna by rt-pcr (dnazol extraction, 5 ng dna input), using ratio of Mitochondrial-encoded (Nadh Dehydrogenase 1, or Nd1 ; Cytochrome C oxidase, subunit 2; or Cox2 ) to Nuclear-encoded Genes (Β-Globin).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('UBERON_0004359', 'corpus epididymis', 45, 'epididymal fat'), ('GO_0005739', 'mitochondrion', 126, 'mitochondrial'), ('CHEBI_13389', 'NAD', 149, 'NADH'), ('PR_000008439', 'heart- and neural crest derivatives-expressed protein 1', 149, 'NADH dehydrogenase 1'), ('PR_000011040', 'nuclear receptor coactivator 1', 174, 'ND1'), ('CHEBI_18070', 'cytochrome c', 180, 'cytochrome C'), ('PR_000005770', 'cytochrome c oxidase assembly protein COX11, mitochondrial', 216, 'Cox2'), ('GO_0005634', 'nucleus', 226, 'nuclear'), ('SO_0000704', 'gene', 242, 'genes'), ('PR_000003676', 'actin, cytoplasmic 1', 249, 'β-globin'), ('CHEBI_5386', 'globin', 251, 'globin')]
PMC2671035	5/2009	S170-PMC2671035	['a : Gonadal fat Expression of Genes related to Mitochondrial biogenesis and Thermogenesis by rt-pcr.']	N/A	N/A	[('UBERON_0000991', 'gonad', 4, 'Gonadal'), ('GO_0010467', 'gene expression', 16, 'expression'), ('SO_0000704', 'gene', 30, 'genes'), ('GO_0005739', 'mitochondrion', 47, 'mitochondrial'), ('GO_0031649', 'heat generation', 76, 'thermogenesis')]
PMC2671035	5/2009	S174-PMC2671035	['b : abundance of the Mitochondrial-encoded Gene Cox-2 relative to the Nuclear-Encoded Gene Β-Globin in Gonadal Fat Pads.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 21, 'mitochondrial-'), ('SO_0000704', 'gene', 43, 'gene'), ('PR_000003266', 'collagen type II alpha chain', 48, 'Cox-2'), ('GO_0005634', 'nucleus', 70, 'nuclear'), ('SO_0000738', 'nuclear_sequence', 70, 'nuclear-encoded'), ('SO_0000704', 'gene', 86, 'gene'), ('PR_000003676', 'actin, cytoplasmic 1', 91, 'β-globin'), ('CHEBI_5386', 'globin', 93, 'globin'), ('UBERON_0003428', 'gonadal fat pad', 103, 'gonadal fat pads')]
PMC2671035	5/2009	S175-PMC2671035	['the relative proportion of Cox-2 to Β-Globin is proportional to the amount of Mitochondrial Dna per cell.']	N/A	N/A	[('PR_000003266', 'collagen type II alpha chain', 27, 'Cox-2'), ('PR_000003676', 'actin, cytoplasmic 1', 36, 'β-globin'), ('CHEBI_5386', 'globin', 38, 'globin'), ('GO_0005739', 'mitochondrion', 78, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 78, 'mitochondrial DNA')]
PMC2671035	5/2009	S177-PMC2671035	['c : abundance of the Mitochondrial-encoded Gene Nd-1 relative to the Nuclear-Encoded Gene Β-Globin in Gonadal Fat Pads.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('SO_0000172', 'CAAT_signal', 21, 'mitochondrial'), ('SO_0000704', 'gene', 43, 'gene'), ('PR_000011039', 'nicalin', 48, 'ND-1'), ('GO_0005634', 'nucleus', 69, 'nuclear'), ('SO_0000738', 'nuclear_sequence', 69, 'nuclear-encoded'), ('SO_0000704', 'gene', 85, 'gene'), ('PR_000003676', 'actin, cytoplasmic 1', 90, 'β-globin'), ('CHEBI_5386', 'globin', 92, 'globin'), ('UBERON_0003428', 'gonadal fat pad', 102, 'gonadal fat pads')]
PMC2671035	5/2009	S178-PMC2671035	['the relative proportion of Nd-1 to Β-Globin is proportional to the amount of Mitochondrial Dna per cell., c-u; ■, u-c; ▨, u-u.']	N/A	N/A	[('PR_000011039', 'nicalin', 27, 'ND-1'), ('PR_000003676', 'actin, cytoplasmic 1', 35, 'β-globin'), ('CHEBI_5386', 'globin', 37, 'globin'), ('GO_0005739', 'mitochondrion', 77, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 77, 'mitochondrial DNA')]
PMC2671035	5/2009	S265-PMC2671035	['a transcriptional signature of lbw with cug (u-c) was upregulation of Mitochondrial oxidative Genes, including Tricarboxylic Acid cycle, Oxidative Phosphorylation, and Fatty Acid oxidation, compared with lbw Mice with reduced Postnatal growth (u-u).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 70, 'mitochondrial'), ('SO_0000704', 'gene', 94, 'genes'), ('CHEBI_27092', 'tricarboxylic acid trianion', 111, 'tricarboxylic acid'), ('GO_0006119', 'oxidative phosphorylation', 137, 'oxidative phosphorylation'), ('CHEBI_35366', 'fatty acid', 168, 'fatty acid'), ('GO_0015915', 'fatty-acyl group transport', 168, 'fatty acid'), ('NCBITaxon_10088', 'Mus <genus>', 208, 'mice'), ('GO_0007567', 'parturition', 226, 'postnatal')]
PMC2749934	9/2009	S28-PMC2749934	['in addition, there was a marked increase in Expression of Genes associated with the Intracellular Trafficking Of Fatty Acids, their Peroxisomal Degradation and their entry into the Mitochondrion to undergo β-oxidation.']	N/A	N/A	[('GO_0010467', 'gene expression', 44, 'expression'), ('SO_0000704', 'gene', 58, 'genes'), ('GO_0005622', 'intracellular anatomical structure', 84, 'intracellular'), ('GO_0006880', 'intracellular sequestering of iron ion', 84, 'intracellular trafficking of fatty acids'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acids'), ('GO_0005777', 'peroxisome', 132, 'peroxisomal'), ('GO_0009056', 'catabolic process', 144, 'degradation'), ('GO_0005739', 'mitochondrion', 181, 'mitochondrion'), ('GO_0007608', 'sensory perception of smell', 181, 'mitochondrion')]
PMC2749934	9/2009	S138-PMC2749934	['blocks Mitochondrial permeabilityei24etoposide induced 2.4 mrna17may suppress cell growth by inducing apoptosisprkchprotein Kinase C eta14anti-apoptotic.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 7, 'mitochondrial'), ('PR_000009211', 'lysine-specific demethylase 3A', 124, 'kinase C')]
PMC2749934	9/2009	S188-PMC2749934	['changes are also observed in Peptidylprolyl isomerase d (Ppid) that Controls the Mitochondrial Permeability Transition Pore and Tim14, a component of the Mitochondrial Protein Import motor.']	N/A	N/A	[('CHEBI_50099', '(4-chloro-2-methylphenoxy)acetic acid', 29, 'peptidylprolyl'), ('CHEBI_75004', 'Tyr-Lys', 57, 'PPID'), ('GO_0065007', 'biological regulation', 68, 'controls'), ('GO_0001405', 'PAM complex, Tim23 associated import motor', 81, 'mitochondrial permeability transition pore'), ('PR_000016339', 'T-cell immunoglobulin and mucin domain-containing protein 4', 128, 'TIM14'), ('GO_0005739', 'mitochondrion', 154, 'mitochondrial'), ('GO_0019230', 'proprioception', 168, 'protein import')]
PMC2780862	12/2009	S70-PMC2780862	['the most well-characterized member, Sirt1, Regulates several Metabolic Pathways including Adipogenesis, Mitochondrial biogenesis, Glucose Utilization, fat oxidation, and Insulin secretion.']	N/A	N/A	[('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 36, 'SIRT1'), ('GO_0065007', 'biological regulation', 43, 'regulates'), ('GO_0009081', 'branched-chain amino acid metabolic process', 61, 'metabolic pathways'), ('GO_0060612', 'adipose tissue development', 90, 'adipogenesis'), ('GO_0005739', 'mitochondrion', 104, 'mitochondrial'), ('CHEBI_17234', 'glucose', 130, 'glucose'), ('GO_0006094', 'gluconeogenesis', 130, 'glucose utilization'), ('PR_000045358', 'insulin family protein', 170, 'insulin')]
PMC2780862	12/2009	S105-PMC2780862	['the transcriptional coactivator Ppargc1A coordinates Gene Expression that stimulates Mitochondrial Oxidative Metabolism in multiple Tissues (77).']	N/A	N/A	[('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 32, 'PPARGC1A'), ('GO_0010467', 'gene expression', 53, 'gene expression'), ('SO_0000704', 'gene', 53, 'gene'), ('GO_0005739', 'mitochondrion', 85, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 99, 'oxidative metabolism'), ('UBERON_0000479', 'tissue', 132, 'tissues')]
PMC2992766	12/2010	S150-PMC2992766	['maternal obesity induces a marked inflammatory response (9,10), which in turn causes Mitochondrial dysfunction resulting in increased Production Of Reactive Oxygen Species (35,36).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 85, 'mitochondrial'), ('GO_1903409', 'reactive oxygen species biosynthetic process', 134, 'production of reactive oxygen species'), ('CHEBI_26523', 'reactive oxygen species', 148, 'reactive oxygen species')]
PMC3001618	1/2011	S4-PMC3001618	['Lipid infiltration and molecular indices of Gluconeogenesis, Lipid Metabolism and Mitochondrial function were measured.']	N/A	N/A	[('CHEBI_18059', 'lipid', 0, 'Lipid'), ('GO_0006094', 'gluconeogenesis', 44, 'gluconeogenesis'), ('CHEBI_18059', 'lipid', 61, 'lipid'), ('GO_0006629', 'lipid metabolic process', 61, 'lipid metabolism'), ('GO_0005739', 'mitochondrion', 82, 'mitochondrial')]
PMC3001618	1/2011	S66-PMC3001618	['Mitochondrial Uncoupling Protein 2 ( Ucp2 ) was also significantly increased in obese Animals, a response that was unaffected by maternal diet during Pregnancy.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('PR_000010650', 'inositol 1,4,5-triphosphate receptor associated 1', 0, 'Mitochondrial uncoupling protein 2'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 37, 'UCP2'), ('NCBITaxon_33208', 'Metazoa', 86, 'animals'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC3127778	5/2011	S257-PMC3127778	['infection can reduce Mitochondrial function of the Diaphragm.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('UBERON_0001103', 'diaphragm', 51, 'diaphragm')]
PMC3138750	7/2011	S65-PMC3138750	['the mrna Expression levels of Genes associated with Glucocorticoid Receptor Signaling, Ran Signaling, Ppar Signaling and Igf-1 Signaling as well as Fatty Acid Elongation in Mitochondria and Mitochondrial dysfunction were increased in hp offspring.']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'expression'), ('SO_0000704', 'gene', 30, 'genes'), ('CHEBI_24261', 'glucocorticoid', 52, 'glucocorticoid'), ('GO_0009740', 'gibberellic acid mediated signaling pathway', 67, 'receptor signaling'), ('GO_0070583', 'spore membrane bending pathway', 87, 'RAN signaling'), ('GO_0038001', 'paracrine signaling', 102, 'PPAR signaling'), ('GO_0038028', 'insulin receptor signaling pathway via phosphatidylinositol 3-kinase', 121, 'IGF-1 signaling'), ('PR_000008929', 'interferon-related developmental regulator 1', 121, 'IGF-1'), ('CHEBI_35366', 'fatty acid', 148, 'fatty acid'), ('GO_0030497', 'fatty acid elongation', 148, 'fatty acid elongation'), ('GO_0005739', 'mitochondrion', 173, 'mitochondria'), ('GO_0005739', 'mitochondrion', 190, 'mitochondrial')]
PMC3138750	7/2011	S71-PMC3138750	['of Regulated Genesgenes involved in pathway94 dpc-----1 dpnran signalingup4.57*e-76ipo5, Kpna3, Kpnb1, Ran, Ranbp2, tnpo1oxidative Phosphorylationdown2.01*e-1523atp5h, Atp5I, Atp5L, atp6v0d1, Cox6A1, Cox6B1, Cox6B2, Cox7A2, Cox7B, Cox8A, Ndufa3, Ndufa4, Ndufa13, Ndufb1, Ndufb5, Ndufb6, Ndufb7, Ndufb11, Ndufs7, Ndufs8, Sdhb, Tcirg1, Uqcr11Biosynthesis of Steroidsdown1.19*e-1010dhcr7, Ebp, Fdft1, fdps, hmgcr, Idi1, Mvk, Nqo2, Pmvk, sqleval, leu, ile degradationdown3.41*e-24acaa1, Acaa2, Acat2, hmgcs128 dpnval leu, ile degradationdown6.50*e-45aldh1a1, Aldh7A1, hadha, Hmgcs1, ivdfatty Acid metabolismdown9.55*e-35acox1, Aldh1A1, aldh7a1, hadha, ivd188 dpnglucocorticoid Receptor Signalingup1.75*10-325a2m, Akt3, Cd163, Fos, Grb2, Gtf2A2, Gtf2E2, Gtf2F2, Hsp90Aa1, Hspa8, Hspa9, Icam1, Il10, Jak1, Map2K1, Mapk1, Mapk14, Ppp3Cb, Rras2, Stat5B, Sumo1, Taf4, Taf7, Taf15, Tgfbr2Ran signalingup8.21*10-34ipo5, Kpna1, Kpna6, Ranigf-1 signalingup3.62*10-312Akt3, Csnk2A1, Fos, Grb2, Igf1, Map2K1, Mapk1, Prkar1A, Rras2, ywhag, ywhaq, ywhazppar signalingup3.82*10-29fos, Grb2, Hsp90Aa1, Il18, Map2K1, Map4K4, Mapk1, Rras2, stat5bfatty Acid elongation in Mitochondriaup1.42*10-35acaa2, Hadhb, Hsd17B4, Pecr, Ppt1Mitochondrial dysfunctionup3.63*10-312Aifm1, App, cycs, Glrx2, Maoa, Ndufb3, Ndufb6, Ndufs1, Pdha1, Psen1, Sod2, Uqcrb\nthe comparison between the dietary Gestational protein levels (hp vs. ap) is shown in dependence of the Regulatory direction (up or down).']	N/A	N/A	[('GO_0065007', 'biological regulation', 3, 'regulated'), ('SO_0000704', 'gene', 13, 'genesGenes'), ('PR_000009429', 'kinase non-catalytic C-lobe domain-containing protein 1', 89, 'KPNA3'), ('PR_000009425', 'killer cell lectin-like receptor subfamily F member 1', 96, 'KPNB1'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 103, 'RAN'), ('PR_000013712', 'E3 SUMO-protein ligase RanBP2', 108, 'RANBP2'), ('GO_0016540', 'protein autoprocessing', 131, 'phosphorylationdown2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 168, 'ATP5I'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 175, 'ATP5L'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 192, 'COX6A1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 200, 'COX6B1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 208, 'COX6B2'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 216, 'COX7A2'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 224, 'COX7B'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 231, 'COX8A'), ('PR_000011159', 'nexilin', 238, 'NDUFA3'), ('PR_000011159', 'nexilin', 246, 'NDUFA4'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 254, 'NDUFA13'), ('PR_000011050', 'kinetochore protein NDC80', 263, 'NDUFB1'), ('PR_000011050', 'kinetochore protein NDC80', 271, 'NDUFB5'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 279, 'NDUFB6'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 287, 'NDUFB7'), ('PR_000011050', 'kinetochore protein NDC80', 295, 'NDUFB11'), ('PR_000011050', 'kinetochore protein NDC80', 304, 'NDUFS7'), ('PR_000011050', 'kinetochore protein NDC80', 312, 'NDUFS8'), ('PR_000014460', 'serine--tRNA ligase, mitochondrial', 320, 'SDHB'), ('PR_000016196', 'transcobalamin-1', 326, 'TCIRG1'), ('PR_000016959', 'ubiquitin-associated protein 2', 334, 'UQCR11Biosynthesis'), ('CHEBI_77776', '1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole', 356, 'steroidsdown1'), ('PR_000007140', 'epsin-3', 386, 'EBP'), ('PR_000007416', 'F-box only protein 48', 391, 'FDFT1'), ('PR_000008893', 'isopentenyl-diphosphate Delta-isomerase 2', 411, 'IDI1'), ('PR_000010778', 'caveolae-associated protein 4', 417, 'MVK'), ('PR_000011339', 'RNA-binding protein Nova-1', 422, 'NQO2'), ('PR_000012920', 'postmeiotic segregation increased 2-like protein 5', 428, 'PMVK'), ('PR_000003569', 'ATP-binding cassette sub-family F member 1', 483, 'ACAA2'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 490, 'ACAT2'), ('PR_000003932', '2-aminomuconic semialdehyde dehydrogenase', 555, 'ALDH7A1'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 571, 'HMGCS1'), ('CHEBI_37527', 'acid', 588, 'acid'), ('PR_000003923', 'aldehyde dehydrogenase X, mitochondrial', 623, 'ALDH1A1'), ('PR_000014368', 'RuvB-like 1', 673, 'receptor'), ('PR_000014760', 'serine/arginine-rich splicing factor 3', 682, 'signalingup1'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 709, 'AKT3'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 715, 'CD163'), ('PR_000007593', 'glutamate carboxypeptidase 2', 722, 'FOS'), ('PR_000008210', 'glutathione peroxidase 1', 727, 'GRB2'), ('PR_000008300', 'glutathione S-transferase mu 1', 733, 'GTF2A2'), ('PR_000008322', 'general transcription factor II-I', 741, 'GTF2E2'), ('PR_000008300', 'glutathione S-transferase mu 1', 749, 'GTF2F2'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 757, 'HSP90AA1'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 767, 'HSPA8'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 774, 'HSPA9'), ('PR_000001868', 'interleukin-6 receptor subunit beta', 781, 'ICAM1'), ('PR_000001470', 'interleukin-28B', 788, 'IL10'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 794, 'JAK1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 800, 'MAP2K1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 808, 'MAPK1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 815, 'MAPK14'), ('PR_000013133', 'neurabin-2', 823, 'PPP3CB'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 831, 'RRAS2'), ('PR_000015790', 'syntaxin-18', 838, 'STAT5B'), ('PR_000015829', 'small ubiquitin-related modifier 1', 846, 'SUMO1'), ('PR_000016022', 'TATA box-binding protein-associated factor RNA polymerase I subunit C', 853, 'TAF4'), ('PR_000016006', 'transforming acidic coiled-coil-containing protein 1', 859, 'TAF7'), ('PR_000016025', 'transcription initiation factor TFIID subunit 2', 865, 'TAF15'), ('PR_000000046', 'TGF-beta', 872, 'TGFBR2RAN'), ('PR_000009429', 'kinase non-catalytic C-lobe domain-containing protein 1', 909, 'KPNA1'), ('PR_000009429', 'kinase non-catalytic C-lobe domain-containing protein 1', 916, 'KPNA6'), ('PR_000013790', 'RNA-binding protein 25', 923, 'RANIGF-1'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 951, '312AKT3'), ('PR_000005920', 'lambda-crystallin', 960, 'CSNK2A1'), ('PR_000007593', 'glutamate carboxypeptidase 2', 969, 'FOS'), ('PR_000008210', 'glutathione peroxidase 1', 974, 'GRB2'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 980, 'IGF1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 986, 'MAP2K1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 994, 'MAPK1'), ('PR_000013283', 'U4/U6 small nuclear ribonucleoprotein Prp4', 1001, 'PRKAR1A'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1010, 'RRAS2'), ('PR_000008210', 'glutathione peroxidase 1', 1067, 'GRB2'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 1073, 'HSP90AA1'), ('PR_000001470', 'interleukin-28B', 1083, 'IL18'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1089, 'MAP2K1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1097, 'MAP4K4'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1105, 'MAPK1'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1112, 'RRAS2'), ('CHEBI_37527', 'acid', 1131, 'acid'), ('GO_0005739', 'mitochondrion', 1150, 'mitochondriaup1'), ('PR_000008440', 'heart- and neural crest derivatives-expressed protein 2', 1181, 'HADHB'), ('PR_000008760', 'heparan sulfate glucosamine 3-O-sulfotransferase 3A1', 1188, 'HSD17B4'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 1197, 'PECR'), ('PR_000013477', 'phosphotidylinositol phosphatase PTPRQ', 1203, 'PPT1Mitochondrial'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 1242, '312AIFM1'), ('PR_000004168', 'amyloid-beta precursor protein', 1252, 'APP'), ('PR_000008034', 'zinc finger protein GLIS1', 1263, 'GLRX2'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1270, 'MAOA'), ('PR_000011050', 'kinetochore protein NDC80', 1276, 'NDUFB3'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 1284, 'NDUFB6'), ('PR_000011159', 'nexilin', 1292, 'NDUFS1'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 1300, 'PDHA1'), ('PR_000013355', 'pregnancy-specific beta-1-glycoprotein 8', 1307, 'PSEN1'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 1314, 'SOD2'), ('PR_000017112', 'uroplakin-1a', 1320, 'UQCRB'), ('GO_0007565', 'female pregnancy', 1361, 'gestational'), ('GO_0065007', 'biological regulation', 1430, 'regulatory')]
PMC3138750	7/2011	S165-PMC3138750	['moreover, at stage 188 dpn in hp offspring a major activator of Mitochondrial Metabolism, Prkaa1 encoding ampk, showed diminished Expression.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('GO_0008152', 'metabolic process', 78, 'metabolism'), ('PR_000013282', 'pre-mRNA-processing factor 39', 90, 'PRKAA1'), ('GO_0010467', 'gene expression', 130, 'expression')]
PMC3156909	9/2011	S91-PMC3156909	['consistent with enhanced Lipid Oxidation, the mrna levels of the Peroxisomal bifunctional enzyme (bfe) and Mitochondrial Uncoupling Protein 3 (Ucp3) as well as oxygen consumption were significantly higher in lipistase-treated ldlrko Mice compared with controls ( figure\xa02b and c ).']	N/A	N/A	[('CHEBI_18059', 'lipid', 25, 'lipid'), ('GO_0034440', 'lipid oxidation', 25, 'lipid oxidation'), ('GO_0005777', 'peroxisome', 65, 'peroxisomal'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('PR_000010505', 'MOB kinase activator 1A', 107, 'mitochondrial uncoupling protein 3'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 143, 'UCP3'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'mice')]
PMC3219760	10/2011	S49-PMC3219760	['once in Cytoplasm, in Hematopoietic Cells, iron enters the Mitochondria to participate in the synthesis of the Heme Group, an essential component of hemoglobin.']	N/A	N/A	[('GO_0005737', 'cytoplasm', 8, 'cytoplasm'), ('CL_0000988', 'hematopoietic cell', 22, 'hematopoietic cells'), ('GO_0030097', 'hemopoiesis', 22, 'hematopoietic'), ('GO_0005739', 'mitochondrion', 59, 'mitochondria'), ('CHEBI_51142', 'amino groups', 111, 'heme group')]
PMC3240629	12/2011	S69-PMC3240629	['genorm software[28]was used to determine these to be the most stable reference Genes in the Adult Mouse Fat Tissues[29].10.1371/journal.pone.0028745.t005\n\ncaption (table-Wrap): table 5\nreal-time pcr Primer details for Gene Expression studies.Gene namegene symbolaccession numberprimer sequencesamplicon lengthprimer efficiencyforward Primerreverse Primeruncoupling Protein 1 (Mitochondrial, Proton Carrier) Ucp1 nm_009463.2 ggcctctacgactcagtcca  taagccggctgagatcttgt 841.99insulin Receptor insr nm_010568.1 ggattattgtctcaaagggctgaa  gagtcgtcatactcactctgattgtg 1021.93adrenergic Receptor, Beta 3 Adrb3 nm_013462.3 cagccagccctgttgaag  ccttcatagccatcaaacctg 611.99insulin-Like Growth Factor I Receptor igf1r nm_010513.2 ccagaagtggagcagaataatc  gccatgccatctgcaatct 891.98succinate Dehydrogenase Complex, Subunit A, Flavoprotein Sdha nm_023281 tgttcagttccaccccaca  tctccacgacacccttctgt 661.99phosphoglycerate Kinase 1 Pgk1 nm_008828 tacctgctggctggatgg  cacagcctcggcatatttct 651.99tata Box Binding Protein Tbp nm_013684.3 gggagaatcatggaccagaa  gatgggaattccaggagtca 901.94peptidylprolyl isomerase b Ppib nm_011149 ttcttcataaccacagtcaagacc  accttccgtaccacatccat 921.95\n\nstatistical analyses\nall data (Postnatal weights, Sbp, Organ allometry, Serum Insulin and Glucose levels and Fat Pad Gene Expression) were analysed using a multilevel random effects regression model (spss version 18) as described previously[30],[31].']	N/A	N/A	[('SO_0000704', 'gene', 79, 'genes'), ('UBERON_0007023', 'adult organism', 92, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 98, 'mouse'), ('UBERON_0000947', 'aorta', 104, 'fat tissues'), ('PR_000017453', 'protein Wnt-9b', 170, 'WRAP'), ('SO_0000112', 'primer', 199, 'primer'), ('GO_0010467', 'gene expression', 218, 'gene expression'), ('SO_0000704', 'gene', 218, 'gene'), ('SO_0000704', 'gene', 242, 'Gene'), ('SO_0001424', 'pyrosequenced_read', 334, 'PrimerReverse'), ('SO_0000112', 'primer', 348, 'PrimerUncoupling'), ('PR_000006745', 'dual specificity protein phosphatase 19', 365, 'protein 1'), ('GO_0005739', 'mitochondrion', 376, 'mitochondrial'), ('PR_000010705', 'metallothionein-3', 376, 'mitochondrial'), ('CHEBI_51219', 'zinc tetrapyrrole', 391, 'proton carrier'), ('PR_000016970', 'ubiquitin-conjugating enzyme E2 D4', 407, 'Ucp1'), ('PR_000014368', 'RuvB-like 1', 481, 'receptor'), ('PR_000013708', 'GTP-binding nuclear protein Ran', 578, 'receptor, beta 3'), ('PR_000003719', 'disintegrin and metalloproteinase domain-containing protein 23', 595, 'Adrb3'), ('PR_000000035', 'BMP receptor type-1A', 668, '-like growth factor I receptor'), ('GO_0044776', 'DNA polymerase III, core complex', 777, 'dehydrogenase complex'), ('PR_000012975', 'DNA polymerase eta', 777, 'dehydrogenase complex, subunit A'), ('CHEBI_5086', 'flavoprotein', 811, 'flavoprotein'), ('PR_000002092', 'signal transducer and activator of transcription 5b', 824, 'Sdha'), ('PR_000009211', 'lysine-specific demethylase 3A', 904, 'kinase 1'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 913, 'Pgk1'), ('PR_000004770', 'Polycomb complex protein BMI-1', 980, 'box binding protein'), ('SO_0000620', 'B_box', 980, 'box'), ('PR_000016193', 'T-cell leukemia/lymphoma protein 1A', 1000, 'Tbp'), ('PR_000013350', 'pregnancy-specific beta-1-glycoprotein 2', 1092, 'Ppib'), ('GO_0007567', 'parturition', 1193, 'postnatal'), ('UBERON_0012176', 'comb', 1212, 'SBP'), ('UBERON_0000062', 'organ', 1217, 'organ'), ('UBERON_0001977', 'blood serum', 1234, 'serum'), ('PR_000045358', 'insulin family protein', 1240, 'insulin'), ('CHEBI_17234', 'glucose', 1252, 'glucose'), ('UBERON_0003916', 'fat pad', 1271, 'fat pad'), ('GO_0010467', 'gene expression', 1279, 'gene expression'), ('SO_0000704', 'gene', 1279, 'gene')]
PMC3321454	3/2012	S2-PMC3321454	['Mitochondrial state 3 and state 4 respiratory rates were decreased by a third in the lp exposed Adults.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('UBERON_0007023', 'adult organism', 96, 'adults')]
PMC3321454	3/2012	S18-PMC3321454	['offspring of Mice rendered obese prior to Pregnancy exhibit functional deficits in Mitochondrial function at the Early Embryonic Stage and Postnatal [17].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 13, 'mice'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0005739', 'mitochondrion', 83, 'mitochondrial'), ('UBERON_0007228', 'vestibular nucleus', 113, 'early embryonic stage'), ('GO_0007567', 'parturition', 139, 'postnatal')]
PMC3321454	3/2012	S20-PMC3321454	['in Rats exposed to a maternal high-fat diet, Kidney Mitochondrial Dna was decreased, and Expression of the Mitochondrial Genome in Aorta was downregulated [18].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('UBERON_0002113', 'kidney', 45, 'kidney'), ('GO_0005739', 'mitochondrion', 52, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 52, 'mitochondrial DNA'), ('GO_0010467', 'gene expression', 89, 'expression'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('SO_0000172', 'CAAT_signal', 107, 'mitochondrial'), ('SO_0001026', 'genome', 121, 'genome'), ('UBERON_0000947', 'aorta', 131, 'aorta')]
PMC3321454	3/2012	S36-PMC3321454	['both Kidneys were collected from a second male from each litter, and these were used for fresh preparation of Mitochondria and analysis of Respiratory Chain function.']	N/A	N/A	[('UBERON_0002113', 'kidney', 5, 'kidneys'), ('GO_0005739', 'mitochondrion', 110, 'mitochondria'), ('GO_0045472', 'response to ether', 139, 'respiratory chain')]
PMC3321454	3/2012	S43-PMC3321454	['Kidney samples from male offspring used for histochemistry, immunohistochemistry, and analysis of Mitochondrial Dna copy number (experiment two) were resnap frozen in Isopentane and stored in a −80°c freezer.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('GO_0005739', 'mitochondrion', 98, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 98, 'mitochondrial DNA'), ('CHEBI_30362', 'isopentane', 167, 'isopentane')]
PMC3321454	3/2012	S48-PMC3321454	['Complex Iv histochemistry\nMitochondrial Respiratory Chain activity was determined using sequential Complex Iv(cox)/Complex Ii (succinate dehydrogenase [Sdh]) histochemistry.']	N/A	N/A	[('GO_0030964', 'NADH dehydrogenase complex', 0, 'Complex IV'), ('GO_0005739', 'mitochondrion', 26, 'Mitochondrial'), ('GO_0045472', 'response to ether', 40, 'respiratory chain'), ('GO_0030964', 'NADH dehydrogenase complex', 99, 'complex IV'), ('GO_0030964', 'NADH dehydrogenase complex', 115, 'complex II'), ('CHEBI_8984', 'sodium dodecyl sulfate', 152, 'SDH')]
PMC3321454	3/2012	S54-PMC3321454	['areas Of Mitochondria were highlighted, and intensity within each area was calculated using the measurement tool.']	N/A	N/A	[('GO_0005657', 'replication fork', 6, 'of'), ('GO_0005739', 'mitochondrion', 9, 'mitochondria')]
PMC3321454	3/2012	S58-PMC3321454	['they are encoded by the Mitochondrial Genome.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 24, 'mitochondrial'), ('SO_0001026', 'genome', 38, 'genome')]
PMC3321454	3/2012	S61-PMC3321454	['Phospho-Histone H2Ax (H2Ax; 1 in 200) and 8-Hydroxy-2′-Deoxyguanosine (8-ohdg; 1 in 200) are markers of oxidative damage to dna, and Superoxide Dismutase 2 (Sod2; 1 in 1000) is an antioxidant produced in the Mitochondria in response to Reactive Oxygen Species.']	N/A	N/A	[('CHEBI_32958', 'phosphate group', 0, 'Phospho'), ('CHEBI_15358', 'histone', 8, 'histone'), ('PR_000027594', 'histone H3', 8, 'histone H2AX'), ('PR_000008594', 'histone H2B type 1-O', 22, 'H2AX'), ('CHEBI_1957', "5'-butyrylphosphouridine", 42, '8-Hydroxy-2′-deoxyguanosine'), ('CHEBI_16379', 'Co-methyl-Co-5-hydroxybenzimidazolylcob(III)amide', 71, '8-'), ('CHEBI_18421', 'superoxide', 133, 'superoxide'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 133, 'superoxide dismutase 2'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 157, 'SOD2'), ('GO_0005739', 'mitochondrion', 208, 'mitochondria'), ('CHEBI_26523', 'reactive oxygen species', 236, 'reactive oxygen species')]
PMC3321454	3/2012	S69-PMC3321454	['Mitochondrial Dna copy number\nfor laser microdissection, cryostat sections (15\u2009 μ m thick) were mounted onto membrane slides (leica), and sdh histochemistry was performed.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA')]
PMC3321454	3/2012	S73-PMC3321454	['Mitochondrial dna copy number was calculated per μ m² from a standard curve.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial')]
PMC3321454	3/2012	S75-PMC3321454	['Rat Kidney Mitochondrial function\nwhole Kidneys from experiment two were chopped and minced, then homogenised in ste (250\u2009mm Sucrose, 5\u2009mm Tris/Hcl at ph 7.4, and 2\u2009mm egta) medium using a teflon dounce homogeniser.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rat'), ('UBERON_0002113', 'kidney', 4, 'Kidney'), ('GO_0005739', 'mitochondrion', 11, 'Mitochondrial'), ('UBERON_0002113', 'kidney', 40, 'kidneys'), ('CHEBI_17992', 'sucrose', 125, 'sucrose'), ('CHEBI_9754', 'tris', 139, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 144, 'HCl')]
PMC3321454	3/2012	S76-PMC3321454	['Mitochondria were prepared by differential centrifugation at 4°c using ste, adapting a method described by rolfe et al.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria')]
PMC3321454	3/2012	S78-PMC3321454	['the protein concentrations of the Mitochondria preparations were determined by the biuret method with Bovine Serum Albumin (bsa) as a standard [23].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 34, 'mitochondria'), ('NCBITaxon_33208', 'Metazoa', 102, 'bovine'), ('PR_000003918', 'albumin', 109, 'serum albumin'), ('UBERON_0001977', 'blood serum', 109, 'serum')]
PMC3321454	3/2012	S80-PMC3321454	['Mitochondrial Respiration\nthe assay medium consisted of 120\u2009mm Kcl, 5\u2009mm Kh2Po4, 3\u2009mm Hepes, 1\u2009mm egta, and 0.3% (w/v) bsa at ph 7.2.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0045333', 'cellular respiration', 14, 'Respiration'), ('CHEBI_32588', 'potassium chloride', 63, 'KCl'), ('CHEBI_63036', 'potassium dihydrogen phosphate', 73, 'KH2PO4'), ('CHEBI_46756', 'HEPES', 86, 'HEPES')]
PMC3321454	3/2012	S83-PMC3321454	['electrodes were monitored for linearity from 100% to 0% air saturation for each Mitochondrial preparation.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 80, 'mitochondrial')]
PMC3321454	3/2012	S84-PMC3321454	['Mitochondria were resuspended to 0.35\u2009mg of protein/ml in assay medium containing Rotenone (5\u2009 μ m) and succinate (4\u2009mm).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('CHEBI_28201', 'rotenone', 82, 'rotenone')]
PMC3321454	3/2012	S108-PMC3321454	['number a9728) protein was determined in Mitochondrial preparations by western blotting using previously described methods [28].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 40, 'mitochondrial')]
PMC3321454	3/2012	S116-PMC3321454	['Mitochondria are the primary source of Reactive Oxygen Species, so functional studies of Mitochondria isolated from Kidneys of control and protein-restricted offspring, were performed.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('CHEBI_26523', 'reactive oxygen species', 39, 'reactive oxygen species'), ('GO_0005739', 'mitochondrion', 89, 'mitochondria'), ('UBERON_0002113', 'kidney', 116, 'kidneys')]
PMC3321454	3/2012	S117-PMC3321454	['as shown infigure 1, Mitochondrial Respiration in Kidneys from Adult Rats was reduced by maternal protein restriction.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 35, 'respiration'), ('UBERON_0002113', 'kidney', 50, 'kidneys'), ('UBERON_0007023', 'adult organism', 63, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rats')]
PMC3321454	3/2012	S119-PMC3321454	['the maximal Respiratory rate for the Renal Mitochondria was reduced by 17% in the lp group.']	N/A	N/A	[('GO_0045333', 'cellular respiration', 12, 'respiratory'), ('UBERON_0002113', 'kidney', 37, 'renal'), ('GO_0005739', 'mitochondrion', 43, 'mitochondria')]
PMC3321454	3/2012	S154-PMC3321454	['Mitochondrial copy number and the Expression of the Mitochondrial Genes decline with Ageing [31].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial'), ('GO_0010467', 'gene expression', 34, 'expression'), ('GO_0005739', 'mitochondrion', 52, 'mitochondrial'), ('SO_0002129', 'mt_tRNA', 52, 'mitochondrial genes'), ('GO_0007568', 'aging', 85, 'ageing')]
PMC3321454	3/2012	S178-PMC3321454	['Mitochondrial Metabolism also determines the wider availability of S-Adenosyl Methionine for Dna Methylation [41].']	N/A	N/A	[('GO_0000900', 'translation repressor activity, mRNA regulatory element binding', 0, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0008152', 'metabolic process', 14, 'metabolism'), ('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 67, 'S-adenosyl methionine'), ('GO_0006306', 'DNA methylation', 93, 'DNA methylation')]
PMC3322122	4/2012	S62-PMC3322122	['of Genes involvedgenes involved in pathway94 dpc vs. 1 dpnapran signalingup8.64*e-33cse1l, Ipo5, Kpna1Apigf1 signalingup3.97*e-26csnk2a1, Map2K1, Prkar2A, Raf1, Sos1, ywhagaporganisation of filamentsdown1.26*e-213b4galt7, bgn, cnp, Col1A2, Col2A1, Col5A1, Evl, Fgf2, Fnbp1, lox, Mtss1, Tgfb1, tnxbhppurine Metabolismup3.19*e-421adcy3, Atp13A2, Atp6V0B, bckdha, bckdhb, Entpd4, gmpr, itpa, Mad2L2, Nme1, Nme2, Nme3, Nudt2, Pold4, Polr1C, Polr2G, Polr2I, Polr2L, Psmc1, Rrm2B, ruvbl1hppyrimidine Metabolismup1.19*e-516entpd4, itpa, Mad2L2, Nme1, Nme2, Nme3, Nudt2, Pold4, Polr1C, Polr2G, Polr2I, Polr2L, Rpusd1, Rpusd2, Rpusd4, rrm2bhpoxidative phosphorylationup1.24*e-210atp6ap1, Atp6V0B, atp6v0e2, Cox6B1, Ndufa8, Ndufb7, Ndufb9, Ndufs3, Rpusd1, Tnni2Hpsynthesis and Degradation Of Ketone Bodiesup4.43*e-33acaa1, Acat2, bdh1hpglucocorticoid receptor signalingdown1.27*e-424ccl2, Fos, Gtf2E2, gtf2h3, Jun, Ncoa1, Ncoa2, Ncoa3, Ncor1, Pik3C3, Pik3R3, Polr2D, Ppp3Cb, Prkacb, Rras2, Serpine1, Shc1, Smad3, Stat1, Sumo1, tbp, Tgfb2, Tgfbr2, traf6hpcyclin and Cell Cycle Regulationdown8.09*e-512atr, Ccna2, Cdkn1B, E2F2, Hdac3, Hdac6, Ppp2Cb, Ppp2R1A, Ppp2R1B, Ppp2R5E, Rb1, Tgfb2Hpg1/s Checkpoint Regulationdown1.86*e-38atr, Cdkn1B, E2F2, Hdac3, Hdac6, Rb1, Smad3, tgfb2hpgrowth Hormone Signalingdown1,71*e-39fos, ghr, Igf1, Igfbp3, Pik3C3, Pik3R3, Rps6Ka3, Rps6Ka5, Stat1Hpmitotic roles of Polo-Like Kinasedown3.51*e-26cdc27, Plk4, Ppp2Cb, Ppp2R1A, Ppp2R1B, Ppp2R5Ehpigf1 signalingdown8.90*e-513fos, Igf1, Igfbp3, Igfbp5, Jun, Pik3C3, Pik3R3, Prkacb, Ptpn11, Rras2, Shc1, Ywhab, Ywhae1 dpn vs. 28 dpnappurine Metabolismup7.50*e-321Acin1, Atp11B, Atp13A2, Atp5G2, atp6v0b, Chrac1, Cilp, Ddx19B, dguok, Nme3, Pde2A, Pde5A, Polg, Polr2D, Polr2E, Polr2F, Polr2J, Polr3K, Prpsap2, Psmc5, Rfc3Appyrimidine Metabolismup5.95*e-313Chrac1, Ctps2, Nme3, Polg, Polr2D, Polr2E, Polr2F, Polr2J, Polr3K, Rfc3, Rpusd1, Rpusd4, uck1aporganisation of filamentsup5.74*e-312Akap2, Col1A1, Col1A2, Col5A2, Cryaa, Dbn1, Dcn, Fn1, Fnbp1, Pdlim3D, Serpinh1, Tgfb1Apfatty acid elongation in Mitochondriadown4.39*e-45acaa2, auh, hadh, Hsd17B4, pecrapran signalingdown2.49*e-23ipo5, Ran, xpo1apoxidative phosphorylationdown1.54*e-925Atp5B, Atp5C1, Atp5F1, Atp5J, atp6v1a, Atp6V1B2, Atp6V1C1, atp6v1h, Cox15, Cox17, Cox6C, Cox7C, Ndufa1, Ndufa9, Ndufab1, Ndufb1, Ndufb3, Ndufb5,Ndufc1, Ndufs2, Ndufv2, Ppa2, Sdha, Uqcr11, Uqcrbhpg2/m Dna Damage Checkpoint Regulationup2.63*e-48atr, Ccnb1, Ccnb2, Ptpmt1, Rprm, Wee1, ywhae, ywhaghpmitotic roles of Polo-Like Kinaseup4.95*e-49Anapc1, Anapc5, Ccnb1, Ccnb2, Plk4, Ppp2R3A, Pttg1, Stag2, wee1hpoxidative phosphorylationup2.23*e-314atp5a1, Atp5O, atp6v1a, atp6v1e1, Cox7B, Fam63B, Ip6K2, Ndufb6, Ndufs1, Ndufs4, ndufv2, Ppa1, Ppa2, Uhrf1Bp1Hpran signalingup2.88*e-34cse1l, Ipo5, Tnpo1, xpo1hporganisation of filamentsdown1.46*e-316Arhgef2, bgn, Col1A1, Col1A2, Col2A1, Col5A1, Dbn1, Dcn, Evl, Fat1, fes, lox, Mark4, Numa1, Ppp1R9Ad, Sirpa28 dpn vs. 188 dpnapampk signalingup1.10*e-211Pik3R1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Prkaa1, Prkaa2, Prkab2, Prkacb, smarca2apmitotic roles of Polo-Like Kinaseup1.56*e-38Anapc11, Hsp90Aa1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Stag2Apmtor Signalingup9.70*e-414eif3a, Eif4B, Napepld, Pik3R1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Prkaa1, Prkaa2, Prkab2, rhoq, rictorapcyclin and cell Cycle Regulationup6.40*e-410atr, Gsk3B, Hdac2, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Raf1, tgfb2hppurine Metabolismup8.46*e-320Ampd3, Atf7Ip, Atp6V0E1, Atp6V1G2, Ddx19B, Eif2Ak4, Mad2L2, Mpp1, Nme6, Nt5C3, Polg, Polr1A, Polr2C, Polr2F, Ppat, Psmc1, Psmc3, Psmc5, Rfc3, vcphppyrimidine Metabolismup2.36*e-211Cmpk1, Eif2Ak4, Mad2L2, Nme6, Nt5C3, Nxn, Polg, Polr1A, Polr2C, Polr2F, rfc3hpglucocorticoid Receptor Signalingup2.13*e-216a2m, agt, Cxcl3, Ep300, Hsp90Aa1, Map3K14, Ncoa2, Ncor2, Nr3C1, Pik3C3, Polr2C, Polr2F, Smad3, Stat5B, tat, tsc22d3hpoxidative phosphorylationdown1.35*e-314cox15, Cox6A1, Cox7C, Ip6K2, Ndufa2, Ndufb3, Ndufb5, Ndufb6, Ndufb10, Ndufs3, Ndufs4, Ndufs6, Ppa2, uqcrbhpmitotic roles of Polo-Like Kinasedown2.30*e-26Ccnb2, Cdk1, Plk4, Prc1, Pttg1, Wee1Hpg2/m Dna Damage Checkpoint Regulationdown2.25*e-25Ccnb2, Cdk1, Cks1B, Wee1, ywhaz\nup and down indicate higher and lower abundance in later compared to earlier stages, respectively.']	N/A	N/A	[('SO_0000704', 'gene', 3, 'genes'), ('PR_000009089', 'importin-7', 91, 'IPO5'), ('PR_000009502', 'keratin, type II cuticular Hb6', 97, 'KPNA1APIGF1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 138, 'MAP2K1'), ('PR_000013283', 'U4/U6 small nuclear ribonucleoprotein Prp4', 146, 'PRKAR2A'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 155, 'RAF1'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 161, 'SOS1'), ('PR_000003266', 'collagen type II alpha chain', 232, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 240, 'COL2A1'), ('PR_000003266', 'collagen type II alpha chain', 248, 'COL5A1'), ('PR_000007120', 'ephrin type-A receptor 1', 256, 'EVL'), ('PR_000007483', 'fibroblast growth factor 13', 261, 'FGF2'), ('PR_000007583', 'ketosamine-3-kinase', 267, 'FNBP1'), ('PR_000010755', 'metaxin-1', 279, 'MTSS1'), ('PR_000000046', 'TGF-beta', 286, 'TGFB1'), ('GO_0008152', 'metabolic process', 306, 'metabolismup3'), ('PR_000004479', 'V-type proton ATPase subunit e 2', 335, 'ATP13A2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 344, 'ATP6V0B'), ('PR_000007070', 'homeobox protein engrailed-1', 369, 'ENTPD4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 389, 'MAD2L2'), ('PR_000011040', 'nuclear receptor coactivator 1', 397, 'NME1'), ('PR_000011040', 'nuclear receptor coactivator 1', 403, 'NME2'), ('PR_000011040', 'nuclear receptor coactivator 1', 409, 'NME3'), ('PR_000011469', 'high affinity nerve growth factor receptor', 415, 'NUDT2'), ('PR_000012939', 'RNA-binding protein PNO1', 422, 'POLD4'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 429, 'POLR1C'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 437, 'POLR2G'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 445, 'POLR2I'), ('PR_000012980', 'DNA polymerase nu', 453, 'POLR2L'), ('PR_000013379', '26S proteasome regulatory subunit 7', 461, 'PSMC1'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 468, 'RRM2B'), ('GO_0008152', 'metabolic process', 494, 'metabolismup1'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 530, 'MAD2L2'), ('PR_000011040', 'nuclear receptor coactivator 1', 538, 'NME1'), ('PR_000011040', 'nuclear receptor coactivator 1', 544, 'NME2'), ('PR_000011040', 'nuclear receptor coactivator 1', 550, 'NME3'), ('PR_000011469', 'high affinity nerve growth factor receptor', 556, 'NUDT2'), ('PR_000012939', 'RNA-binding protein PNO1', 563, 'POLD4'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 570, 'POLR1C'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 578, 'POLR2G'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 586, 'POLR2I'), ('PR_000012980', 'DNA polymerase nu', 594, 'POLR2L'), ('PR_000014339', 'radial spoke head 14 homolog', 602, 'RPUSD1'), ('PR_000014173', 'replication protein A 30 kDa subunit', 610, 'RPUSD2'), ('PR_000014173', 'replication protein A 30 kDa subunit', 618, 'RPUSD4'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 679, 'ATP6V0B'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 698, 'COX6B1'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 706, 'NDUFA8'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 714, 'NDUFB7'), ('PR_000011050', 'kinetochore protein NDC80', 722, 'NDUFB9'), ('PR_000011050', 'kinetochore protein NDC80', 730, 'NDUFS3'), ('PR_000014339', 'radial spoke head 14 homolog', 738, 'RPUSD1'), ('PR_000016473', 'tumor necrosis factor alpha-induced protein 2', 746, 'TNNI2HPSynthesis'), ('GO_0009600', 'detection of nematode', 767, 'degradation of ketone'), ('CHEBI_17087', 'ketone', 782, 'ketone'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 789, 'bodiesup4'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 813, 'ACAT2'), ('PR_000007593', 'glutamate carboxypeptidase 2', 879, 'FOS'), ('PR_000008322', 'general transcription factor II-I', 884, 'GTF2E2'), ('PR_000009211', 'lysine-specific demethylase 3A', 900, 'JUN'), ('PR_000011209', 'nidogen-2', 905, 'NCOA1'), ('PR_000011209', 'nidogen-2', 912, 'NCOA2'), ('PR_000011209', 'nidogen-2', 919, 'NCOA3'), ('PR_000011209', 'nidogen-2', 926, 'NCOR1'), ('PR_000012777', 'fibrocystin', 933, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 941, 'PIK3R3'), ('PR_000012980', 'DNA polymerase nu', 949, 'POLR2D'), ('PR_000013133', 'neurabin-2', 957, 'PPP3CB'), ('PR_000013502', 'parvalbumin alpha', 965, 'PRKACB'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 973, 'RRAS2'), ('PR_000014693', 'serpin B13', 980, 'SERPINE1'), ('PR_000000364', 'smad2', 990, 'SHC1'), ('PR_000000364', 'smad2', 996, 'SMAD3'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 1003, 'STAT1'), ('PR_000015829', 'small ubiquitin-related modifier 1', 1010, 'SUMO1'), ('PR_000000046', 'TGF-beta', 1022, 'TGFB2'), ('PR_000000183', 'TGF-beta 2', 1029, 'TGFBR2'), ('GO_0048469', 'cell maturation', 1055, 'cell cycle regulationdown8'), ('PR_000001202', 'C-C chemokine receptor type 6', 1095, 'CCNA2'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 1102, 'CDKN1B'), ('PR_000006853', 'transcription factor E2F2', 1110, 'E2F2'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1116, 'HDAC3'), ('PR_000008488', 'histone deacetylase 9', 1123, 'HDAC6'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1130, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 1138, 'PPP2R1A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1147, 'PPP2R1B'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1156, 'PPP2R5E'), ('PR_000013830', 'calcipressin-2', 1165, 'RB1'), ('PR_000000183', 'TGF-beta 2', 1170, 'TGFB2HPG1'), ('GO_0010031', 'circumnutation', 1182, 'checkpoint regulationdown1'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 1221, 'CDKN1B'), ('PR_000006853', 'transcription factor E2F2', 1229, 'E2F2'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1235, 'HDAC3'), ('PR_000008488', 'histone deacetylase 9', 1242, 'HDAC6'), ('PR_000013830', 'calcipressin-2', 1249, 'RB1'), ('PR_000000364', 'smad2', 1254, 'SMAD3'), ('GO_0035852', 'horizontal cell localization', 1275, 'hormone signalingdown1'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 1315, 'IGF1'), ('PR_000008940', 'intraflagellar transport protein 88', 1321, 'IGFBP3'), ('PR_000012777', 'fibrocystin', 1329, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 1337, 'PIK3R3'), ('PR_000014290', '40S ribosomal protein S7', 1345, 'RPS6KA3'), ('PR_000014298', 'Ras-related GTP-binding protein B', 1354, 'RPS6KA5'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 1363, 'STAT1HPMitotic'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1387, 'Polo-like kinasedown3'), ('PR_000012888', 'phospholipid transfer protein', 1423, 'PLK4'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1429, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 1437, 'PPP2R1A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1446, 'PPP2R1B'), ('PR_000013444', 'very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3', 1455, 'PPP2R5EHPIGF1'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 1497, 'IGF1'), ('PR_000008940', 'intraflagellar transport protein 88', 1503, 'IGFBP3'), ('PR_000008940', 'intraflagellar transport protein 88', 1511, 'IGFBP5'), ('PR_000009211', 'lysine-specific demethylase 3A', 1519, 'JUN'), ('PR_000012777', 'fibrocystin', 1524, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 1532, 'PIK3R3'), ('PR_000013502', 'parvalbumin alpha', 1540, 'PRKACB'), ('PR_000013451', 'tyrosine-protein phosphatase non-receptor type 13', 1548, 'PTPN11'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1556, 'RRAS2'), ('PR_000000364', 'smad2', 1563, 'SHC1'), ('PR_000017539', 'synaptobrevin homolog YKT6', 1569, 'YWHAB'), ('PR_000017551', '14-3-3 protein eta', 1576, 'YWHAE1'), ('GO_0051238', 'sequestering of metal ion', 1606, 'metabolismup7'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1625, '321ACIN1'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 1635, 'ATP11B'), ('PR_000004479', 'V-type proton ATPase subunit e 2', 1643, 'ATP13A2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 1652, 'ATP5G2'), ('PR_000005438', 'charged multivesicular body protein 4c', 1669, 'CHRAC1'), ('PR_000005433', 'charged multivesicular body protein 1b', 1677, 'CILP'), ('PR_000029393', 'probable ATP-dependent RNA helicase DDX56', 1683, 'DDX19B'), ('PR_000011040', 'nuclear receptor coactivator 1', 1698, 'NME3'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 1704, 'PDE2A'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 1711, 'PDE5A'), ('PR_000012978', 'DNA polymerase lambda', 1718, 'POLG'), ('PR_000012980', 'DNA polymerase nu', 1724, 'POLR2D'), ('PR_000012980', 'DNA polymerase nu', 1732, 'POLR2E'), ('PR_000012980', 'DNA polymerase nu', 1740, 'POLR2F'), ('PR_000012980', 'DNA polymerase nu', 1748, 'POLR2J'), ('PR_000012980', 'DNA polymerase nu', 1756, 'POLR3K'), ('PR_000013271', 'protor-1', 1764, 'PRPSAP2'), ('PR_000013379', '26S proteasome regulatory subunit 7', 1773, 'PSMC5'), ('PR_000001245', 'rhodopsin', 1780, 'RFC3APPyrimidine'), ('GO_0015976', 'carbon utilization', 1797, 'metabolismup5'), ('PR_000011029', 'neurochondrin', 1816, '313CHRAC1'), ('PR_000006020', 'chymotrypsin-C', 1827, 'CTPS2'), ('PR_000011040', 'nuclear receptor coactivator 1', 1834, 'NME3'), ('PR_000012978', 'DNA polymerase lambda', 1840, 'POLG'), ('PR_000012980', 'DNA polymerase nu', 1846, 'POLR2D'), ('PR_000012980', 'DNA polymerase nu', 1854, 'POLR2E'), ('PR_000012980', 'DNA polymerase nu', 1862, 'POLR2F'), ('PR_000012980', 'DNA polymerase nu', 1870, 'POLR2J'), ('PR_000012980', 'DNA polymerase nu', 1878, 'POLR3K'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 1886, 'RFC3'), ('PR_000014339', 'radial spoke head 14 homolog', 1892, 'RPUSD1'), ('PR_000014173', 'replication protein A 30 kDa subunit', 1900, 'RPUSD4'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 1948, '312AKAP2'), ('PR_000003266', 'collagen type II alpha chain', 1958, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 1966, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 1974, 'COL5A2'), ('PR_000005866', 'cAMP-responsive element modulator', 1982, 'CRYAA'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 1989, 'DBN1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 1995, 'DCN'), ('PR_000007581', 'fibronectin', 2000, 'FN1'), ('PR_000007583', 'ketosamine-3-kinase', 2005, 'FNBP1'), ('PR_000012579', '6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2', 2012, 'PDLIM3D'), ('PR_000014690', 'serpin B10', 2021, 'SERPINH1'), ('PR_000021911', 'activin/inhibin beta A chain isoform 1, signal peptide removed form', 2031, 'TGFB1APFatty'), ('GO_0005739', 'mitochondrion', 2063, 'mitochondriadown4'), ('PR_000008760', 'heparan sulfate glucosamine 3-O-sulfotransferase 3A1', 2106, 'HSD17B4'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 2153, 'RAN'), ('PR_000017506', 'DNA repair protein XRCC3', 2200, '925ATP5B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2210, 'ATP5C1'), ('PR_000004489', 'V-type proton ATPase subunit G 1', 2218, 'ATP5F1'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2226, 'ATP5J'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2242, 'ATP6V1B2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2252, 'ATP6V1C1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2271, 'COX15'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 2278, 'COX17'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2285, 'COX6C'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2292, 'COX7C'), ('PR_000011159', 'nexilin', 2299, 'NDUFA1'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 2307, 'NDUFA9'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 2315, 'NDUFAB1'), ('PR_000011050', 'kinetochore protein NDC80', 2324, 'NDUFB1'), ('PR_000011050', 'kinetochore protein NDC80', 2332, 'NDUFB3'), ('PR_000011050', 'kinetochore protein NDC80', 2340, 'NDUFB5'), ('PR_000011050', 'kinetochore protein NDC80', 2347, 'NDUFC1'), ('PR_000011050', 'kinetochore protein NDC80', 2355, 'NDUFS2'), ('PR_000011050', 'kinetochore protein NDC80', 2363, 'NDUFV2'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2371, 'PPA2'), ('PR_000014460', 'serine--tRNA ligase, mitochondrial', 2377, 'SDHA'), ('PR_000017120', 'ubiquinol-cytochrome-c reductase complex assembly factor 1', 2383, 'UQCR11'), ('PR_000017112', 'uroplakin-1a', 2391, 'UQCRBHPG2'), ('GO_0000729', 'DNA double-strand break processing', 2403, 'DNA damage checkpoint regulationup2'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2451, 'CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2458, 'CCNB2'), ('PR_000013441', 'protein tyrosine phosphatase type IVA 2', 2465, 'PTPMT1'), ('PR_000014190', '60S ribosomal protein L11', 2473, 'RPRM'), ('PR_000017405', 'WAP four-disulfide core domain protein 1', 2479, 'WEE1'), ('PR_000012733', 'serine/threonine-protein kinase Pim-2', 2516, 'Polo-like kinaseup4'), ('PR_000012509', 'PDZ and LIM domain protein 2', 2541, '49ANAPC1'), ('PR_000004051', 'ankyrin repeat and SAM domain-containing protein 1A', 2551, 'ANAPC5'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2559, 'CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2566, 'CCNB2'), ('PR_000012888', 'phospholipid transfer protein', 2573, 'PLK4'), ('PR_000013133', 'neurabin-2', 2579, 'PPP2R3A'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 2588, 'PTTG1'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 2595, 'STAG2'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 2653, 'ATP5O'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2679, 'COX7B'), ('PR_000029469', 'spermatogenesis-associated protein 31D1', 2686, 'FAM63B'), ('PR_000009089', 'importin-7', 2694, 'IP6K2'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 2701, 'NDUFB6'), ('PR_000011159', 'nexilin', 2709, 'NDUFS1'), ('PR_000011159', 'nexilin', 2717, 'NDUFS4'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2733, 'PPA1'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2739, 'PPA2'), ('PR_000017022', 'UBX domain-containing protein 6', 2745, 'UHRF1BP1HPRAN'), ('PR_000009089', 'importin-7', 2786, 'IPO5'), ('PR_000016501', 'tenascin-N', 2792, 'TNPO1'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 2841, '316ARHGEF2'), ('PR_000003266', 'collagen type II alpha chain', 2858, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 2866, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 2874, 'COL2A1'), ('PR_000003266', 'collagen type II alpha chain', 2882, 'COL5A1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 2890, 'DBN1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 2896, 'DCN'), ('PR_000007120', 'ephrin type-A receptor 1', 2901, 'EVL'), ('PR_000007319', 'fatty acid desaturase 3', 2906, 'FAT1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 2922, 'MARK4'), ('PR_000011490', '8-oxo-dGDP phosphatase NUDT18', 2929, 'NUMA1'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2936, 'PPP1R9AD'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 2946, 'SIRPA28'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 2994, '211PIK3R1'), ('PR_000013090', 'protein phosphatase 1A', 3005, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3013, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3021, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3030, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3039, 'PPP2R5E'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3048, 'PRKAA1'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3056, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 3064, 'PRKAB2'), ('PR_000013502', 'parvalbumin alpha', 3072, 'PRKACB'), ('PR_000012733', 'serine/threonine-protein kinase Pim-2', 3106, 'Polo-like kinaseup1'), ('PR_000010980', 'Nck-associated protein 5', 3131, '38ANAPC11'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 3142, 'HSP90AA1'), ('PR_000013090', 'protein phosphatase 1A', 3152, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3160, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3168, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3177, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3186, 'PPP2R5E'), ('PR_000015418', 'transcription factor SOX-10', 3195, 'STAG2APmTOR signalingup9'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 3235, 'EIF4B'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 3242, 'NAPEPLD'), ('PR_000012722', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform', 3251, 'PIK3R1'), ('PR_000013090', 'protein phosphatase 1A', 3259, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3267, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3275, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3284, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3293, 'PPP2R5E'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3302, 'PRKAA1'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3310, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 3318, 'PRKAB2'), ('GO_0008306', 'associative learning', 3356, 'cycle regulationup6'), ('PR_000008300', 'glutathione S-transferase mu 1', 3389, 'GSK3B'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 3396, 'HDAC2'), ('PR_000013090', 'protein phosphatase 1A', 3403, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3411, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3419, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3428, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3437, 'PPP2R5E'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 3446, 'RAF1'), ('GO_0008150', 'biological_process', 3466, 'metabolismup8'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 3485, '320AMPD3'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 3495, 'ATF7IP'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 3503, 'ATP6V0E1'), ('PR_000004489', 'V-type proton ATPase subunit G 1', 3513, 'ATP6V1G2'), ('PR_000029393', 'probable ATP-dependent RNA helicase DDX56', 3523, 'DDX19B'), ('PR_000006971', 'eukaryotic translation initiation factor 2 subunit 1', 3531, 'EIF2AK4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 3540, 'MAD2L2'), ('PR_000010550', '3-mercaptopyruvate sulfurtransferase', 3548, 'MPP1'), ('PR_000011286', 'nucleoside diphosphate kinase 6', 3554, 'NME6'), ('PR_000011459', 'neurotrophin-3', 3560, 'NT5C3'), ('PR_000012978', 'DNA polymerase lambda', 3567, 'POLG'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 3573, 'POLR1A'), ('PR_000012980', 'DNA polymerase nu', 3581, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3589, 'POLR2F'), ('PR_000013058', 'peroxisome proliferator-activated receptor gamma', 3597, 'PPAT'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3603, 'PSMC1'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3610, 'PSMC3'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3617, 'PSMC5'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 3624, 'RFC3'), ('GO_0008150', 'biological_process', 3646, 'metabolismup2'), ('PR_000007365', 'fructose-1,6-bisphosphatase 1', 3665, '211CMPK1'), ('PR_000006971', 'eukaryotic translation initiation factor 2 subunit 1', 3675, 'EIF2AK4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 3684, 'MAD2L2'), ('PR_000011286', 'nucleoside diphosphate kinase 6', 3692, 'NME6'), ('PR_000011459', 'neurotrophin-3', 3698, 'NT5C3'), ('PR_000011528', 'nucleoporin NUP42', 3705, 'NXN'), ('PR_000012978', 'DNA polymerase lambda', 3710, 'POLG'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 3716, 'POLR1A'), ('PR_000012980', 'DNA polymerase nu', 3724, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3732, 'POLR2F'), ('PR_000014378', 'ryanodine receptor 2', 3761, 'receptor signalingup2'), ('PR_000006069', 'C-X-C motif chemokine 2', 3801, 'CXCL3'), ('PR_000007140', 'epsin-3', 3808, 'EP300'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 3815, 'HSP90AA1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 3825, 'MAP3K14'), ('PR_000011209', 'nidogen-2', 3834, 'NCOA2'), ('PR_000001622', 'neuropeptide Y receptor type 1', 3841, 'NCOR2'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 3848, 'NR3C1'), ('PR_000012777', 'fibrocystin', 3855, 'PIK3C3'), ('PR_000012980', 'DNA polymerase nu', 3863, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3871, 'POLR2F'), ('PR_000000364', 'smad2', 3879, 'SMAD3'), ('PR_000015790', 'syntaxin-18', 3886, 'STAT5B'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 3954, 'COX6A1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 3962, 'COX7C'), ('PR_000009089', 'importin-7', 3969, 'IP6K2'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 3976, 'NDUFA2'), ('PR_000011050', 'kinetochore protein NDC80', 3984, 'NDUFB3'), ('PR_000011050', 'kinetochore protein NDC80', 3992, 'NDUFB5'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 4000, 'NDUFB6'), ('PR_000011050', 'kinetochore protein NDC80', 4008, 'NDUFB10'), ('PR_000011050', 'kinetochore protein NDC80', 4017, 'NDUFS3'), ('PR_000011159', 'nexilin', 4025, 'NDUFS4'), ('PR_000011050', 'kinetochore protein NDC80', 4033, 'NDUFS6'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 4041, 'PPA2'), ('PR_000013431', 'tuberoinfundibular peptide of 39 residues', 4071, 'Polo-like kinasedown2'), ('PR_000010300', 'mediator of RNA polymerase II transcription subunit 28', 4098, '26CCNB2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 4107, 'CDK1'), ('PR_000012888', 'phospholipid transfer protein', 4113, 'PLK4'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 4119, 'PRC1'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 4125, 'PTTG1'), ('PR_000017400', 'WD repeat-containing protein 82', 4132, 'WEE1HPG2'), ('GO_0000729', 'DNA double-strand break processing', 4143, 'DNA damage checkpoint regulationdown2'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 4186, '25CCNB2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 4195, 'CDK1'), ('PR_000005593', 'ceroid-lipofuscinosis neuronal protein 6', 4201, 'CKS1B'), ('PR_000017405', 'WAP four-disulfide core domain protein 1', 4208, 'WEE1')]
PMC3322122	4/2012	S66-PMC3322122	['Genes participating in the organisation of Filaments as well as in Purine and pyrimidine Metabolism were more highly Expressed, while Genes associated with Fatty Acid Elongation in Mitochondria, Ran Signaling, and Oxidative Phosphorylation were decreased during that period in ap offspring.']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genes'), ('GO_0005883', 'neurofilament', 43, 'filaments'), ('CHEBI_36540', 'ent-kaurane', 67, 'purine'), ('GO_0006144', 'purine nucleobase metabolic process', 67, 'purine ... metabolism'), ('GO_0010467', 'gene expression', 117, 'expressed'), ('SO_0000704', 'gene', 134, 'genes'), ('CHEBI_35366', 'fatty acid', 156, 'fatty acid'), ('GO_0030497', 'fatty acid elongation', 156, 'fatty acid elongation'), ('GO_0005739', 'mitochondrion', 181, 'mitochondria'), ('GO_0070583', 'spore membrane bending pathway', 195, 'RAN signaling'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 195, 'RAN'), ('GO_0006119', 'oxidative phosphorylation', 214, 'oxidative phosphorylation')]
PMC3322122	4/2012	S114-PMC3322122	['in rodents and Pigs Mitochondria are sensitive, at the transcriptional level, to Prenatal dietary modifications[9],[39],[40]and the maternal Metabolic status[41].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 15, 'pigs'), ('GO_0005739', 'mitochondrion', 20, 'mitochondria'), ('GO_0007565', 'female pregnancy', 81, 'prenatal'), ('GO_0008152', 'metabolic process', 141, 'metabolic')]
PMC3342123	3/2012	S9-PMC3342123	['Fatty Acid Metabolism, Biosynthesis Of Steroids, Synthesis and degradation of Ketone bodies, Fa Elongation in Mitochondria, Bile Acid Synthesis) and Cell Cycle Regulation (e.g.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 0, 'Fatty acid metabolism'), ('GO_0001783', 'B cell apoptotic process', 23, 'Biosynthesis of steroids'), ('CHEBI_35341', 'steroid', 39, 'steroids'), ('GO_0009057', 'macromolecule catabolic process', 49, 'Synthesis'), ('CHEBI_17087', 'ketone', 78, 'ketone'), ('GO_0001947', 'heart looping', 78, 'ketone'), ('CHEBI_30751', 'formic acid', 93, 'FA'), ('GO_0051236', 'establishment of RNA localization', 96, 'elongation'), ('GO_0005739', 'mitochondrion', 110, 'mitochondria'), ('CHEBI_3098', 'bile acid', 124, 'Bile acid'), ('GO_0009851', 'auxin biosynthetic process', 129, 'acid synthesis'), ('GO_0051726', 'regulation of cell cycle', 149, 'cell cycle regulation')]
PMC3342123	3/2012	S94-PMC3342123	["in lp offspring, Genes involved in 'Mtor Signaling', 'Fatty Acid Elongation In Mitochondria' as well as the 'degradation of valine, leucine and isoleucine' were up regulated."]	N/A	N/A	[('SO_0000704', 'gene', 17, 'genes'), ('GO_0038109', 'Kit signaling pathway', 36, 'mTOR signaling'), ('CHEBI_35366', 'fatty acid', 54, 'fatty acid'), ('GO_0016063', 'rhodopsin biosynthetic process', 54, 'fatty acid elongation in mitochondria'), ('GO_0005739', 'mitochondrion', 79, 'mitochondria')]
PMC3342123	3/2012	S167-PMC3342123	['in particular, the cellular energy sensor ampk is essential for a proper Mitochondrial activity and Metabolic health citetowler2007.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 73, 'mitochondrial'), ('GO_0008152', 'metabolic process', 100, 'metabolic')]
PMC3350070	1/2011	S57-PMC3350070	['Mitochondrial Dna testing for Mitochondrial encephalomyopathy, Lactic Acidosis, and stroke-like episodes (melas) was normal.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('GO_0005739', 'mitochondrion', 30, 'mitochondrial'), ('CHEBI_35381', 'monosaccharide', 63, 'lactic acidosis')]
PMC3403156	7/2012	S54-PMC3403156	['Superoxide Anions are generated by Plasmalemmal- and Mitochondrial-associated nadph oxidases, xanthine oxidase, Mitochondrial Respiration and by products of several Metabolic pathways, such as, Fatty Acid Oxidation [55].']	N/A	N/A	[('CHEBI_26836', 'sulfuric acid', 0, 'Superoxide anions'), ('GO_0005886', 'plasma membrane', 35, 'plasmalemmal'), ('GO_0005739', 'mitochondrion', 53, 'mitochondrial'), ('GO_0005739', 'mitochondrion', 112, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 126, 'respiration'), ('GO_0008152', 'metabolic process', 165, 'metabolic'), ('CHEBI_35366', 'fatty acid', 194, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 194, 'fatty acid oxidation')]
PMC3403156	7/2012	S57-PMC3403156	['under normal oxygen conditions, the Electron Transport chain leaks O2−from Complexes i and iii, which are normally balanced by Mitochondrial sod (i.e., mnsod) [57].']	N/A	N/A	[('CHEBI_10545', 'electron', 36, 'electron'), ('GO_0043698', 'iridosome', 36, 'electron transport'), ('CHEBI_37952', 'succinyl group', 67, 'O2−'), ('GO_0032991', 'protein-containing complex', 75, 'Complexes'), ('GO_0005739', 'mitochondrion', 127, 'mitochondrial')]
PMC3403156	7/2012	S92-PMC3403156	['maternal administration of the Steroid, Dexamethasone, generates offspring that exhibit increased Ros Production (i.e., H2O2) in the Coronary Circulation [76] and in Mitochondria of Hearts of programmed Sheep [77].']	N/A	N/A	[('CHEBI_35341', 'steroid', 31, 'steroid'), ('CHEBI_41879', 'dexamethasone', 40, 'dexamethasone'), ('CHEBI_8756', 'RNA (poly(A))', 98, 'ROS'), ('GO_0071605', 'monocyte chemotactic protein-1 production', 98, 'ROS production'), ('CHEBI_16240', 'hydrogen peroxide', 120, 'H2O2'), ('UBERON_0009539', 'mesenchyme of submandibular gland primordium', 133, 'coronary circulation'), ('GO_0005739', 'mitochondrion', 166, 'mitochondria'), ('UBERON_0000948', 'heart', 182, 'hearts'), ('NCBITaxon_10088', 'Mus <genus>', 203, 'sheep')]
PMC3404662	4/2012	S180-PMC3404662	['Oxidative Stress and Mitochondrial dysfunction\nCellular Energy Production through the Degradation Of Atp by Mitochondria is necessary for muscle development and Brain function.']	N/A	N/A	[('GO_0045733', 'acetate catabolic process', 0, 'Oxidative Stress'), ('GO_0005739', 'mitochondrion', 21, 'Mitochondrial'), ('GO_0007049', 'cell cycle', 47, 'Cellular'), ('GO_0072565', 'endothelial microparticle formation', 56, 'energy production'), ('GO_0006190', 'inosine salvage', 86, 'degradation of ATP'), ('GO_0000085', 'mitotic G2 phase', 108, 'mitochondria'), ('GO_0005739', 'mitochondrion', 108, 'mitochondria'), ('UBERON_0000955', 'brain', 161, 'brain')]
PMC3404662	4/2012	S194-PMC3404662	['2005) and to cause Mitochondrial dysfunction and oxidative damage in the Mouse Ovary (gupta et al.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 19, 'mitochondrial'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'mouse'), ('UBERON_0000992', 'ovary', 79, 'ovary')]
PMC3404662	4/2012	S284-PMC3404662	['1998inhibition of Gabageneral function of oc, Pyrethroid Pesticidesoc, Pyrethroidinhibition of achegeneral function of op, cb Pesticidesops, cbsmitochondrial dysfunctionoxidative stressapoptosis Of Neuronal Cellsdichlorvos (Rat Brain)opsinhibition of Mitochondrial Respirationmethoxychlor (Mice Brain)ocskaur et al.']	N/A	N/A	[('CHEBI_51627', 'diazirines', 18, 'GABAGeneral'), ('CHEBI_39397', 'tetramethrin', 46, 'pyrethroid'), ('CHEBI_70785', 'CDP-3,6-dideoxy-alpha-D-glucose(2-)', 57, 'pesticidesOC'), ('CHEBI_58141', "P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-)", 71, 'pyrethroidInhibition'), ('CHEBI_63246', 'DY-732(2-)', 126, 'pesticidesOPs'), ('GO_0016345', 'female meiotic chromosome movement towards spindle pole', 195, 'of neuronal cellsDichlorvos'), ('CL_0000032', 'neuroplacodal cell', 198, 'neuronal cellsDichlorvos'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 224, 'rat'), ('UBERON_0000955', 'brain', 228, 'brain'), ('GO_0005739', 'mitochondrion', 251, 'mitochondrial'), ('GO_0097466', 'ubiquitin-dependent glycoprotein ERAD pathway', 265, 'respirationMethoxychlor'), ('NCBITaxon_10088', 'Mus <genus>', 290, 'mice'), ('UBERON_0000955', 'brain', 295, 'brain')]
PMC3407139	7/2012	S124-PMC3407139	['Mitochondria are present in the Cytoplasm of cells, and contain their own 16,569 Base-Pair circular genome[34].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('GO_0005737', 'cytoplasm', 32, 'cytoplasm'), ('SO_0000028', 'base_pair', 81, 'base-pair')]
PMC3423345	8/2012	S27-PMC3423345	['10-formyl-thf: 10-Formyl-Tetrahydrofolate; 5,10-Ch\u200a=\u200athf: 5,10-methenyltetrahydrofolate; 5,10-Ch2-thf: 5,10-Methylenetetrahydrofolate; 5-Ch3-thf: 5-Methyltetrahydrofolate; badh: betaine Aldehyde dehydrogenase; bhmt: betaine-Homocysteine s -methyltransferase; Cbs: cystathionine beta synthase; chdh: Choline dehydrogenase; cys: cysteine; cshmt: Cytoplasmic serine hydroxymethyltransferase; dd: Dimethylglycine dehydrogenase; Dhf: Dihydrofolate; dhfr: Dihydrofolatereductase; dmg: dimethylglycine; dump: 2′-Deoxyuridine 5′-monophosphate; ftd: 10-Formyl-Tetrahydrofolate dehydrogenase; fts: 10-Formyl-Tetrahydrofolate synthase; gdc: glycine decarboxylase; gly: glycine; Gnmt: glycine n -methyltransferase; Hcy: Homocysteine; mat, methionine adenosyltransferase; met: methionine; ms: methionine synthase; mshmt: Mitochondrial serine hydroxymethyltransferase; mtch: 5,10-Methylenetetrahydrofolate Cyclohydrolase; mthfd: 5,10-Methylenetetrahydrofolate dehydrogenase; mthfr: 5,10-Methylenetetrahydrofolate reductase; mts, s -adenosyl methionine-dependent methyltransferases; sah, s -Adenosyl Homocysteine; sahh: S -Adenosyl Homocysteine hydrolase; sam: S -Adenosyl Methionine; Sarc: Sarcosine; Sdh: sarcosine dehydrogenase; ser: serine; thf: Tetrahydrofolate; ts: thymidylate synthase.']	N/A	N/A	[('CHEBI_42485', 'formyl group', 18, 'formyl'), ('CHEBI_67016', 'tetrahydrofolate', 25, 'tetrahydrofolate'), ('CHEBI_17996', 'chloride', 48, 'CH'), ('CHEBI_17883', 'hydrogen chloride', 94, 'CH2'), ('CHEBI_20612', '5-methyltetrahydrofolate', 103, '5,10-methylenetetrahydrofolate'), ('CHEBI_65934', 'furowanin B', 135, '5-CH3'), ('CHEBI_20612', '5-methyltetrahydrofolate', 146, '5-methyltetrahydrofolate'), ('CHEBI_17478', 'aldehyde', 186, 'aldehyde'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 224, 'homocysteine'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 259, 'CBS'), ('CHEBI_15354', 'choline', 299, 'choline'), ('GO_0005737', 'cytoplasm', 344, 'cytoplasmic'), ('CHEBI_28212', 'deethylatrazine', 393, 'dimethylglycine'), ('CHEBI_42098', 'digoxigenin', 424, 'DHF'), ('CHEBI_36263', 'hydrogenmolybdate', 429, 'dihydrofolate'), ('CHEBI_33974', 'magnesium(1+)', 450, 'dihydrofolatereductase'), ('CHEBI_73956', '(S)-2-chloropropanoic acid', 502, '2′-deoxyuridine'), ('CHEBI_37983', 'sulfur-35 atom', 541, '10'), ('CHEBI_42485', 'formyl group', 544, 'formyl'), ('CHEBI_67016', 'tetrahydrofolate', 551, 'tetrahydrofolate'), ('CHEBI_19641', '2-hydroxyisobutyrate', 588, '10-formyl-tetrahydrofolate'), ('GO_0051318', 'G1 phase', 667, 'GNMT'), ('CHEBI_37958', 'dye', 703, 'Hcy'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 708, 'homocysteine'), ('GO_0005739', 'mitochondrion', 808, 'mitochondrial'), ('CHEBI_20612', '5-methyltetrahydrofolate', 861, '5,10-methylenetetrahydrofolate'), ('CHEBI_495055', 'beta-cyclodextrin', 892, 'cyclohydrolase'), ('CHEBI_52071', 'dextran', 915, '5,'), ('CHEBI_18123', 'N-methylnicotinate', 917, '10-methylenetetrahydrofolate'), ('CHEBI_18123', 'N-methylnicotinate', 970, '10-methylenetetrahydrofolate'), ('CHEBI_59650', 'amino fatty acid', 1075, '-adenosyl homocysteine'), ('CHEBI_17575', 'S-(5-deoxy-D-ribos-5-yl)-L-homocysteine', 1105, 'S -adenosyl homocysteine'), ('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 1146, 'S -adenosyl methionine'), ('PR_000014759', 'protein SCAF11', 1170, 'Sarc'), ('PR_000002097', 'sodium channel protein type 11 subunit alpha', 1176, 'sarcosine'), ('CHEBI_8984', 'sodium dodecyl sulfate', 1187, 'SDH'), ('CHEBI_67016', 'tetrahydrofolate', 1235, 'tetrahydrofolate')]
PMC3496584	7/2012	S23-PMC3496584	['crh, Corticotropin-Releasing Hormone; Ige, Immunoglobulin e; il, interleukin; Lps, Lipopolysaccharide; Mcp-1, Macrophage Chemo-Attractant Protein-1; mtdna, Mitochondrial Dna; nt, neurotensin; pcb, Polychlorinated Biphenyl; Ros, Reactive Oxygen Species; sp, Substance p; tnf, tumor Necrosis Factor .']	N/A	N/A	[('CHEBI_3918', 'crocetin', 5, 'corticotropin'), ('PR_000005968', 'cystatin-M', 5, 'corticotropin-releasing hormone'), ('CHEBI_33280', 'molecular messenger', 29, 'hormone'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 38, 'IgE'), ('GO_0019814', 'immunoglobulin complex', 43, 'immunoglobulin'), ('CHEBI_16412', 'lipopolysaccharide', 78, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 83, 'lipopolysaccharide'), ('PR_000010439', 'myeloid leukemia factor 1', 103, 'MCP-1'), ('CL_0000235', 'macrophage', 110, 'macrophage'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 110, 'macrophage chemo-attractant protein'), ('CHEBI_35255', 'chloroform', 121, 'chemo'), ('GO_0005739', 'mitochondrion', 156, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 156, 'mitochondrial DNA'), ('CHEBI_53156', 'polychlorobiphenyl', 197, 'polychlorinated biphenyl'), ('CHEBI_8756', 'RNA (poly(A))', 223, 'ROS'), ('CHEBI_26523', 'reactive oxygen species', 228, 'reactive oxygen species'), ('CHEBI_50992', '1,3-thiazolidine-2,4-dione', 257, 'substance'), ('PR_000011040', 'nuclear receptor coactivator 1', 281, 'necrosis factor')]
PMC3518064	11/2012	S50-PMC3518064	['in Bat, multilocular Adipose Cells usually contain many small Vacuoles of Lipid and large Mitochondria with closely packed parallel Cristae [39,40], where the uncoupling protein 1 (Ucp1) is highly Expressed and is regarded as a Bat-specific marker [41].']	N/A	N/A	[('UBERON_0001348', 'brown adipose tissue', 3, 'BAT'), ('CL_0000136', 'fat cell', 21, 'adipose cells'), ('UBERON_2000251', 'adipose fin', 21, 'adipose'), ('GO_0005773', 'vacuole', 62, 'vacuoles'), ('CHEBI_18059', 'lipid', 74, 'lipid'), ('GO_0005739', 'mitochondrion', 90, 'mitochondria'), ('UBERON_0004721', 'crista ampullaris', 132, 'cristae'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 181, 'UCP1'), ('GO_0010467', 'gene expression', 197, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 228, 'BAT')]
PMC3653849	5/2013	S10-PMC3653849	['most of the atp required to maintain the normal functions of the cell is produced through Oxidative Phosphorylation (oxphos) in Mitochondria.']	N/A	N/A	[('GO_0006119', 'oxidative phosphorylation', 90, 'oxidative phosphorylation'), ('GO_0005739', 'mitochondrion', 128, 'mitochondria')]
PMC3653849	5/2013	S17-PMC3653849	["in Mammals, 13 oxphos-related proteins are encoded by Mitochondria's own Genome (mtdna) and their Expression is under the Control of various hormones."]	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('GO_0005739', 'mitochondrion', 54, 'mitochondria'), ('SO_0001026', 'genome', 73, 'genome'), ('GO_0010467', 'gene expression', 98, 'expression'), ('GO_0065007', 'biological regulation', 122, 'control')]
PMC3653849	5/2013	S23-PMC3653849	['in addition, 5-Methylcytosine (5mc) and 5-Hydroxymethylcytosine (5hmc) are reported to present in Mammalian mtdna, and Dna Methyltransferase 1 (Dnmt1) is found to translocate to the Mitochondria to Regulate Cytosine Methylation and hydroxymethylation in Mammals[25].']	N/A	N/A	[('CHEBI_20791', '7-hydroxyoxindole-3-acetic acid', 13, '5-methylcytosine'), ('CHEBI_70971', '7-methylinosine', 40, '5-hydroxymethylcytosine'), ('NCBITaxon_40674', 'Mammalia', 98, 'mammalian'), ('PR_000006633', 'docking protein 6', 119, 'DNA methyltransferase 1'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 144, 'DNMT1'), ('GO_0005739', 'mitochondrion', 182, 'mitochondria'), ('GO_0065007', 'biological regulation', 198, 'regulate'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 207, 'cytosine methylation'), ('NCBITaxon_40674', 'Mammalia', 254, 'mammals')]
PMC3653849	5/2013	S37-PMC3653849	['mtdna, Mitochondrial Dna.10.1371/journal.pone.0063855.t002\n\ncaption (table-wrap): table 2\neffect of maternal lp diet on Hepatic atp, adp, Amp, nadh and nad in newborn Piglets.parametermalefemale2-way anova p-valuesplpsplpdsd × satp µmol/g, Liver 1.48±0.121.55±0.111.22±0.091.69±0.220.060.640.17adp µmol/g, Liver 1.18±0.161.42±0.211.12±0.181.32±0.140.250.690.93Amp µmol/g, Liver 4.91±0.59ab6.12±0.26a5.99±0.75a3.32±0.81b0.310.230.01ec0.36±0.01ab0.32±0.01b0.29±0.03b0.47±0.08a0.760.280.01nadh µmol/g, Liver 0.40±0.090.69±0.060.36±0.100.65±0.040.010.660.97nad µmol/g, Liver 3.45±0.263.73±0.243.87±0.263.38±0.180.660.900.14nadh/nad0.10±0.020.16±0.010.08±0.020.17±0.010.010.830.50\nvalues are mean ± sem, means without a common letter differ, p<0.05.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 7, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 7, 'mitochondrial DNA'), ('UBERON_0002107', 'liver', 120, 'hepatic'), ('CHEBI_16027', "adenosine 5'-monophosphate", 138, 'AMP'), ('NCBITaxon_33208', 'Metazoa', 167, 'piglets'), ('UBERON_0002107', 'liver', 240, 'liver'), ('UBERON_0002107', 'liver', 306, 'liver'), ('CHEBI_75599', 'EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor', 358, '93AMP'), ('UBERON_0002107', 'liver', 372, 'liver'), ('UBERON_0002107', 'liver', 499, 'liver'), ('UBERON_0002107', 'liver', 565, 'liver')]
PMC3653849	5/2013	S40-PMC3653849	['Mitochondrial Dna-encoded mrna Expression and Cytochrome C oxidase (cox) enzyme activity\nthe mrna abundances of 13 Genes involved in Hepatic oxphos were determined by real-time pcr, and a sexual dimorphic response of these Genes to maternal lp diet was observed in the Liver of newborn Piglets.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('GO_0010467', 'gene expression', 31, 'expression'), ('CHEBI_18070', 'cytochrome c', 46, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 46, 'cytochrome c'), ('SO_0000704', 'gene', 115, 'genes'), ('UBERON_0002107', 'liver', 133, 'hepatic'), ('SO_0000704', 'gene', 223, 'genes'), ('UBERON_0002107', 'liver', 269, 'liver'), ('NCBITaxon_33208', 'Metazoa', 286, 'piglets')]
PMC3653849	5/2013	S147-PMC3653849	['Primers specific for the control region of Mitochondrial Dna were used for the quantification of the mtdna Molecules, whereas Primers specific for the Glucose-6-phosphatase Nuclear Gene were used for standardization (table 4).']	N/A	N/A	[('SO_0000112', 'primer', 0, 'Primers'), ('GO_0005739', 'mitochondrion', 43, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 43, 'mitochondrial DNA'), ('CHEBI_36357', 'polyatomic entity', 107, 'molecules'), ('SO_0000112', 'primer', 126, 'primers'), ('CHEBI_17234', 'glucose', 151, 'glucose'), ('GO_0005634', 'nucleus', 173, 'nuclear'), ('SO_0000704', 'gene', 181, 'gene')]
PMC3653849	5/2013	S148-PMC3653849	["relative mtdna copy number was calculated with 2−δδctmethod[63].10.1371/journal.pone.0063855.t004\n\ncaption (table-wrap): table 4\nPrimers.namesequenceproduct (Bp)mrna Expression \u2003Cox1 F: tggtgcctgagcaggaatagtg88r: atcatcgccaagtagggttccg \u2003Cox2 F: gcttccaagacgccacttcac154r: tgggcatccattgtgctagtgt \u2003Cox3 F: ggctacagggtttcacgggttg130r: tcagtatcaggctgcggcttca \u2003nd3 f: agcacgcctcccattctcaat172r: tgctaggcttgctgctagtagg \u2003cytb F: ctgaggagctacggtcatcaca162r: gctgcgagggcggtaatgat \u2003nd1 F: tcctactggccgtagcattcct165r: ttgaggatgtggctggtcgtag \u2003nd2 F: atcggagggtgaggagggctaa191r: gttgtggttgctgagctgtgga \u2003nd4l f: gatcgcccttgcagggttactt182r: ctagtgcagcttcgcaggct \u2003nd4 f: tcgcctattcatcagtaagtca174r: ggattatggttcggctgtgta \u2003nd5 F: cggatgagaaggcgtaggaa103r: gcggttgtataggattgcttgt \u2003nd6 F: actgctatggctactgagatgt124r: cttcctcttccttcaacgcata \u2003Atp8 F: tgccacaactagatacatcc107r: gcttgctgggtatgagtag \u2003atp6 F: actcattcacacccaccacaca232r: cctgctgtaatgttggctgtca \u2003ppia f: gactgagtggttggatgg116r: tgatcttcttgctggtcttmtdna copy number, medip and chip \u2003g6pc F: aagccaagcgaaggtgtgagc165r: ggaacgggaaccacttgctgagmpf: acacaccctataacgccttgcc149r: gggtaggtgcctgctttcgtag\nAtp8 , Atp Synthase F0 Subunit 8; Atp6 : Atp Synthase F0 Subunit 6; Cox1 , Cytochrome C Oxidase Subunit 1; Cox2 , Cytochrome C oxidase subunit 2; Cox3 , Cytochrome C Oxidase Subunit 3, Cytb , Cytochrome B; g6pc , Glucose-6-phosphatase; mp, Mitochondrial dna Promoter; Nd1 , Nadh Dehydrogenase Subunit 1; Nd2 , nadh dehydrogenase Subunit 2; Nd3 , Nadh Dehydrogenase Subunit 3; Nd4 , Nadh Dehydrogenase Subunit 4; Nd4L , Nadh Dehydrogenase Subunit 4 L; Nd5 , nadh dehydrogenase subunit 5; Nd6 , Nadh Dehydrogenase Subunit 6; Ppia , Peptidylprolyl Isomerase A.\n\nrna isolation, cdna synthesis and real-time pcr\ntotal rna was isolated from Liver samples using trizol Reagent (15596026, invitrogen) according to the manufacturer's instructions and Reverse Transcribed with the primescript 1st strand cdna synthesis kit (d6110a, takara)."]	N/A	N/A	[('SO_0000112', 'primer', 129, 'Primers'), ('SO_0000028', 'base_pair', 158, 'bp'), ('GO_0010467', 'gene expression', 166, 'expression'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 178, 'COX1'), ('SO_0001030', 'forward', 183, 'F'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 237, 'COX2'), ('SO_0001030', 'forward', 242, 'F'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 296, 'COX3'), ('SO_0001030', 'forward', 301, 'F'), ('SO_0001030', 'forward', 419, 'F'), ('SO_0001030', 'forward', 476, 'F'), ('SO_0001030', 'forward', 535, 'F'), ('SO_0001030', 'forward', 710, 'F'), ('SO_0001030', 'forward', 767, 'F'), ('PR_000004409', 'autophagy-related protein 16-1', 822, 'ATP8'), ('SO_0001030', 'forward', 827, 'F'), ('SO_0001030', 'forward', 882, 'F'), ('SO_0001030', 'forward', 1028, 'F'), ('PR_000004409', 'autophagy-related protein 16-1', 1136, 'ATP8'), ('PR_000004516', 'aurora kinase A-interacting protein', 1143, 'ATP synthase F0 subunit 8'), ('PR_000004450', 'calcium-transporting ATPase type 2C member 2', 1170, 'ATP6'), ('PR_000004516', 'aurora kinase A-interacting protein', 1177, 'ATP synthase F0 subunit 6'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 1204, 'COX1'), ('CHEBI_18070', 'cytochrome c', 1211, 'cytochrome c'), ('PR_000005960', 'cysteine-rich protein 2-binding protein', 1211, 'cytochrome c oxidase subunit 1'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 1243, 'COX2'), ('CHEBI_18070', 'cytochrome c', 1250, 'cytochrome c'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 1282, 'COX3'), ('CHEBI_18070', 'cytochrome c', 1289, 'cytochrome c'), ('PR_000005991', 'cTAGE family member 4', 1289, 'cytochrome c oxidase subunit 3'), ('PR_000006090', 'cytoplasmic FMR1-interacting protein 1', 1321, 'CYTB'), ('CHEBI_38551', 'cytochrome b', 1328, 'cytochrome b'), ('PR_000002311', 'caspase-2', 1328, 'cytochrome b'), ('CHEBI_79307', 'glas#26', 1349, 'glucose-6'), ('GO_0005739', 'mitochondrion', 1376, 'mitochondrial'), ('SO_0000167', 'promoter', 1394, 'promoter'), ('PR_000011040', 'nuclear receptor coactivator 1', 1404, 'ND1'), ('PR_000011039', 'nicalin', 1410, 'NADH dehydrogenase subunit 1'), ('PR_000011040', 'nuclear receptor coactivator 1', 1440, 'ND2'), ('PR_000028799', 'tubulin', 1465, 'subunit 2'), ('PR_000011040', 'nuclear receptor coactivator 1', 1476, 'ND3'), ('PR_000011039', 'nicalin', 1482, 'NADH dehydrogenase subunit 3'), ('PR_000011040', 'nuclear receptor coactivator 1', 1512, 'ND4'), ('PR_000011039', 'nicalin', 1518, 'NADH dehydrogenase subunit 4'), ('PR_000011279', 'neuromedin-B', 1548, 'ND4L'), ('PR_000011049', 'nicastrin', 1555, 'NADH dehydrogenase subunit 4 L'), ('PR_000011040', 'nuclear receptor coactivator 1', 1587, 'ND5'), ('PR_000011040', 'nuclear receptor coactivator 1', 1623, 'ND6'), ('PR_000011039', 'nicalin', 1629, 'NADH dehydrogenase subunit 6'), ('PR_000013058', 'peroxisome proliferator-activated receptor gamma', 1659, 'PPIA'), ('CHEBI_50099', '(4-chloro-2-methylphenoxy)acetic acid', 1666, 'peptidylprolyl'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1666, 'peptidylprolyl isomerase A'), ('UBERON_0002107', 'liver', 1771, 'liver'), ('CHEBI_33893', 'reagent', 1798, 'Reagent'), ('GO_0001171', 'reverse transcription', 1878, 'reverse transcribed')]
PMC3653849	5/2013	S152-PMC3653849	['cox enzyme activity assay\nLiver Mitochondria were isolated according to a previously described protocol with some modifications[64].']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'Liver'), ('GO_0005739', 'mitochondrion', 32, 'mitochondria')]
PMC3653849	5/2013	S158-PMC3653849	['the final washed Mitochondrial pellet was dispersed with the isolation buffer and stored at −70°c until assayed.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 17, 'mitochondrial')]
PMC3653849	5/2013	S160-PMC3653849	['Mitochondrial protein concentration was measured by a bca protein assay kit (23225, pierce).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial')]
PMC3653849	5/2013	S161-PMC3653849	['cox activity in Liver Mitochondria was determined according to the instruction of a commercial kit (gms10014.2, genmed scientifics, inc.).']	N/A	N/A	[('UBERON_0002107', 'liver', 16, 'liver'), ('GO_0005739', 'mitochondrion', 22, 'mitochondria')]
PMC3653849	5/2013	S162-PMC3653849	['in brief, 5 µg of the Mitochondrial protein were incubated with 100 mm reduced Ferrocytochrome C , and cox activity was measured at 25°c by the decrease of reduced Cytochrome C in absorption at 550 nm.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 22, 'mitochondrial'), ('CHEBI_16928', 'ferrocytochrome c', 79, 'ferrocytochrome c'), ('CHEBI_18070', 'cytochrome c', 164, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 164, 'cytochrome c')]
PMC3653849	5/2013	S163-PMC3653849	['Mitochondrial 5mc and 5hmc immunoprecipitation\nmedip analysis was performed as previously described[23].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial')]
PMC3653849	5/2013	S168-PMC3653849	['gr protein content in Mitochondria\nequal amount of proteins were subjected to 7.5% and 12% Sds/page gels according to the protein molecular weight and separated by electrophoresis, transferred to 0.45 µm pore-size Nitrocellulose filter membranes (66485, pall) and immunoblotted with anti-Gr (sc-1004, santa cruz, 1∶200) or anti-Cox4 (mb0102, bioworld, 1∶200).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 22, 'mitochondria'), ('CHEBI_8984', 'sodium dodecyl sulfate', 91, 'SDS'), ('CHEBI_53325', 'nitrocellulose', 214, 'nitrocellulose'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 288, 'GR'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 328, 'COX4')]
PMC3674738	5/2013	S5-PMC3674738	['selected diseases are organized by the defective Molecule or mechanism and categorized as small Molecule disorders (involving Amino and Organic Acids, Fatty Acids, neurotransmitters, Urea cycle, vitamers and Cofactors, and Mitochondria) and large Molecule disorders (including Lysosomal storage disorders, Peroxisomal disorders, glycosylation disorders, and leukodystrophies).']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 49, 'molecule'), ('CHEBI_36357', 'polyatomic entity', 96, 'molecule'), ('CHEBI_48310', 'apiitol', 126, 'amino'), ('CHEBI_64709', 'organic acid', 136, 'organic acids'), ('CHEBI_35366', 'fatty acid', 151, 'fatty acids'), ('CHEBI_16199', 'urea', 183, 'urea'), ('CHEBI_23357', 'cofactor', 208, 'cofactors'), ('GO_0005739', 'mitochondrion', 223, 'mitochondria'), ('CHEBI_36357', 'polyatomic entity', 247, 'molecule'), ('GO_0005764', 'lysosome', 277, 'lysosomal'), ('GO_0005777', 'peroxisome', 306, 'peroxisomal')]
PMC3674738	5/2013	S174-PMC3674738	['Urea Cycle disorders\nthe Urea Cycle (figure 6), the Metabolic mechanism for Nitrogen Detoxification and removal, is facilitated by six enzymes and a Mitochondrial transporter and carrier, each being susceptible to dysfunction (table 7).']	N/A	N/A	[('CHEBI_16199', 'urea', 0, 'Urea'), ('GO_0006909', 'phagocytosis', 0, 'Urea Cycle'), ('CHEBI_16199', 'urea', 25, 'urea'), ('GO_0000050', 'urea cycle', 25, 'urea cycle'), ('GO_0008152', 'metabolic process', 52, 'metabolic'), ('CHEBI_33300', 'pnictogen', 76, 'nitrogen'), ('GO_0051170', 'import into nucleus', 76, 'nitrogen detoxification'), ('GO_0005739', 'mitochondrion', 149, 'mitochondrial')]
PMC3674738	5/2013	S194-PMC3674738	['glycine encephalopathy\nglycine encephalopathy is an inherited disorder of Glycine Degradation resulting from defects in the Mitochondrial glycine cleavage system (gcs).']	N/A	N/A	[('GO_0006546', 'glycine catabolic process', 74, 'glycine degradation'), ('GO_0005739', 'mitochondrion', 124, 'mitochondrial')]
PMC3794936	10/2013	S52-PMC3794936	['the samples were then assayed for Peroxisomal β-oxidation with or without Potassium Cyanide, which inhibits Mitochondrial β-oxidation.']	N/A	N/A	[('GO_0005777', 'peroxisome', 34, 'peroxisomal'), ('CHEBI_38904', 'potassium cyanate', 74, 'potassium cyanide'), ('GO_0005739', 'mitochondrion', 108, 'mitochondrial')]
PMC3794936	10/2013	S372-PMC3794936	['Expression of mrnas of Mitochondrial oxidation related Genes ( pparα, cpt1a, acox1, acadlv, acadl, acadm ) in Livers of Fed and fasted Mice of indicated genotypes (normalized to random Fed wt Mice, mean ± sem, n\u200a=\u200a8).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0005739', 'mitochondrion', 23, 'mitochondrial'), ('SO_0000704', 'gene', 55, 'genes'), ('UBERON_0002107', 'liver', 110, 'livers'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 135, 'mice'), ('GO_0007631', 'feeding behavior', 185, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'mice')]
PMC3821942	10/2013	S85-PMC3821942	['by numerous mechanisms, including Endocrine disruption [34], cytotoxicity [35], Mitochondrial dysfunction [36], and oxidative stress [37,38], a spectrum of toxic elements is able to disturb Cellular and Metabolic Homeostasis and induce clinical illness.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 34, 'endocrine'), ('GO_0005739', 'mitochondrion', 80, 'mitochondrial'), ('GO_0007049', 'cell cycle', 190, 'cellular ...'), ('GO_0055064', 'chloride ion homeostasis', 203, 'metabolic homeostasis')]
PMC3907150	1/2014	S161-PMC3907150	['evidence of Coevolution of the male Mitochondrial Genome with the Nuclear Genome is abundant [10,85,86].']	N/A	N/A	[('GO_0000746', 'conjugation', 12, 'coevolution'), ('GO_0005739', 'mitochondrion', 36, 'mitochondrial'), ('SO_0000172', 'CAAT_signal', 36, 'mitochondrial'), ('SO_0001026', 'genome', 50, 'genome'), ('GO_0005634', 'nucleus', 66, 'nuclear'), ('SO_0001026', 'genome', 74, 'genome')]
PMC3907150	1/2014	S163-PMC3907150	['finally, interspecific cellular hybrids with mismatched Nuclear-Mitochondria pair display a range of anomalies [87].']	N/A	N/A	[('GO_0005634', 'nucleus', 56, 'nuclear'), ('GO_0005739', 'mitochondrion', 64, 'mitochondria')]
PMC3953741	3/2014	S18-PMC3953741	['upon reaching the developing Liver, nefas diffuse into Hepatocytes and they are rapidly converted into Fatty Acyl-Coenzyme A (Coa).10primarily, fatty acyl-coas enter the Mitochondria for β-oxidation.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('CL_0000182', 'hepatocyte', 55, 'hepatocytes'), ('CHEBI_39015', 'apolipoprotein', 103, 'fatty acyl-coenzyme A'), ('CHEBI_15346', 'coenzyme A', 126, 'CoA'), ('GO_0005739', 'mitochondrion', 170, 'mitochondria')]
PMC4051754	6/2014	S54-PMC4051754	['in our microarray we measured the Expression of Genes coding for 2 out of 3 enzymes involved in the Formation Of Creatine Phosphate from glycine and arginine, the guanidinoacetate n-methyltransferase ( gamt ) and the Creatine Kinase, Mitochondrial 1B ( Ckmt1B ).']	N/A	N/A	[('GO_0010467', 'gene expression', 34, 'expression'), ('SO_0000704', 'gene', 48, 'genes'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 100, 'formation of creatine phosphate'), ('CHEBI_23237', 'chromium molecular entity', 113, 'creatine phosphate'), ('PR_000005840', 'inactive carboxypeptidase-like protein X2', 217, 'creatine kinase, mitochondrial 1B'), ('GO_0005739', 'mitochondrion', 234, 'mitochondrial'), ('PR_000005559', 'C-type lectin domain family 12 member A', 253, 'CKMT1B')]
PMC4051754	6/2014	S131-PMC4051754	['the latter also was enriched in david analysis together with enrichment of Mitochondria and oxidative related terms (figure 4andfile s5).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 75, 'mitochondria')]
PMC4051754	6/2014	S132-PMC4051754	['terms related to Mitochondria and oxidation were also among the most-impacted go bp terms in dia, at least at −14 d (file s4).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 17, 'mitochondria')]
PMC4129499	8/2014	S3-PMC4129499	['promising biomarkers include those for Mitochondrial function, oxidative stress, and Immune function.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 39, 'mitochondrial'), ('UBERON_0002405', 'immune system', 85, 'immune')]
PMC4129499	8/2014	S114-PMC4129499	['caption (table-wrap): table 2\n\noxidative stress biomarkers in asd (see text for references) .Glutathione – reduced/oxidizedmethioninecysteineorganic Acid test – alpha hydroxybutyrate, pyroglutamate, and Sulfateplasma f2t-Isoprostanes (f2-isops)Urine8-ohdgtransferrinceruloplasminplasma 3-Chlortyrosine (3Ct)3-Nitrotyrosine (3Nt)\nmeasurements of antioxidant status include measurement of Glutathione , the primary antioxidant in the protection against oxidative stress, Neuroinflammation, and Mitochondrial damage (68,69).']	N/A	N/A	[('CHEBI_16856', 'glutathione', 93, 'Glutathione'), ('CHEBI_37527', 'acid', 149, 'acid'), ('CHEBI_82535', 'Sudan III', 203, 'sulfatePlasma'), ('CHEBI_39015', 'apolipoprotein', 221, 'isoprostanes'), ('UBERON_0003062', 'primitive knot', 244, 'Urine8'), ('CHEBI_39992', '3-methylcytosine', 286, '3-chlortyrosine'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 303, '3CT'), ('CHEBI_31115', '3-Epimacronine', 307, '3-Nitrotyrosine'), ('CHEBI_75390', '3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid', 324, '3NT'), ('CHEBI_16856', 'glutathione', 387, 'glutathione'), ('GO_0007009', 'plasma membrane organization', 469, 'neuroinflammation'), ('GO_0005739', 'mitochondrion', 492, 'mitochondrial')]
PMC4129499	8/2014	S135-PMC4129499	['Mitochondrial dysfunction markers\nMitochondrial dysfunction is marked by impaired energy production.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 34, 'Mitochondrial')]
PMC4129499	8/2014	S138-PMC4129499	['there is no reliable biomarker to identify all cases of Mitochondrial dysfunction (79).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 56, 'mitochondrial')]
PMC4129499	8/2014	S141-PMC4129499	['other sources of Mitochondrial distress include Medications such as Valproic Acid (vpa), which inhibits Oxidative Phosphorylation (96) and neuroleptics (97,98).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 17, 'mitochondrial'), ('CHEBI_25441', 'mycothiols', 48, 'medications'), ('CHEBI_9921', 'valerenic acid', 68, 'valproic acid'), ('GO_0006119', 'oxidative phosphorylation', 104, 'oxidative phosphorylation')]
PMC4129499	8/2014	S142-PMC4129499	['markers of Mitochondrial dysfunction include Lactate, Pyruvate and lactate-to-Pyruvate ratio, Carnitine (free and total), quantitative Plasma amino acids, ubiquinone, ammonia, cd, ast, alt, Co2Glucose, and Creatine kinase (ck) (44).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 11, 'mitochondrial'), ('CHEBI_24996', 'lactate', 45, 'lactate'), ('CHEBI_15361', 'pyruvate', 54, 'pyruvate'), ('CHEBI_15361', 'pyruvate', 78, 'pyruvate'), ('CHEBI_17126', 'carnitine', 94, 'carnitine'), ('UBERON_0001969', 'blood plasma', 135, 'plasma'), ('CHEBI_27773', 'cis-3-enoyl-CoA', 190, 'CO2glucose'), ('CHEBI_16737', 'creatinine', 206, 'creatine')]
PMC4132016	8/2014	S72-PMC4132016	['Mitochondrial density measurement\ntotal dna was extracted from White Adipose Tissue and from Gastrocnemius using Phenol/Chloroform/Isoamyl Alcohol (25∶24∶1) followed by Ethanol precipitation.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('UBERON_0001347', 'white adipose tissue', 63, 'white adipose tissue'), ('UBERON_0001388', 'gastrocnemius', 93, 'gastrocnemius'), ('CHEBI_15882', 'phenol', 113, 'phenol'), ('CHEBI_35255', 'chloroform', 120, 'chloroform'), ('CHEBI_17184', 'chlordecone alcohol', 131, 'isoamyl alcohol'), ('CHEBI_16236', 'ethanol', 169, 'ethanol')]
PMC4132016	8/2014	S73-PMC4132016	['the content of mtdna was calculated using real-time quantitative pcr by measuring the threshold cycle ratio (δct) of a Mitochondrial-encoded Gene (Cox1, Forward 5′-actatactactactaacagaccg-3′ , Reverse 5′-ggttctttttttccggagta-3′ ) versus a Nuclear-encoded Gene (cyclophilin a, Forward 5′-acacgccataatggcactgg-3′ , Reverse 5′-cagtcttggcagtgcagat-3′ ).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 119, 'mitochondrial'), ('SO_0000704', 'gene', 141, 'gene'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 147, 'COX1'), ('SO_0001030', 'forward', 153, 'forward'), ('SO_0001031', 'reverse', 193, 'reverse'), ('GO_0005634', 'nucleus', 239, 'nuclear'), ('SO_0000704', 'gene', 255, 'gene'), ('SO_0001030', 'forward', 276, 'forward'), ('SO_0001031', 'reverse', 313, 'reverse')]
PMC4132016	8/2014	S152-PMC4132016	['a, b) mrna Expression levels of Genes encoding proteins involved in the Mitochondrial function in (a) brown Adipose Tissue (Bat) and (b) White Adipose Tissue (Wat) from 7-months-old f1-cd and f1-lpd males Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 11, 'expression'), ('SO_0000704', 'gene', 32, 'genes'), ('GO_0005739', 'mitochondrion', 72, 'mitochondrial'), ('UBERON_0001013', 'adipose tissue', 108, 'Adipose Tissue'), ('UBERON_0001348', 'brown adipose tissue', 124, 'BAT'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 137, 'White Adipose Tissue'), ('UBERON_0006337', 'distal early tubule', 159, 'WAT'), ('NCBITaxon_10088', 'Mus <genus>', 205, 'mice')]
PMC4132016	8/2014	S158-PMC4132016	['d) Mitochondrial density is estimated by measuring the Mitochondria dna (mtdna) content relatively to the Nuclear dna (nucldna) content in White Adipose Tissue.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 3, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 55, 'mitochondria'), ('GO_0005634', 'nucleus', 106, 'nuclear'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 139, 'White Adipose Tissue')]
PMC4132016	8/2014	S175-PMC4132016	['a) mrna Expression levels of Genes encoding proteins involved in the Mitochondrial function in Gastrocnemius from 7-months-old f1-cd and f1-lpd males Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 8, 'expression'), ('SO_0000704', 'gene', 29, 'genes'), ('GO_0005739', 'mitochondrion', 69, 'mitochondrial'), ('UBERON_0001388', 'gastrocnemius', 95, 'Gastrocnemius'), ('NCBITaxon_10088', 'Mus <genus>', 150, 'mice')]
PMC4132016	8/2014	S179-PMC4132016	['b) Mitochondrial density is estimated by measuring the Mitochondria dna (mtdna) content relatively to the Nuclear dna (nucldna) content in Gastrocnemius from 7-months-old f1-cd and f1-lpd males Mice.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 3, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 55, 'mitochondria'), ('GO_0005634', 'nucleus', 106, 'nuclear'), ('UBERON_0001388', 'gastrocnemius', 139, 'Gastrocnemius'), ('NCBITaxon_10088', 'Mus <genus>', 194, 'mice')]
PMC4193194	10/2014	S49-PMC4193194	['within the Trophoblast Cell, oxidative stress from unbalanced Free Radical Formation is formed from different sources like xo, enos uncoupling, nadph oxidase, and Mitochondria.']	N/A	N/A	[('CL_0000351', 'trophoblast cell', 11, 'trophoblast cell'), ('UBERON_0000088', 'trophoblast', 11, 'trophoblast'), ('CHEBI_26519', 'radical', 62, 'free radical'), ('GO_0031169', 'ferrichrome biosynthetic process', 62, 'free radical formation'), ('GO_0005739', 'mitochondrion', 163, 'mitochondria')]
PMC4193194	10/2014	S117-PMC4193194	['Tnf-Α downregulates enos and Mitochondrial biogenesis leading to Mitochondrial dysfunction (md) and elevated Ros (valerio et al.,2006).']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 0, 'TNF-α'), ('GO_0005739', 'mitochondrion', 29, 'mitochondrial'), ('GO_0005739', 'mitochondrion', 65, 'mitochondrial'), ('CHEBI_8756', 'RNA (poly(A))', 109, 'ROS')]
PMC4193194	10/2014	S151-PMC4193194	['after Reperfusion injury, re-oxygenation induces Tissue and Mitochondrial damage.']	N/A	N/A	[('GO_0000003', 'reproduction', 6, 'reperfusion'), ('UBERON_0000479', 'tissue', 49, 'tissue'), ('GO_0005739', 'mitochondrion', 60, 'mitochondrial')]
PMC4193194	10/2014	S158-PMC4193194	['Placental Metabolism is maintained throughout Gestation by increasing Mitochondrial biogenesis and activity (mandò et al.,2014).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0008152', 'metabolic process', 10, 'metabolism'), ('GO_0007565', 'female pregnancy', 46, 'gestation'), ('GO_0005739', 'mitochondrion', 70, 'mitochondrial')]
PMC4208652	6/2014	S243-PMC4208652	['this is caused by abnormal Regulation Of Mitochondrial Death Pathways and results in overproduction of Neural Tissue.']	N/A	N/A	[('GO_0010909', 'positive regulation of heparan sulfate proteoglycan biosynthetic process', 27, 'regulation of mitochondrial death pathways'), ('GO_0005739', 'mitochondrion', 41, 'mitochondrial'), ('UBERON_0003714', 'neural tissue', 103, 'neural tissue')]
PMC4208652	6/2014	S246-PMC4208652	['P53 enhances Oxidative Phosphorylation by inducing the Expression of the Cytochrome C Oxidase 2 Subunit 1 and of the ribonucleotide reductase subunit P52R2, which are involved in the maintenance of Mitochondrial Dna.']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 0, 'p53'), ('GO_0006119', 'oxidative phosphorylation', 13, 'oxidative phosphorylation'), ('GO_0010467', 'gene expression', 55, 'expression'), ('CHEBI_18070', 'cytochrome c', 73, 'cytochrome c'), ('PR_000005811', 'complexin-3', 73, 'cytochrome c oxidase 2 subunit 1'), ('PR_000001245', 'rhodopsin', 150, 'p52R2'), ('GO_0005739', 'mitochondrion', 198, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 198, 'mitochondrial DNA')]
PMC4210909	10/2014	S20-PMC4210909	['within cells, stored iron (as ferritin) can be located in the Cytoplasm, Nucleus or Mitochondria [10].']	N/A	N/A	[('GO_0005737', 'cytoplasm', 62, 'cytoplasm'), ('GO_0005634', 'nucleus', 73, 'nucleus'), ('GO_0005739', 'mitochondrion', 84, 'mitochondria')]
PMC4258799	11/2014	S23-PMC4258799	['ros are constantly generated, as part of normal aerobic Life, during the intermediate steps of oxygen reduction along the Mitochondrial Electron Transport Chain [7].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 56, 'life'), ('GO_0005739', 'mitochondrion', 122, 'mitochondrial'), ('CHEBI_10545', 'electron', 136, 'electron'), ('GO_0045251', 'electron transfer flavoprotein complex', 136, 'electron transport chain')]
PMC4258799	11/2014	S72-PMC4258799	['originating from the Embryo\nthe fast developing Embryo produces energy via Atp Generation through Mitochondrial Oxidative Phosphorylation and Glycolysis.']	N/A	N/A	[('UBERON_0000922', 'embryo', 21, 'embryo'), ('UBERON_0000922', 'embryo', 48, 'embryo'), ('GO_0046693', 'sperm storage', 75, 'ATP generation'), ('GO_0005739', 'mitochondrion', 98, 'mitochondrial'), ('GO_0006119', 'oxidative phosphorylation', 112, 'oxidative phosphorylation'), ('GO_0006096', 'glycolytic process', 142, 'glycolysis')]
PMC4258799	11/2014	S133-PMC4258799	['both 0.3\xa0mg/ml and 0.6\xa0mg/ml\xa0L-Carnitine reduced the blocking effect of Actinomycin-D, Hydrogen Peroxide or tumor Necrosis Factor Alpha and reduced the level of dna damage\n\nph and temperature\nIntracellular Homeostasis is highly susceptible to changes in ph (most occur within a ph of 6 to 8), especially key processes such as Protein Synthesis, Mitochondrial function, Cytoskeletal Regulation and Cellular Metabolism [68].']	N/A	N/A	[('CHEBI_16533', 'L-tryptophanamide', 29, 'L-carnitine'), ('CHEBI_28618', '1,4-dichlorobenzene', 72, 'actinomycin-D'), ('CHEBI_16240', 'hydrogen peroxide', 87, 'hydrogen peroxide'), ('PR_000011193', 'ephexin-1', 114, 'necrosis factor alpha'), ('GO_0005622', 'intracellular anatomical structure', 192, 'Intracellular'), ('GO_0071836', 'nectar secretion', 192, 'Intracellular homeostasis'), ('GO_0006412', 'translation', 326, 'protein synthesis'), ('GO_0005739', 'mitochondrion', 345, 'mitochondrial'), ('GO_0005856', 'cytoskeleton', 369, 'cytoskeletal'), ('GO_0065007', 'biological regulation', 382, 'regulation'), ('GO_0044237', 'cellular metabolic process', 397, 'cellular metabolism')]
PMC4258799	11/2014	S275-PMC4258799	['Superoxide dismutase\nIsoforms of sod found in Mitochondria (manganese sod) and Cytoplasm (copper/zinc sod) provide fundamental Defense against Ros [136].']	N/A	N/A	[('CHEBI_9358', 'Sumatrol', 0, 'Superoxide'), ('SO_0001060', 'sequence_variant', 21, 'Isoforms'), ('GO_0005739', 'mitochondrion', 46, 'mitochondria'), ('GO_0005737', 'cytoplasm', 79, 'cytoplasm'), ('GO_0006952', 'defense response', 127, 'defense'), ('CHEBI_8756', 'RNA (poly(A))', 143, 'ROS')]
PMC4258799	11/2014	S328-PMC4258799	['coenzyme q10\ncoenzyme q10is a Vitamin-like, Lipid soluble substance present in most Eukaryotic Cells as it forms part of the the Mitochondrial Respiratory Chain.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 30, 'vitamin'), ('CHEBI_18059', 'lipid', 44, 'lipid'), ('CL_0000255', 'eukaryotic cell', 84, 'eukaryotic cells'), ('GO_0005739', 'mitochondrion', 129, 'mitochondrial'), ('GO_0045472', 'response to ether', 143, 'respiratory chain'), ('GO_0005712', 'chiasma', 155, 'chain')]
PMC4280220	12/2014	S2-PMC4280220	['we examined 118,782 Genome-wide Snps and 333 Snps in 32 candidate Genes from Mitochondrial biogenesis and Oxidative Phosphorylation pathways in Placental dna from 280 pa cases and 244 controls.']	N/A	N/A	[('SO_0001026', 'genome', 20, 'genome'), ('SO_0000694', 'SNP', 32, 'SNPs'), ('SO_0000694', 'SNP', 45, 'SNPs'), ('SO_0000704', 'gene', 66, 'genes'), ('GO_0005739', 'mitochondrion', 77, 'mitochondrial'), ('GO_0006119', 'oxidative phosphorylation', 106, 'oxidative phosphorylation'), ('UBERON_0001987', 'placenta', 144, 'placental')]
PMC4280220	12/2014	S153-PMC4280220	['Cox10 encodes for the Cytochrome C oxidase protein, the terminal component of the Mitochondrial Respiratory Chain that catalyzes the Electron transfer from Reduced Cytochrome C to Oxygen.']	N/A	N/A	[('PR_000005773', 'cytochrome c oxidase copper chaperone', 0, 'COX10'), ('CHEBI_18070', 'cytochrome c', 22, 'cytochrome C'), ('PR_000002199', 'cytochrome c protein', 22, 'cytochrome C'), ('GO_0005739', 'mitochondrion', 82, 'mitochondrial'), ('GO_0045472', 'response to ether', 96, 'respiratory chain'), ('CHEBI_10545', 'electron', 133, 'electron'), ('CHEBI_33893', 'reagent', 156, 'reduced'), ('CHEBI_18070', 'cytochrome c', 164, 'cytochrome C'), ('CHEBI_33303', 'chalcogen', 180, 'oxygen')]
PMC4311629	1/2015	S32-PMC4311629	['White Adipocytes are composed of a large single, spherical Lipid Vacuole and a peripherally located Nucleus, together with few Mitochondria.']	N/A	N/A	[('CL_0000235', 'macrophage', 0, 'White adipocytes'), ('CHEBI_18059', 'lipid', 59, 'lipid'), ('GO_0005773', 'vacuole', 65, 'vacuole'), ('GO_0005634', 'nucleus', 100, 'nucleus'), ('GO_0005739', 'mitochondrion', 127, 'mitochondria')]
PMC4311629	1/2015	S36-PMC4311629	['Bat consists in Brown Adipocytes, characterized by multiple, small, multilocular Lipid droplets with a central Nucleus and a high number of Mitochondria.']	N/A	N/A	[('UBERON_0001348', 'brown adipose tissue', 0, 'BAT'), ('CL_0000449', 'brown fat cell', 16, 'brown adipocytes'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('GO_0005634', 'nucleus', 111, 'nucleus'), ('GO_0005739', 'mitochondrion', 140, 'mitochondria')]
PMC4311629	1/2015	S38-PMC4311629	['the Mitochondria of Bat are characterized by the presence of Uncoupling Protein-1 (Ucp1) in the Inner Mitochondrial Membrane.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 4, 'mitochondria'), ('UBERON_0001348', 'brown adipose tissue', 20, 'BAT'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 61, 'uncoupling protein-1'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 83, 'UCP1'), ('GO_0005743', 'mitochondrial inner membrane', 96, 'inner mitochondrial membrane')]
PMC4311629	1/2015	S39-PMC4311629	['when activated, this protein uncouples Mitochondrial Respiration from Atp Synthesis, resulting in Heat Production, a process that consumes substantial amounts of fuels.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 39, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 53, 'respiration'), ('GO_0006754', 'ATP biosynthetic process', 70, 'ATP synthesis'), ('GO_0031649', 'heat generation', 98, 'heat production')]
PMC4314531	11/2014	S115-PMC4314531	['several of the targets that we identified to be transcriptionally altered have roles in Regulation Of Metabolism, immunity or inflammation, Mitochondrial functions, Cell Migration or adhesion, stress, Insulin Signaling, Hematopoiesis, and other processes (table\xa01).']	N/A	N/A	[('GO_0009894', 'regulation of catabolic process', 88, 'regulation of metabolism'), ('GO_0005739', 'mitochondrion', 140, 'mitochondrial'), ('GO_0016477', 'cell migration', 165, 'cell migration'), ('GO_0031129', 'inductive cell-cell signaling', 201, 'insulin signaling'), ('PR_000045358', 'insulin family protein', 201, 'insulin'), ('GO_0030097', 'hemopoiesis', 220, 'hematopoiesis')]
PMC4334623	2/2015	S63-PMC4334623	['pathophysiological mechanisms of harm include Mitochondrial damage [56], oxidative stress [57], Cell Death [58], Neurotransmitter dysregulation [56], Endocrine disruption [59], and epigenetic modification [60].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 46, 'mitochondrial'), ('GO_0008219', 'cell death', 96, 'cell death'), ('CHEBI_25512', 'neurotransmitter', 113, 'neurotransmitter'), ('GO_0006397', 'mRNA processing', 150, 'endocrine')]
PMC4390148	4/2015	S41-PMC4390148	['sirtuin 3 (Sirt3) is a Mitochondrial sirtuin and its Expression increases with exercise and caloric restriction, while it decreases upon long-term high fat Feeding [26,27].']	N/A	N/A	[('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 11, 'SIRT3'), ('GO_0005739', 'mitochondrion', 23, 'mitochondrial'), ('GO_0010467', 'gene expression', 53, 'expression'), ('GO_0007631', 'feeding behavior', 156, 'feeding')]
PMC4392553	3/2015	S247-PMC4392553	['in another study, cells from children with autism exhibited higher oxidative stress than control cells, including a 1.6-fold increase in Reactive Oxygen Species (Ros) Production, 1.5-fold increase in Mitochondrial Dna copy number per cell, and more deletions.']	N/A	N/A	[('CHEBI_26523', 'reactive oxygen species', 137, 'reactive oxygen species'), ('CHEBI_8756', 'RNA (poly(A))', 162, 'ROS'), ('GO_0006302', 'double-strand break repair', 162, 'ROS ... production'), ('GO_0005739', 'mitochondrion', 200, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 200, 'mitochondrial DNA')]
PMC4392553	3/2015	S595-PMC4392553	['at the same time, impaired function of mn-Sod in the Mitochondria results in Mitochondrial damage, also a hallmark of many Neurological diseases.']	N/A	N/A	[('PR_000004803', 'breast cancer type 1 susceptibility protein', 41, '-SOD'), ('GO_0005739', 'mitochondrion', 53, 'mitochondria'), ('GO_0005739', 'mitochondrion', 77, 'mitochondrial'), ('UBERON_0001016', 'nervous system', 123, 'neurological')]
PMC4473145	12/2014	S199-PMC4473145	['substrate Oxidation occurs in the Mitochondria, and citrate synthase activity is commonly used as a marker of Mitochondrial density(32).']	N/A	N/A	[('GO_0015671', 'oxygen transport', 10, 'oxidation'), ('GO_0005739', 'mitochondrion', 34, 'mitochondria'), ('GO_0005739', 'mitochondrion', 110, 'mitochondrial')]
PMC4499266	4/2015	S181-PMC4499266	['the 125probands used were excluded of mutations in the most common deafness Genes amongst this population namely Gjb2, Slc26A and a Mitochondrial mutation in Mt-Rnr1 .']	N/A	N/A	[('SO_0000704', 'gene', 76, 'genes'), ('PR_000007999', 'gap junction beta-3 protein', 113, 'GJB2'), ('PR_000014932', 'solute carrier family 12 member 9', 119, 'SLC26A'), ('GO_0005739', 'mitochondrion', 132, 'mitochondrial'), ('PR_000001673', 'lysophospholipid (S1P) receptor', 158, 'MT-RNR1')]
PMC4571073	9/2015	S83-PMC4571073	['for quantification of mtdna copy number, real-time dna pcr analysis was performed with the novaquant™ Human Mitochondrial to Nuclear dna ratio kit (catalog #72620 emd millipore, billerica, ma, usa) according to the manufacturer’s instructions [21].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 102, 'Human'), ('GO_0005739', 'mitochondrion', 108, 'Mitochondrial'), ('GO_0005634', 'nucleus', 125, 'Nuclear')]
PMC4571073	9/2015	S84-PMC4571073	['this kit provides plates pre-aliquoted with the Primers to compare the levels of two Nuclear Genes (Becn1 and Neb) to two Mitochondrial Genes (Nd1 and nd6) in a real-time quantitative polymerase chain reaction.']	N/A	N/A	[('SO_0000112', 'primer', 48, 'primers'), ('GO_0005634', 'nucleus', 85, 'nuclear'), ('SO_0000087', 'nuclear_gene', 85, 'nuclear genes'), ('PR_000004703', 'B-cell CLL/lymphoma 7 protein family member C', 100, 'BECN1'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 110, 'NEB'), ('GO_0005739', 'mitochondrion', 122, 'mitochondrial'), ('SO_0002129', 'mt_tRNA', 122, 'mitochondrial genes'), ('PR_000011040', 'nuclear receptor coactivator 1', 143, 'ND1')]
PMC4630792	11/2015	S51-PMC4630792	['Expression levels of the master regulator of Mitochondrial Dna Biogenesis (Transcription Factor A, Mitochondrial; Tfam) were also measured.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0005739', 'mitochondrion', 45, 'mitochondrial'), ('GO_0002074', 'extraocular skeletal muscle development', 59, 'DNA biogenesis'), ('PR_000000035', 'BMP receptor type-1A', 75, 'Transcription factor A'), ('GO_0005739', 'mitochondrion', 99, 'mitochondrial'), ('PR_000010705', 'metallothionein-3', 99, 'mitochondrial'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 114, 'Tfam')]
PMC4630792	11/2015	S162-PMC4630792	['Mitochondrial Dna copy number quantification\ntotal dna (Mitochondrial and Nuclear) was extracted using the dneasy Blood and Tissue kit (qiagen, hilden, germany) according to the manufacturer’s instructions.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('GO_0005739', 'mitochondrion', 56, 'mitochondrial'), ('GO_0005634', 'nucleus', 74, 'nuclear'), ('UBERON_0000178', 'blood', 114, 'Blood'), ('UBERON_0000479', 'tissue', 124, 'Tissue')]
PMC4630792	11/2015	S163-PMC4630792	['a ratiometric assay of the levels of a single-copy Mitochondrial Gene, Cytochrome C oxidase (Cox1 ; Primer sequences; Forward 5′-agacacctctctttgtatgatcc-3′; Reverse 5′-cggtctgtaaggagtatagtgat-3′), against a single-copy Nuclear Gene, nth Endonuclease Iii-Like 1 (Nthl1 ; Primer sequences; Forward 5′-gattttgccttcctgtccatc-3′; reverse 5′-gaagcccaaaaccctcaga-3′), was used to estimate the average copy number of Mitochondrial dna (mtdna)/Nuclear dna (ndna) (22).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 51, 'mitochondrial'), ('SO_0000172', 'CAAT_signal', 51, 'mitochondrial'), ('SO_0000704', 'gene', 65, 'gene'), ('CHEBI_18070', 'cytochrome c', 71, 'cytochrome c'), ('PR_000005770', 'cytochrome c oxidase assembly protein COX11, mitochondrial', 93, 'Cox1'), ('SO_0000112', 'primer', 100, 'primer'), ('SO_0001030', 'forward', 118, 'Forward'), ('SO_0001031', 'reverse', 157, 'Reverse'), ('GO_0005634', 'nucleus', 219, 'nuclear'), ('SO_0000704', 'gene', 227, 'gene'), ('PR_000007059', 'echinoderm microtubule-associated protein-like 4', 237, 'endonuclease III-like 1'), ('PR_000011460', 'neurotrophin-4', 262, 'NTHL1'), ('SO_0000112', 'primer', 270, 'primer'), ('SO_0001030', 'forward', 288, 'Forward'), ('GO_0005739', 'mitochondrion', 409, 'mitochondrial'), ('GO_0005634', 'nucleus', 435, 'nuclear')]
PMC4661500	11/2014	S16-PMC4661500	['with sufficient magnesium supply the Mitochondria supply enough atp and energy-dependent processes such as Iodine uptake are maintained.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 37, 'mitochondria'), ('CHEBI_24859', 'iodine atom', 107, 'iodine')]
PMC4661500	11/2014	S20-PMC4661500	['Thyroid Hormones stimulate Mitochondrial biogenesis as well as muscle Repair.']	N/A	N/A	[('CHEBI_28266', 'fluorene', 0, 'Thyroid hormones'), ('GO_0005739', 'mitochondrion', 27, 'mitochondrial'), ('GO_0006281', 'DNA repair', 70, 'repair')]
PMC4661500	11/2014	S411-PMC4661500	['Mg++and Thyroid Hormones are antagonists in vivo and in vitro when Mitochondrial function is measured” (page 357 in[104]).']	N/A	N/A	[('CHEBI_29103', 'potassium(1+)', 0, 'Mg++'), ('CHEBI_26935', 'tetraterpenoid', 8, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 8, 'thyroid'), ('GO_0005739', 'mitochondrion', 67, 'mitochondrial')]
PMC4661500	11/2014	S553-PMC4661500	['in turn Thyroid Hormones are effective on Mitochondrial biogenesis as well as on muscle Repair[209],[210],[211].']	N/A	N/A	[('CHEBI_26935', 'tetraterpenoid', 8, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 8, 'thyroid'), ('GO_0005739', 'mitochondrion', 42, 'mitochondrial'), ('GO_0006281', 'DNA repair', 88, 'repair')]
PMC4682815	12/2015	S134-PMC4682815	['multiparous women had increased Asct2 , Aspartate Aminotransferase 2, Cytosolic branched chain aminotransferase and Eaat3 and decreased Mitochondrial glutamate dehydrogenase Placental mrna Expression (fig 4).']	N/A	N/A	[('PR_000004355', 'ankyrin repeat and SOCS box protein 6', 32, 'ASCT2'), ('PR_000003639', 'putative cytosolic acyl coenzyme A thioester hydrolase-like', 40, 'aspartate aminotransferase 2'), ('GO_0005829', 'cytosol', 70, 'cytosolic'), ('PR_000006884', 'evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial', 116, 'EAAT3'), ('GO_0005739', 'mitochondrion', 136, 'mitochondrial'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 174, 'placental'), ('UBERON_0001987', 'placenta', 174, 'placental'), ('GO_0010467', 'gene expression', 189, 'expression')]
PMC4701853	1/2016	S142-PMC4701853	['Mitochondria also Regulate Ros Production and oxidative stress by uncoupling energy supply, with both ampk and mtor Modulating oxidative stress through changes in Ucp2 (47) and Nuclear Factor Κb action (26,48), thereby promoting proinflammatory and pro-oxidative pathways within Trophoblast Cells.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('GO_0065007', 'biological regulation', 18, 'regulate'), ('CHEBI_8756', 'RNA (poly(A))', 27, 'ROS'), ('GO_0071605', 'monocyte chemotactic protein-1 production', 27, 'ROS production'), ('GO_0065007', 'biological regulation', 116, 'modulating'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 163, 'UCP2'), ('GO_0005634', 'nucleus', 177, 'nuclear'), ('PR_000007591', 'protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha', 185, 'factor κB'), ('CL_0000351', 'trophoblast cell', 279, 'trophoblast cells'), ('UBERON_0000088', 'trophoblast', 279, 'trophoblast')]
PMC4739392	2/2016	S81-PMC4739392	['8-Oxodg\nUrinary 7,8-dihydro-8-oxo-2’-deoxyguanosine (8-Oxodg), a marker of Free Radical-induced oxidative lesions of Nuclear and Mitochondrial Dna, was determined by means of hplc and electrochemical detection as previously described [14].']	N/A	N/A	[('CHEBI_82778', 'citrate-coated silver nanoparticle', 0, '8-oxodG'), ('UBERON_0001088', 'urine', 8, 'Urinary'), ('CHEBI_82778', 'citrate-coated silver nanoparticle', 53, '8-oxodG'), ('CHEBI_26519', 'radical', 75, 'free radical'), ('GO_0005634', 'nucleus', 117, 'nuclear'), ('SO_0000007', 'read_pair', 117, 'nuclear ...'), ('GO_0005739', 'mitochondrion', 129, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 129, 'mitochondrial DNA')]
PMC4789467	3/2016	S79-PMC4789467	['switching Conceptus Metabolism from Aerobic to anaerobic by inhibiting Mitochondrial oxidation early in Blastocyst development also alters Placental Formation in Rats near term (wakefield et al.,2011).']	N/A	N/A	[('UBERON_0004716', 'conceptus', 10, 'conceptus'), ('GO_0008152', 'metabolic process', 20, 'metabolism'), ('GO_0009057', 'macromolecule catabolic process', 36, 'aerobic'), ('GO_0005739', 'mitochondrion', 71, 'mitochondrial'), ('UBERON_0000358', 'blastocyst', 104, 'blastocyst'), ('GO_0006596', 'polyamine biosynthetic process', 139, 'placental formation'), ('UBERON_0001987', 'placenta', 139, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 162, 'rats')]
PMC4835505	4/2016	S27-PMC4835505	['Fibroblasts from >60 years old asymptomatic premutation carriers presented altered protein Expression of the zn transporters Znt6/Znt4 (napoli et al.,2011) accompanied by Mitochondrial dysfunction (md; ross-inta et al.,2010; napoli et al.,2011).']	N/A	N/A	[('CL_0000057', 'fibroblast', 0, 'Fibroblasts'), ('GO_0010467', 'gene expression', 91, 'expression'), ('PR_000015078', 'zinc transporter 5', 125, 'ZnT6'), ('PR_000015078', 'zinc transporter 5', 130, 'ZnT4'), ('GO_0005739', 'mitochondrion', 171, 'mitochondrial')]
PMC4835505	4/2016	S29-PMC4835505	['this scenario was significantly reversed upon zn supplementation, which allowed zn-Dependent Import/Processing Pathways Of Nuclearly-Encoded Mitochondrial Proteins to occur (napoli et al.,2011).']	N/A	N/A	[('GO_0006273', 'lagging strand elongation', 82, '-dependent'), ('GO_0002414', 'immunoglobulin transcytosis in epithelial cells', 93, 'import ... processing pathways of ... encoded mitochondrial proteins'), ('GO_0005634', 'nucleus', 123, 'nuclearly'), ('GO_0005739', 'mitochondrion', 141, 'mitochondrial')]
PMC4835505	4/2016	S52-PMC4835505	['at pnd0, 9 (or 7), 21, and 210, Mitochondria were isolated from hippocampus, Cerebellum and Cortex from wt and ki male Mice ( n = 9–13 at each time point for a total of 54 wt and 55 ki).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 32, 'mitochondria'), ('UBERON_0002037', 'cerebellum', 77, 'cerebellum'), ('UBERON_0001851', 'cortex', 92, 'cortex'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'mice')]
PMC4835505	4/2016	S60-PMC4835505	['the Cortex, Cerebellum, and hippocampus were removed post-mortem and processed immediately to isolate Mitochondria.']	N/A	N/A	[('UBERON_0001851', 'cortex', 4, 'cortex'), ('UBERON_0002037', 'cerebellum', 12, 'cerebellum'), ('GO_0005739', 'mitochondrion', 102, 'mitochondria')]
PMC4835505	4/2016	S61-PMC4835505	['isolation and purification of Mitochondria from Brain Regions\nenriched Mitochondrial fractions were obtained from Cortex, Cerebellum and hippocampus at pnd0 ( n = 13 wt and 13 ki), pnd7 ( n = 9 wt and 9 ki), pnd21 ( n = 12 wt and 12 ki), and pnd210 ( n = 11 wt and 12 ki).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 30, 'mitochondria'), ('UBERON_0002616', 'regional part of brain', 48, 'brain regions'), ('GO_0005739', 'mitochondrion', 71, 'mitochondrial'), ('UBERON_0001851', 'cortex', 114, 'cortex'), ('UBERON_0002037', 'cerebellum', 122, 'cerebellum')]
PMC4835505	4/2016	S62-PMC4835505	['intact, highly purified, non-Synaptosomal Mitochondria from the same Brain Tissues were isolated through a percoll gradient as previously described in detail (napoli et al.,2012,2013), resuspended in iso-osmotic 150 mm Kcl and immediately used for oxygen consumption measurements.']	N/A	N/A	[('GO_0005819', 'spindle', 29, 'synaptosomal'), ('GO_0005739', 'mitochondrion', 42, 'mitochondria'), ('UBERON_0000955', 'brain', 69, 'brain'), ('UBERON_0000479', 'tissue', 75, 'tissues'), ('CHEBI_32588', 'potassium chloride', 219, 'KCl')]
PMC4835505	4/2016	S70-PMC4835505	["Mitochondrial outcomes\nenriched Mitochondrial fractions or in intact, purified Mitochondria were used for evaluation of oxygen consumption using a clark-type oxygen electrode (hansatech, king's lynn, uk) as described (napoli et al.,2013)."]	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 32, 'mitochondrial'), ('GO_0005739', 'mitochondrion', 79, 'mitochondria')]
PMC4835505	4/2016	S71-PMC4835505	['an aliquot (0.1–0.3 mg protein/ml) of Mitochondria was added to the oxygen chamber in a buffer containing 0.22 m Sucrose, 50 mm Kcl, 1 mm edta, 10 mm Kh2Po4, and 10 mm Hepes, ph 7.4.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 38, 'mitochondria'), ('CHEBI_17992', 'sucrose', 113, 'sucrose'), ('CHEBI_32588', 'potassium chloride', 128, 'KCl'), ('CHEBI_63036', 'potassium dihydrogen phosphate', 150, 'KH2PO4'), ('CHEBI_46756', 'HEPES', 168, 'HEPES')]
PMC4835505	4/2016	S73-PMC4835505	['the activities of Mitochondrial nadh oxidase, succinate oxidase, and Cytochrome C oxidase were evaluated as the difference of oxygen uptake recorded before and after the addition of Rotenone, malonate, antimycin a, and Kcn respectively, and normalized by the activity of citrate synthase (a marker of Mitochondrial mass).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 18, 'mitochondrial'), ('CHEBI_18070', 'cytochrome c', 69, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 69, 'cytochrome c'), ('CHEBI_28201', 'rotenone', 182, 'rotenone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 219, 'KCN'), ('GO_0005739', 'mitochondrion', 301, 'mitochondrial')]
PMC4835505	4/2016	S74-PMC4835505	['citrate synthase activity was evaluated spectrophotometrically as described elsewhere (napoli et al.,2013) using 1–2 μg of Mitochondrial protein.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 123, 'mitochondrial')]
PMC4835505	4/2016	S177-PMC4835505	['deficits in bioenergetics in Brain Regions from young ki Mice\ndifferent segments of the Electron Transport Chain from Brain Mitochondria (hippocampus, Cerebellum, and Cortex) were tested for their capacity to generate atp in wt and ki Mice: nadh oxidase (using nad-linked substrates such as Glucose and comprising Complex I, iii, iv, and v), succinate oxidase (using fad-linked substrates such as Fatty Acids and comprising Complex Ii, iii, iv, and v), as well as citrate synthase activity as a normalizing marker of Mitochondrial mass.']	N/A	N/A	[('UBERON_0002616', 'regional part of brain', 29, 'brain regions'), ('NCBITaxon_10088', 'Mus <genus>', 57, 'mice'), ('CHEBI_10545', 'electron', 88, 'electron'), ('GO_0045251', 'electron transfer flavoprotein complex', 88, 'electron transport chain'), ('UBERON_0000955', 'brain', 118, 'brain'), ('GO_0005739', 'mitochondrion', 124, 'mitochondria'), ('UBERON_0002037', 'cerebellum', 151, 'cerebellum'), ('UBERON_0001851', 'cortex', 167, 'cortex'), ('NCBITaxon_10088', 'Mus <genus>', 235, 'mice'), ('CHEBI_17234', 'glucose', 291, 'glucose'), ('GO_0030964', 'NADH dehydrogenase complex', 314, 'Complex I'), ('CHEBI_35366', 'fatty acid', 397, 'fatty acids'), ('GO_0030964', 'NADH dehydrogenase complex', 424, 'Complex II'), ('GO_0005739', 'mitochondrion', 517, 'mitochondrial')]
PMC4835505	4/2016	S179-PMC4835505	['at pnd0-7, no statistically significant differences were observed in Mitochondrial outcomes between wt and ki pups in any of the Brain Regions tested (figure2).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 69, 'mitochondrial'), ('UBERON_0002616', 'regional part of brain', 129, 'brain regions')]
PMC4835505	4/2016	S184-PMC4835505	['Mitochondria were isolated from Cortex, Cerebellum, and hippocampus of wt and ki pups as described in the methods section.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('UBERON_0001851', 'cortex', 32, 'cortex'), ('UBERON_0002037', 'cerebellum', 40, 'cerebellum')]
PMC4835505	4/2016	S192-PMC4835505	['Mitochondrial protein levels (relative to total protein) were evaluated by measuring the Expression of the abundant protein Atpase Β-Subunit Of Complex V [Atpb; (elfering et al.,2004; haynes et al.,2010), figure3].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0010467', 'gene expression', 89, 'expression'), ('PR_000029977', '6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase', 124, 'ATPase β-subunit of Complex V'), ('GO_0030964', 'NADH dehydrogenase complex', 144, 'Complex V'), ('PR_000004372', 'agouti-signaling protein', 155, 'ATPB')]
PMC4835505	4/2016	S195-PMC4835505	['caption (fig): figure 3\n\nprotein Expression levels of Mitochondrial Atpase Β-Subunit in Brain from ki Mice .']	N/A	N/A	[('GO_0010467', 'gene expression', 33, 'expression'), ('GO_0005739', 'mitochondrion', 54, 'mitochondrial'), ('PR_000010475', 'matrix metalloproteinase-15', 54, 'mitochondrial ATPase β-subunit'), ('UBERON_0000955', 'brain', 88, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice')]
PMC4835505	4/2016	S212-PMC4835505	['caption (table-Wrap): table 1\n\ncomparison of outcomes in Mitochondria-enriched fractions vs. purified, non-Synaptosomal Mitochondria from Cerebellum and Cortex at pnd21 in wt and ki Mice .outcomescerebellumcortextotal Mitochondrianon-Synaptosomal Mitochondriatotal Mitochondrianon-Synaptosomal Mitochondriawtkiwtkiwtkiwtkioxygen uptake rates nadh oxidase5.38 ± 0.014.5 ± 0.352.4 ± 1.358.3 ± 5.68.8 ± 3.38.4 ± 1.050 ± 1145 ± 6succinate oxidase6.31 ± 0.022.33 ± 0.01**47.1 ± 1.026 ± 2**8.1 ± 0.86.5 ± 1.0*74 ± 1545 ± 2*activities Cytochrome C oxidase14.3 ± 0.110 ± 1**168 ± 28116 ± 19**27 ± 116 ± 1**149 ± 1764 ± 4**citrate synthase274 ± 52293 ± 312314 ± 3052400 ± 320263 ± 27282 ± 392258 ± 3602324 ± 199\nall activities were expressed as nmol oxygen consumed × (min × mg protein)−1.']	N/A	N/A	[('PR_000017453', 'protein Wnt-9b', 15, 'WRAP'), ('GO_0005739', 'mitochondrion', 57, 'mitochondria'), ('GO_0005819', 'spindle', 107, 'synaptosomal'), ('GO_0005739', 'mitochondrion', 120, 'mitochondria'), ('UBERON_0002037', 'cerebellum', 138, 'cerebellum'), ('UBERON_0001851', 'cortex', 153, 'cortex'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mice'), ('GO_0005739', 'mitochondrion', 218, 'mitochondriaNon'), ('GO_0005819', 'spindle', 234, 'synaptosomal'), ('GO_0005739', 'mitochondrion', 247, 'mitochondriaTotal'), ('GO_0005739', 'mitochondrion', 265, 'mitochondriaNon'), ('GO_0005819', 'spindle', 281, 'synaptosomal'), ('GO_1990677', 'mitochondrial inner membrane assembly complex', 294, 'mitochondriaWTKIWTKIWTKIWTKIOXYGEN'), ('CHEBI_18070', 'cytochrome c', 528, 'Cytochrome c'), ('PR_000002199', 'cytochrome c protein', 528, 'Cytochrome c')]
PMC4835505	4/2016	S220-PMC4835505	['subsequent addition of fccp, an uncoupler of Atp Production and Electron transfer, allowed evaluating the maximum Mitochondrial oxygen uptake capacity.']	N/A	N/A	[('GO_0006754', 'ATP biosynthetic process', 45, 'ATP production'), ('CHEBI_10545', 'electron', 64, 'electron'), ('GO_0005739', 'mitochondrion', 114, 'mitochondrial')]
PMC4835505	4/2016	S223-PMC4835505	['caption (table-wrap): table 2\n\nMitochondrial coupling and Respiratory capacity in intact, isolated Neurons from wt and ki Mice at pnd0 .outcomeshippocampuscerebellumcortex(% basal rate)Oxygen Consumption rateswtkiwtkiwtki Oligomycin-sensitive90 ± 185 ± 1**89 ± 380 ± 684 ± 277 ± 3oligomycin-resistant0.33 ± 0.336.9 ± 0.5***−0.22 ± 0.220.9 ± 0.2*3 ± 519 ± 3*spare Respiratory capacity128 ± 1262 ± 2**102 ± 3074 ± 42110 ± 1767 ± 12 couplinghippocampuscerebellumcortex rcru11 ± 23.4 ± 0.8*9 ± 11.7 ± 0.4**7 ± 10.9 ± 0.3***\noxygen consumption rates under basal conditions (in the presence of Glucose only) were not statistically significant different between wt and ki in any of the Brain Regions [average of wt and ki = 6.5 ± 0.7; 3.4 ± 0.9; and 3.1 ± 0.5 nmol oxygen consumed × (min × 106cells)−1for Cortex, Cerebellum and hippocampus, respectively].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 31, 'Mitochondrial'), ('GO_0045333', 'cellular respiration', 58, 'respiratory'), ('CL_0000540', 'neuron', 99, 'neurons'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'mice'), ('CHEBI_33309', 'noble gas atom', 185, 'Oxygen'), ('GO_0007631', 'feeding behavior', 192, 'consumption'), ('CHEBI_7765', 'Oligouronides', 222, 'Oligomycin'), ('GO_0045333', 'cellular respiration', 363, 'respiratory'), ('UBERON_0001004', 'respiratory system', 363, 'respiratory'), ('CHEBI_17234', 'glucose', 588, 'glucose'), ('UBERON_0002616', 'regional part of brain', 679, 'brain regions'), ('UBERON_0001851', 'cortex', 798, 'cortex'), ('UBERON_0002037', 'cerebellum', 806, 'cerebellum')]
PMC4835505	4/2016	S240-PMC4835505	['caption (fig): figure 4\n\ncorrelation between Mitochondrial outcomes and Fmrp or Fmr1 Expression levels .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 45, 'mitochondrial'), ('PR_000007555', 'filamin-A', 72, 'FMRP'), ('PR_000007447', 'follicular dendritic cell secreted peptide', 80, 'FMR1'), ('GO_0010467', 'gene expression', 85, 'expression')]
PMC4835505	4/2016	S246-PMC4835505	['that study ascribed the Bioenergetic deficits to altered Znt6 protein level and lower Transport Of Cytoplasmic Zn (napoli et al.,2011), which resulted in deficient zn-mediated Import/processing of Nuclearly-encoded Mitochondrial subunits (napoli et al.,2011).']	N/A	N/A	[('GO_0060349', 'bone morphogenesis', 24, 'bioenergetic'), ('PR_000015078', 'zinc transporter 5', 57, 'ZnT6'), ('GO_0006412', 'translation', 86, 'transport of ... Zn'), ('GO_0005737', 'cytoplasm', 99, 'cytoplasmic'), ('GO_0007566', 'embryo implantation', 176, 'import'), ('GO_0005634', 'nucleus', 197, 'nuclearly'), ('GO_0005739', 'mitochondrion', 215, 'mitochondrial')]
PMC4835505	4/2016	S267-PMC4835505	['this 2.5 kda difference was close to the theoretical calculated molecular weight (2.4 kda) of the 22 residues of amino acids (mlatrvfslvgkraistsvcvr) present in the precursor form, which is cleaved by Mitochondrial Matrix peptidases (isaya et al.,1991) to produce the mature Mitochondrial form of the protein (uniprotkb p13073).']	N/A	N/A	[('GO_0005759', 'mitochondrial matrix', 201, 'mitochondrial matrix'), ('GO_0005739', 'mitochondrion', 275, 'mitochondrial')]
PMC4835505	4/2016	S284-PMC4835505	['caption (fig): figure 7\n\ncorrelations among zn levels, selected Mitochondrial outcomes, and protein Expression of Fmrp and Shank3, in Brain of wt and ki Mice .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('GO_0010467', 'gene expression', 100, 'expression'), ('PR_000007555', 'filamin-A', 114, 'FMRP'), ('PR_000014662', 'selenoprotein W', 123, 'Shank3'), ('UBERON_0000955', 'brain', 134, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 153, 'mice')]
PMC4835505	4/2016	S288-PMC4835505	['all the other Mitochondrial outcomes did not show a correlation with zn.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 14, 'mitochondrial')]
PMC4835505	4/2016	S346-PMC4835505	['caption (fig): figure 10\n\nchanges in Mitochondrial outcomes in hippocampus, Cerebellum and Cortex of Suckling wt and ki pups Nursed on wt or ki dams .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 37, 'mitochondrial'), ('UBERON_0002037', 'cerebellum', 76, 'cerebellum'), ('UBERON_0001851', 'cortex', 91, 'cortex'), ('GO_0001967', 'suckling behavior', 101, 'suckling'), ('GO_0001967', 'suckling behavior', 125, 'nursed')]
PMC4835505	4/2016	S348-PMC4835505	['after 21 days, Mitochondria were isolated from Cortex, Cerebellum, and hippocampus and activities of nadh oxidase, succinate oxidase, Cytochrome C oxidase, and citrate synthase and rcr were evaluated as described in the methods section.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 15, 'mitochondria'), ('UBERON_0001851', 'cortex', 47, 'cortex'), ('UBERON_0002037', 'cerebellum', 55, 'cerebellum'), ('CHEBI_18070', 'cytochrome c', 134, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 134, 'cytochrome c')]
PMC4835505	4/2016	S361-PMC4835505	['furthermore, the hippocampus of wt pups Nursing on ki milk showed a significant decrease in Mitochondrial mass.']	N/A	N/A	[('GO_0001967', 'suckling behavior', 40, 'nursing'), ('GO_0005739', 'mitochondrion', 92, 'mitochondrial')]
PMC4835505	4/2016	S363-PMC4835505	['ki pups Nursing on wt Milk compared to ki pups Nursed on ki Milk exhibited some Mitochondrial improvement, as judged by a partial recovery of succinate oxidase activity in Cerebellum (from 60 to 82% of wt) and complete recovery of succinate oxidase and coupling in Cortex (figure10).']	N/A	N/A	[('GO_0001967', 'suckling behavior', 8, 'nursing'), ('UBERON_0001913', 'milk', 22, 'milk'), ('GO_0001967', 'suckling behavior', 47, 'nursed'), ('UBERON_0001913', 'milk', 60, 'milk'), ('GO_0005739', 'mitochondrion', 80, 'mitochondrial'), ('UBERON_0002037', 'cerebellum', 172, 'cerebellum'), ('UBERON_0001851', 'cortex', 265, 'cortex')]
PMC4835505	4/2016	S365-PMC4835505	['the effect of the diet (ki vs. wt milk) and genotype on Mitochondrial outcomes was evaluated by two-way anova (table4).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 56, 'mitochondrial')]
PMC4835505	4/2016	S407-PMC4835505	['this situation would ensue in the suboptimal Delivery Of Zn Into Milk, Mitochondrial dysfunction, and Synaptic dysregulation.']	N/A	N/A	[('GO_0030154', 'cell differentiation', 45, 'delivery of Zn into milk'), ('GO_0005739', 'mitochondrion', 71, 'mitochondrial'), ('GO_0045202', 'synapse', 102, 'synaptic')]
PMC4835505	4/2016	S439-PMC4835505	['author contributions\nen measured Mitochondrial outcomes in Mice at pnd21 and 210, zn, Fmrp, and Shank3 levels, zn in milk, run all western blots from rodents and Human cells, analyzed the data, helped drafting, and reviewed the manuscript; ci measured Mitochondrial outcomes isolated Neurons and in Mice at pnd0-9 and pnd21; gs measured alp activity, proteins, and Lactose levels in Human Milk and reviewed the manuscript; sw evaluated the Fmr1 Expression in Fibroblasts and znt s Gene Expression, and reviewed the manuscript; lg recruited the patients, collected the medical history, and the premutation Milk samples; js provided all Milk samples from controls; ft determined the cgg repeats in Fibroblasts and Milk samples from gdna extracted by wong; cg conceptualized the work, wrote, and reviewed the manuscript.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 33, 'mitochondrial'), ('NCBITaxon_10088', 'Mus <genus>', 59, 'mice'), ('PR_000007555', 'filamin-A', 86, 'FMRP'), ('PR_000014662', 'selenoprotein W', 96, 'Shank3'), ('NCBITaxon_9606', 'Homo sapiens', 162, 'human'), ('GO_0005739', 'mitochondrion', 252, 'mitochondrial'), ('CL_0000540', 'neuron', 284, 'neurons'), ('NCBITaxon_10088', 'Mus <genus>', 299, 'mice'), ('CHEBI_17716', 'lactose', 365, 'lactose'), ('NCBITaxon_9606', 'Homo sapiens', 383, 'human'), ('UBERON_0001913', 'milk', 389, 'milk'), ('PR_000007447', 'follicular dendritic cell secreted peptide', 440, 'FMR1'), ('GO_0010467', 'gene expression', 445, 'expression'), ('CL_0000057', 'fibroblast', 459, 'fibroblasts'), ('GO_0010467', 'gene expression', 481, 'gene expression'), ('SO_0000704', 'gene', 481, 'gene'), ('UBERON_0001913', 'milk', 605, 'milk'), ('UBERON_0001913', 'milk', 635, 'milk'), ('CL_0000057', 'fibroblast', 696, 'fibroblasts'), ('UBERON_0001913', 'milk', 712, 'milk')]
PMC4892656	6/2016	S18-PMC4892656	['for example, Postnatal Consumption of a high-fat diet induced Mitochondrial dysfunction in Skeletal muscle in Intrauterine growth restricted Pig offspring [6].']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'postnatal'), ('GO_0007631', 'feeding behavior', 23, 'consumption'), ('GO_0005739', 'mitochondrion', 62, 'mitochondrial'), ('UBERON_0004288', 'skeleton', 91, 'skeletal'), ('UBERON_0022293', 'reproductive gland secretion', 110, 'intrauterine'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'pig')]
PMC4896250	4/2016	S3216-PMC4896250	['Mitochondrial translocation from subcellular fractionation of Human Bronchial Epithelial Cell line and Mouse Lung Tissue under oxidative stress were analyzed by immunoblotting.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('NCBITaxon_9606', 'Homo sapiens', 62, 'human'), ('CL_0002328', 'bronchial epithelial cell', 68, 'bronchial epithelial cell'), ('UBERON_0002031', 'epithelium of bronchus', 68, 'bronchial epithelial'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'mouse'), ('UBERON_0002048', 'lung', 109, 'lung'), ('UBERON_0000479', 'tissue', 114, 'tissue')]
PMC4896250	4/2016	S3217-PMC4896250	['we evaluated changed Mitochondrial function by measuring o2consumption, Atp Synthesis, and Ros Generation.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('GO_0006754', 'ATP biosynthetic process', 72, 'ATP synthesis'), ('CHEBI_8756', 'RNA (poly(A))', 91, 'ROS'), ('GO_0031099', 'regeneration', 91, 'ROS generation')]
PMC4908484	6/2016	S163-PMC4908484	['Neuronal death is preceded by the change in the Mitochondria morphology, from a continuous to a fragmented profile, and by the loss of the Mitochondrial Membrane Potential (pelizzoni et\xa0al.2011; park et\xa0al.2015).']	N/A	N/A	[('CL_0000540', 'neuron', 0, 'Neuronal'), ('GO_0007608', 'sensory perception of smell', 0, 'Neuronal'), ('GO_0005739', 'mitochondrion', 48, 'mitochondria'), ('GO_0005763', 'mitochondrial small ribosomal subunit', 139, 'mitochondrial membrane potential')]
PMC4915063	6/2016	S88-PMC4915063	['the largest methylation differences were found in the Promoter region of the Decr1 Gene, which encodes 2,4 Dienoyl-Coa reductase (decr), a Mitochondrial enzyme in the Unsaturated Fatty Acid Beta Oxidation pathway vital for Unsaturated Fat Metabolism.']	N/A	N/A	[('SO_0000167', 'promoter', 54, 'promoter'), ('PR_000006395', 'beta-defensin 116', 77, 'DECR1'), ('SO_0000704', 'gene', 83, 'gene'), ('CHEBI_27490', '2-fluorobenzoyl-CoA', 103, '2,4 dienoyl-CoA'), ('GO_0005739', 'mitochondrion', 139, 'mitochondrial'), ('GO_0042755', 'eating behavior', 167, 'unsaturated'), ('CHEBI_35366', 'fatty acid', 179, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 179, 'fatty acid beta oxidation'), ('GO_0046435', '3-(3-hydroxy)phenylpropionate metabolic process', 223, 'unsaturated fat metabolism')]
PMC4998730	4/2016	S94-PMC4998730	['their physiological roles include acting as the sole carrier of long-chain fatty acids and transporting long-chain fatty acids into the Mitochondria for β-oxidation and Regulating the balance between Intracellular free Coa and Acyl-Coa.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 136, 'mitochondria'), ('GO_0065007', 'biological regulation', 169, 'regulating'), ('GO_0005622', 'intracellular anatomical structure', 200, 'intracellular'), ('CHEBI_15346', 'coenzyme A', 219, 'CoA'), ('CHEBI_17984', 'acyl-CoA', 227, 'acyl-CoA')]
PMC5025055	9/2016	S48-PMC5025055	['Dha treatment\nwj-Mscs were incubated with different concentrations of Dha (sigma, d2534) before rna isolation or measurement of Mitochondrial ocr.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('CL_0000186', 'myofibroblast cell', 17, 'MSCs'), ('CHEBI_17874', 'dihydrozeatin', 70, 'DHA'), ('GO_0005739', 'mitochondrion', 128, 'mitochondrial')]
PMC5025055	9/2016	S114-PMC5025055	['(a) basal and Drug-stimulated Mitochondrial oxygen consumption rates (ocr) between 9 sga and 5 aga lines as measured by the seahorse xf analyser.']	N/A	N/A	[('CHEBI_23888', 'drug', 14, 'drug'), ('GO_0005739', 'mitochondrion', 30, 'mitochondrial')]
PMC5025055	9/2016	S135-PMC5025055	['(c) basal and Drug-induced Mitochondrial ocr in the Mscs was measured after transient Transfection.']	N/A	N/A	[('CHEBI_23888', 'drug', 14, 'drug'), ('GO_0005739', 'mitochondrion', 27, 'mitochondrial'), ('CL_0000186', 'myofibroblast cell', 52, 'MSCs'), ('GO_0009294', 'DNA mediated transformation', 86, 'transfection')]
PMC5025055	9/2016	S223-PMC5025055	['(d) after Sirna Transfection, Mitochondrial ocr was measured in the absence and presence of Drug stimulation in 6 representative Msc lines (msc-01, Msc-56, msc-75, msc-44, msc-57 and msc-60).']	N/A	N/A	[('SO_0000646', 'siRNA', 10, 'siRNA'), ('GO_0009294', 'DNA mediated transformation', 16, 'transfection'), ('GO_0005739', 'mitochondrion', 30, 'mitochondrial'), ('CHEBI_23888', 'drug', 92, 'drug'), ('CL_0000186', 'myofibroblast cell', 129, 'MSC'), ('CL_0000186', 'myofibroblast cell', 148, 'MSC')]
PMC5025055	9/2016	S226-PMC5025055	['elovl2-Regulation of Mitochondrial Genes via dha\nelovl2 is known for catalyzing the elongation of 22-carbon Pufas to 24-carbon precursors necessary for Dha formation.']	N/A	N/A	[('GO_0065007', 'biological regulation', 7, 'regulation'), ('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('SO_0000704', 'gene', 35, 'genes'), ('CHEBI_16382', 'iodide', 98, '22-'), ('CHEBI_86926', 'S a S b S', 108, 'PUFAs'), ('CHEBI_17874', 'dihydrozeatin', 152, 'DHA')]
PMC5025055	9/2016	S233-PMC5025055	['(a) upon treatment of increasing Dha concentration for 24 hrs, Mitochondrial ocr was measured in a representative aga derived Msc line (msc-60).']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 33, 'DHA'), ('GO_0005739', 'mitochondrion', 63, 'mitochondrial'), ('CL_0000186', 'myofibroblast cell', 126, 'MSC')]
PMC5025055	9/2016	S235-PMC5025055	['(b) assessment of Mitochondrial ocr in a representative aga derived Msc line (msc-60) before and after Elovl2 Overexpression, respectively.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 18, 'mitochondrial'), ('CL_0000186', 'myofibroblast cell', 68, 'MSC'), ('PR_000007050', 'emerin', 103, 'ELOVL2'), ('GO_0007308', 'oocyte construction', 110, 'overexpression')]
PMC5025055	9/2016	S243-PMC5025055	['rapidly dividing cells also utilize more Glucose thereby increasing their Glycolytic rate with concomitant decrease in Mitochondrial Oxidative Phosphorylation [23].']	N/A	N/A	[('CHEBI_17234', 'glucose', 41, 'glucose'), ('GO_0006096', 'glycolytic process', 74, 'glycolytic'), ('GO_0005739', 'mitochondrion', 119, 'mitochondrial'), ('GO_0006119', 'oxidative phosphorylation', 133, 'oxidative phosphorylation')]
PMC5025055	9/2016	S248-PMC5025055	['in particular, E2F1 was reported to suppress Oxidative Metabolism by acting as a Metabolic switch changing from Mitochondrial Respiration to increased Glycolysis [35].']	N/A	N/A	[('PR_000006852', 'transcription factor E2F1', 15, 'E2F1'), ('GO_0045333', 'cellular respiration', 45, 'oxidative metabolism'), ('GO_0008152', 'metabolic process', 81, 'metabolic'), ('GO_0005739', 'mitochondrion', 112, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 126, 'respiration'), ('GO_0006096', 'glycolytic process', 151, 'glycolysis')]
PMC5025055	9/2016	S266-PMC5025055	['depletion of Elovl2 (fig 5d) led to similar Mitochondrial ocr changes as sie2f1 (fig 2c) and elovl2 Overexpression was able to reverse the Metabolic phenotype (fig 6bands9b fig).']	N/A	N/A	[('PR_000007050', 'emerin', 13, 'ELOVL2'), ('GO_0005739', 'mitochondrion', 44, 'mitochondrial'), ('GO_0007308', 'oocyte construction', 100, 'overexpression'), ('GO_0008152', 'metabolic process', 139, 'metabolic')]
PMC5025055	9/2016	S322-PMC5025055	['(a) upon treatment with increasing Dha concentration for 24 hrs, Mitochondrial ocr was measured in 3 additional msc lines (msc-44, msc-56 and msc-70).']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 35, 'DHA'), ('GO_0005739', 'mitochondrion', 65, 'mitochondrial')]
PMC5025055	9/2016	S324-PMC5025055	['(b) assessment of Mitochondrial ocr in 2 additional Msc lines (msc-70 and msc-56) before and after Elovl2 Overexpression, respectively.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 18, 'mitochondrial'), ('CL_0000186', 'myofibroblast cell', 52, 'MSC'), ('PR_000007050', 'emerin', 99, 'ELOVL2'), ('GO_0007308', 'oocyte construction', 106, 'overexpression')]
PMC5041052	8/2016	S114-PMC5041052	['these techniques—which include Maternal-spindle transfer, Pronuclear transfer, and Polar Body transfer—involve substituting the maternal Mitochondria in Oocytes with Mitochondria from a healthy donor to prevent the transmission of Mitochondrial Dna (mtdna) diseases from mother to child.']	N/A	N/A	[('GO_0007618', 'mating', 31, 'maternal'), ('GO_0045120', 'pronucleus', 58, 'pronuclear'), ('GO_0042735', 'protein body', 83, 'polar body'), ('GO_0005739', 'mitochondrion', 137, 'mitochondria'), ('CL_0000023', 'oocyte', 153, 'oocytes'), ('GO_0005739', 'mitochondrion', 166, 'mitochondria'), ('GO_0005739', 'mitochondrion', 231, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 231, 'mitochondrial DNA')]
PMC5065689	10/2016	S153-PMC5065689	['2013 [70]us (impaact 1025)cohort2025birth, 6 monthstdf+ vs. tdf-wazno differences in waz at 6 months between groups Mitochondrial toxicity Perinatal safety review working group.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 116, 'Mitochondrial'), ('GO_0036268', 'swimming', 139, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 139, 'Perinatal')]
PMC5065689	10/2016	S156-PMC5065689	['2010 [40]us (wits, pactg 1009)cohort624birth to 5 yearazt-3tc+/hiv+ vs. azt+/hiv+ vs.azt-/hiv+ vs.azt-/hiv-Mitochondrial dna contentdecreased Mitochondrial dna levels(azt or azt-3tc+/hiv+ vs. azt-/hiv-)increased Mitochondrial Dna (azt+/hiv+ vs. azt-/hiv+ & azt-3Tc+/hiv+ vs. azt+/hiv+)brogly et al .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 107, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 142, 'mitochondrial'), ('GO_0005739', 'mitochondrion', 212, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 212, 'mitochondrial DNA'), ('CHEBI_37983', 'sulfur-35 atom', 261, '3TC')]
PMC5065689	10/2016	S158-PMC5065689	['2008 [42]us (actg 5084)cohort136birthcart+/hiv+ vs.cart-/hiv-Mitochondrial dna content; respiratory chain activityincreased Mitochondrial dna levelsno difference in Complex ii:iv ratiocôté et al .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 61, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 124, 'mitochondrial'), ('GO_0032991', 'protein-containing complex', 165, 'Complex')]
PMC5065689	10/2016	S159-PMC5065689	['2008 [43]canadacohort154birth to 6 monthscart+/hiv+ vs.cart-/hiv-Mitochondrial dna contentincreased Mitochondrial dna levelskunz et al .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 65, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 100, 'mitochondrial')]
PMC5065689	10/2016	S160-PMC5065689	['2012 [41]tanzaniacohort83birthazt+/sdnvp+/hiv+ vs.azt-/sdnvp+/hiv+Mitochondrial dna content; Mitochondrial deletion dmtdna4977increased Mitochondrial dna levelsno deletion of dmtdna4977 intermediary Metabolism kirmse et al .']	N/A	N/A	[('GO_0005739', 'mitochondrion', 66, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 93, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 136, 'mitochondrial'), ('GO_0008152', 'metabolic process', 199, 'Metabolism')]
PMC5094567	6/2016	S57-PMC5094567	['in the Embryo, Alcohol (Etoh) is slowly Metabolized to Acetaldehyde and eventually to Acetyl Coa formation in Mitochondria serving as a Metabolite in fat and Lipid Synthesis.']	N/A	N/A	[('UBERON_0000922', 'embryo', 7, 'embryo'), ('CHEBI_30879', 'alcohol', 15, 'alcohol'), ('CHEBI_16236', 'ethanol', 24, 'EtOH'), ('GO_0008152', 'metabolic process', 40, 'metabolized'), ('CHEBI_15343', 'acetaldehyde', 55, 'acetaldehyde'), ('CHEBI_15513', 'acryloyl-CoA', 86, 'acetyl CoA'), ('GO_0097268', 'cytoophidium', 93, 'CoA'), ('GO_0005739', 'mitochondrion', 110, 'mitochondria'), ('CHEBI_39382', 'flufenoxuron', 136, 'metabolite'), ('CHEBI_18059', 'lipid', 158, 'lipid'), ('GO_0008610', 'lipid biosynthetic process', 158, 'lipid synthesis')]
PMC5187359	12/2016	S4-PMC5187359	['the Gene Expression of the Cannabinoid receptors cnr1 and Cnr2 was increased in rc male Hypothalamus, but a down-Expression of most ecbs-Metabolizing enzymes ( faah, Dagl Α , Dagl Β , mgll ) and several key regulators of Fatty-Acid Β-Oxidation ( cpt1b, acox1 ), Mitochondrial Respiration ( Cox4I1 ), and Lipid flux ( ppar γ) was found in their Pat.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'gene expression'), ('SO_0000704', 'gene', 4, 'gene'), ('CHEBI_67194', 'cannabinoid', 27, 'cannabinoid'), ('PR_000004968', 'calretinin', 58, 'Cnr2'), ('UBERON_0001898', 'hypothalamus', 88, 'hypothalamus'), ('GO_0010467', 'gene expression', 113, 'expression'), ('GO_0008152', 'metabolic process', 137, 'metabolizing'), ('PR_000006490', 'solute carrier family 49 member 4', 166, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 175, 'Dagl β'), ('CHEBI_35366', 'fatty acid', 221, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 221, 'fatty-acid β-oxidation'), ('GO_0005739', 'mitochondrion', 262, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 276, 'respiration'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 290, 'Cox4i1'), ('CHEBI_18059', 'lipid', 304, 'lipid'), ('UBERON_0004363', 'pharyngeal arch artery', 344, 'PAT')]
PMC5187359	12/2016	S200-PMC5187359	['long-term effect of Prenatal caloric restriction on the Gene Expression of Lipid and Cholesterol Metabolism in Liver and Perirenal Adipose Tissue of Adult offspring\nGene Expression of relevant Metabolic enzymes Regulating de novo Lipogenesis ( Acaca, Fasn, Scd1 ) and Fatty-Acid Β-Oxidation ( cpt1a, cpt1b, acox1 ), and key regulators of Lipid and Cholesterol Metabolism ( chrebp, Srebp1/2, insig1/2, hmgcr ) and Mitochondrial Respiration ( Ucp1, Cox4I1 ) was also evaluated in the Liver and the Pat (figure5).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('GO_0010467', 'gene expression', 56, 'gene expression'), ('SO_0000704', 'gene', 56, 'gene'), ('CHEBI_18059', 'lipid', 75, 'lipid'), ('GO_0006266', 'DNA ligation', 75, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 85, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 85, 'cholesterol metabolism'), ('UBERON_0002107', 'liver', 111, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 121, 'perirenal adipose tissue'), ('UBERON_0007023', 'adult organism', 149, 'adult'), ('GO_0010467', 'gene expression', 165, 'Gene expression'), ('SO_0000704', 'gene', 165, 'Gene'), ('GO_0008152', 'metabolic process', 193, 'metabolic'), ('GO_0065007', 'biological regulation', 211, 'regulating'), ('GO_0008610', 'lipid biosynthetic process', 230, 'lipogenesis'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 244, 'Acaca'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 251, 'Fasn'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 257, 'Scd1'), ('CHEBI_35366', 'fatty acid', 268, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 268, 'fatty-acid β-oxidation'), ('CHEBI_18059', 'lipid', 338, 'lipid'), ('GO_0006266', 'DNA ligation', 338, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 348, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 348, 'cholesterol metabolism'), ('PR_000015909', 'synaptotagmin-7', 381, 'Srebp1'), ('GO_0005739', 'mitochondrion', 413, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 427, 'respiration'), ('PR_000016970', 'ubiquitin-conjugating enzyme E2 D4', 441, 'Ucp1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 447, 'Cox4i1'), ('UBERON_0002107', 'liver', 482, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 496, 'PAT')]
PMC5187359	12/2016	S201-PMC5187359	['caption (fig): figure 5\n\neffect of Prenatal caloric restriction on the Gene Expression of enzymes and regulators of the Lipogenesis ( chrebp , acaca , Fasn , Scd1 ), Fatty-Acid Β-Oxidation ( cpt1a/b , acox1 ), Cholesterol Metabolism ( srebf1/2 , insig1/2 , hmgcr ), and Thermogenesis/Mitochondria Respiration ( Ucp1 , Cox4I1 ) in the Liver (a,b) and/or Perirenal Adipose Tissue (Pat) (c,d) of male and female offspring at Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 120, 'lipogenesis'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 151, 'Fasn'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 158, 'Scd1'), ('CHEBI_35366', 'fatty acid', 166, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 166, 'fatty-acid β-oxidation'), ('CHEBI_16113', 'cholesterol', 210, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 210, 'cholesterol metabolism'), ('GO_0031649', 'heat generation', 270, 'thermogenesis'), ('GO_0000085', 'mitotic G2 phase', 284, 'mitochondria'), ('GO_0005739', 'mitochondrion', 284, 'mitochondria'), ('GO_0045333', 'cellular respiration', 297, 'respiration'), ('PR_000016970', 'ubiquitin-conjugating enzyme E2 D4', 311, 'Ucp1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 318, 'Cox4i1'), ('UBERON_0002107', 'liver', 334, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 353, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 379, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 422, 'adulthood')]
PMC5187359	12/2016	S304-PMC5187359	['the Pat of Adult male offspring from calorie-restricted dams specifically exhibited a decrease in the Gene Expression of the β-Oxidation enzymes cpt1b and acox1 , the Mitochondrial Respiratory Chain subunit Cox4I1 and the Lipid Storage-stimulating transcription factor ppar γ.']	N/A	N/A	[('UBERON_0004363', 'pharyngeal arch artery', 4, 'PAT'), ('UBERON_0007023', 'adult organism', 11, 'adult'), ('GO_0010467', 'gene expression', 102, 'gene expression'), ('SO_0000704', 'gene', 102, 'gene'), ('GO_0006196', 'AMP catabolic process', 126, '-oxidation'), ('GO_0005739', 'mitochondrion', 167, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 181, 'respiratory'), ('GO_0099537', 'trans-synaptic signaling', 181, 'respiratory'), ('SO_0000100', 'endogenous_retroviral_gene', 193, 'chain'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 207, 'Cox4i1'), ('CHEBI_18059', 'lipid', 222, 'lipid'), ('GO_0019915', 'lipid storage', 222, 'lipid storage')]
PMC5215441	7/2016	S208-PMC5215441	['caption (table-wrap): table 3\n\ncorrelation analysis of the top‐25 Genes with the highest iqrnrsymboldescriptionchr r> 0.75 witha r<−0.75 witha1xistinactive x‐specific Transcriptsx——2eif2s3yeukaryotic Translation Initiation Factor 2, Subunit 3, structural gene Y‐linkedy——3utyubiquitously transcribed tetratricopeptide repeat Gene, Y Chromosomey——4ddx3ydead (asp‐glu‐ala‐asp) box polypeptide 3, y‐linkedy——5kdm5dlysine (k)‐specific demethylase 5dy——6lect2bleukocyte Cell‐derived chemotaxin 213Lb,p7gm10768predicted Gene 1076819—b,p8g6pcbglucose‐6‐phosphatase, Catalytic11—b,p9lctblactase1lb,p10sval1seminal Vesicle Antigen‐Like 16—–11lyz1blysozyme 110—b,p12fgf15bfibroblast Growth Factor 157——13hyal5hyaluronoglucosaminidase 56—b,p14saa1bserum Amyloid A 17——15fabp6bfatty Acid Binding Protein 6, ileal (gastrotropin)11——16Abcc2Batp‐Binding Cassette, Subfamily C (Cftr/Mrp), Member 219—b,p17slc6a19bsolute Carrier Family 6 (Neurotransmitter Transporter), member 1913—b,p18mamdc4mam Domain Containing 42—b,p19olfm4bolfactomedin 414——20nplbn‐acetylneuraminate Pyruvate lyase1——21mfi2bantigen P97 (melanoma associated)16——22abcg5batp‐binding Cassette, sub‐family g (White), Member 517——23smcpsperm Mitochondria‐Associated Cysteine‐Rich Protein3—b,p24slc23a1bsolute Carrier Family 23 (Nucleobase Transporters), member 118—b,p25lgals2lectin, Galactose‐binding, soluble 215——\npls‐based canonical correlation.']	N/A	N/A	[('SO_0000704', 'gene', 66, 'genes'), ('SO_0000673', 'transcript', 167, 'transcriptsX'), ('GO_0006413', 'translational initiation', 200, 'translation initiation'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 200, 'translation initiation factor 2, subunit 3'), ('GO_0000806', 'Y chromosome', 260, 'Y'), ('SO_0000704', 'gene', 325, 'gene'), ('GO_0000806', 'Y chromosome', 331, 'Y chromosomeY'), ('CL_0000573', 'retinal cone cell', 465, 'cell'), ('PR_000005050', 'kinetochore scaffold 1', 489, '213LB'), ('SO_0000704', 'gene', 514, 'gene'), ('PR_000005269', 'cyclin-dependent kinase-like 1', 559, 'catalytic11'), ('GO_0031982', 'vesicle', 606, 'vesicle'), ('PR_000017279', 'testis-specific basic protein Y 1', 606, 'vesicle antigen‐like 16'), ('CHEBI_59132', 'antigen', 614, 'antigen'), ('PR_000007893', 'GTP cyclohydrolase 1', 673, 'growth factor 157'), ('PR_000008840', 'huntingtin', 724, '56'), ('CHEBI_60425', 'amyloid fibril', 743, 'amyloid'), ('PR_000005908', 'alpha-crystallin B chain', 743, 'amyloid A'), ('CHEBI_37527', 'acid', 771, 'acid'), ('PR_000003609', 'Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3', 771, 'acid binding protein 6'), ('PR_000003930', 'methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial', 819, '16Abcc2bATP ... binding cassette, subfamily C ...'), ('SO_0005853', 'gene_cassette', 839, 'cassette'), ('PR_000005170', 'CD37 molecule', 862, 'CFTR ...'), ('PR_000029690', 'POTE ankyrin domain family member E', 867, 'MRP ... member 219'), ('PR_000005170', 'CD37 molecule', 904, 'carrier family 6 ...'), ('CHEBI_25512', 'neurotransmitter', 922, 'neurotransmitter'), ('PR_000014933', 'solute carrier family 13 member 1', 922, 'neurotransmitter transporter ...'), ('PR_000006364', 'ATP-dependent RNA helicase DDX3X', 980, 'domain containing 42'), ('SO_0000417', 'polypeptide_domain', 980, 'domain'), ('PR_000017550', '14-3-3 protein gamma', 1025, '414'), ('CHEBI_15361', 'pyruvate', 1056, 'pyruvate'), ('PR_000005409', 'chromodomain-helicase-DNA-binding protein 3', 1088, 'p97'), ('SO_0005853', 'gene_cassette', 1137, 'cassette'), ('PR_000017403', 'Wee1-like protein kinase', 1161, 'WHITE'), ('PR_000010283', 'mediator of RNA polymerase II transcription subunit 12-like protein', 1169, 'member 517'), ('GO_0005739', 'mitochondrion', 1193, 'mitochondria'), ('PR_000029620', 'MARVEL domain-containing protein 3', 1193, 'mitochondria‐associated cysteine‐rich protein3'), ('PR_000005159', 'scavenger receptor cysteine-rich type 1 protein M160', 1260, 'carrier family 23'), ('PR_000014938', 'urea transporter 1', 1279, 'nucleobase transporters'), ('CHEBI_28260', 'galactose', 1335, 'galactose')]
PMC5216338	1/2017	S11-PMC5216338	['exogenous Cort administration causes abnormal accumulation of fat in the Liver67, which is manifested with Mitochondrial dysfunction, Lipid Peroxidation and inflammation, thereby increasing the susceptibility of Liver to more severe damages68.']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 10, 'CORT'), ('UBERON_0001113', 'lobe of liver', 73, 'liver67'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('CHEBI_18059', 'lipid', 134, 'lipid'), ('GO_0032622', 'interleukin-19 production', 134, 'lipid peroxidation'), ('UBERON_0002107', 'liver', 212, 'liver')]
PMC5216338	1/2017	S14-PMC5216338	['Fatty Acids Β-Oxidation in the Liver is Regulated by Carnitine Palmitoyl Transferase 1 (Cpt-1) that catalyzes the rate-limiting step of Fatty Acid oxidation210, and the key transcription factor Peroxiisome Proliferator-Activated Receptor Alpha (Pparα) that activates Mitochondrial β-Oxidation and Oxidative Phosphorylation (oxphos)14.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acids'), ('GO_0019395', 'fatty acid oxidation', 0, 'Fatty acids β-oxidation'), ('UBERON_0002107', 'liver', 31, 'liver'), ('GO_0065007', 'biological regulation', 40, 'regulated'), ('CHEBI_48080', 'brefeldin A', 53, 'carnitine palmitoyl'), ('PR_000005448', 'chondroitin sulfate synthase 2', 53, 'carnitine palmitoyl transferase 1'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 88, 'CPT-1'), ('CHEBI_35366', 'fatty acid', 136, 'fatty acid'), ('GO_0005777', 'peroxisome', 194, 'peroxiisome'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 194, 'peroxiisome proliferator-activated receptor alpha'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 245, 'PPARα'), ('GO_0005739', 'mitochondrion', 267, 'mitochondrial'), ('GO_0006196', 'AMP catabolic process', 282, '-oxidation'), ('GO_0006119', 'oxidative phosphorylation', 297, 'oxidative phosphorylation')]
PMC5216338	1/2017	S16-PMC5216338	['gr, a transcription factor belonging to the superfamily of Nuclear receptors, can also translocate to Mitochondria to Regulate the Replication and transcription Of Mitochondrial Dna (mtdna) in mammals17and hepg2 cells18.']	N/A	N/A	[('GO_0005634', 'nucleus', 59, 'nuclear'), ('GO_0005739', 'mitochondrion', 102, 'mitochondria'), ('GO_0065007', 'biological regulation', 118, 'regulate'), ('GO_0006264', 'mitochondrial DNA replication', 131, 'replication ... of mitochondrial DNA'), ('GO_0005739', 'mitochondrion', 164, 'mitochondrial')]
PMC5216338	1/2017	S101-PMC5216338	['oxphos Genes Expression, mtdna copy number and cox enzyme activity\nthe structure chart of rugao yellow chicken Mitochondria is shown infig.']	N/A	N/A	[('SO_0000704', 'gene', 7, 'genes'), ('GO_0010467', 'gene expression', 13, 'expression'), ('GO_0005739', 'mitochondrion', 111, 'mitochondria')]
PMC5216338	1/2017	S116-PMC5216338	['6d) and Mitochondrial Transcription Factor A (Tfam) protein content (fig.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 8, 'mitochondrial'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 8, 'mitochondrial transcription factor A'), ('PR_000016282', 'transferrin receptor protein 2', 46, 'TFAM')]
PMC5216338	1/2017	S155-PMC5216338	['furthermore, betaine was shown to attenuate the Liver injury and oxidative stress induced by Ethanol through improving Mitochondrial function in rats45.']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('CHEBI_16236', 'ethanol', 93, 'ethanol'), ('GO_0005739', 'mitochondrion', 119, 'mitochondrial')]
PMC5216338	1/2017	S219-PMC5216338	['western blot analysis for Methionine Adenosyltransferase 2B (Mat2B) (15952–1-ap, proteintech, usa, diluted 1:1000), dna (cytosine-5-)-methyltransferase 1 (Dnmt1) (sc-20701, santa cruz, uk, diluted 1:200), gr (sc-1004, santa cruz, uk, diluted 1:200), 11Β-Hsd Type 1 (11Β-Hsd1) (ab109554, abcam, uk, diluted 1:1000), type 2 11Β-Hsd (11Β-Hsd2) (sc-20176, santa cruz, uk, diluted 1:200), Pparα (ab2779, abcam, uk, diluted 1:1000), Mitochondrial Transcription Factor A (Tfam) (bs7319, bioworld technology, usa, diluted 1:1000), Cox4 (ap0707, bioworld technology, usa, diluted 1:1000) were carried out according to the recommended protocols provided by the manufacturers.']	N/A	N/A	[('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 26, 'methionine adenosyltransferase 2B'), ('PR_000010220', 'mannose-binding protein C', 61, 'MAT2B'), ('CHEBI_70385', 'Ludongnin F', 130, '5-)-'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 152, '1'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 155, 'DNMT1'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 250, '11β-HSD type 1'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 266, '11β-HSD1'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 322, '11β-HSD'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 331, '11β-HSD2'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 384, 'PPARα'), ('GO_0005739', 'mitochondrion', 427, 'mitochondrial'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 427, 'mitochondrial transcription factor A'), ('PR_000016282', 'transferrin receptor protein 2', 465, 'TFAM'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 523, 'COX4')]
PMC5216338	1/2017	S224-PMC5216338	['for measuring cox enzyme activity, Liver Mitochondria were isolated according to a previously described protocol53.']	N/A	N/A	[('UBERON_0002107', 'liver', 35, 'liver'), ('GO_0005739', 'mitochondrion', 41, 'mitochondria')]
PMC5303734	2/2017	S16-PMC5303734	['this process recycles intact Mitochondrial fragments to generate new healthy Mitochondria through fission and fusion (bereiter-hahn,1990; westermann,2010) to maintain Mitochondrial integrity.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 29, 'mitochondrial'), ('GO_0005739', 'mitochondrion', 77, 'mitochondria'), ('GO_0005739', 'mitochondrion', 167, 'mitochondrial')]
PMC5303734	2/2017	S20-PMC5303734	['this is due to the changes of Mitochondrial dynamics in the Brain from Birth to Adulthood (hagberg et al.,2014).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 30, 'mitochondrial'), ('UBERON_0000955', 'brain', 60, 'brain'), ('GO_0007567', 'parturition', 71, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 80, 'adulthood')]
PMC5303734	2/2017	S42-PMC5303734	['Brains were homogenized using Lysis buffer for whole protein and Mitochondrial protein extraction as previously described (nguyen et al.,2015).']	N/A	N/A	[('UBERON_0000955', 'brain', 0, 'Brains'), ('GO_0019835', 'cytolysis', 30, 'lysis'), ('GO_0005739', 'mitochondrion', 65, 'mitochondrial')]
PMC5303734	2/2017	S76-PMC5303734	['maternal L-Carnitine supplementation significantly normalized Mitochondrial Drp-1 and reduced Fis-1 levels in the se offspring ( p< 0.05, figures1a,d), but had no impact on Pink-1, Parkin and Opa-1 proteins at p1 (figures1g,j,m).']	N/A	N/A	[('CHEBI_16857', 'L-threonine', 9, 'L-Carnitine'), ('GO_0005739', 'mitochondrion', 62, 'mitochondrial'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 76, 'Drp-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 94, 'Fis-1'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 173, 'Pink-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 181, 'Parkin'), ('PR_000012086', 'homeobox protein OTX2', 192, 'Opa-1')]
PMC5303734	2/2017	S78-PMC5303734	['the other Mitochondrial fission and fusion markers were not different among the three experimental groups (figures1b,h,k,n).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 10, 'mitochondrial')]
PMC5303734	2/2017	S79-PMC5303734	['at 13 weeks, Brain Mitochondrial levels of Drp-1, Fis-1, and Opa-1 were decreased in the se offspring ( p< 0.05, figures1c,f,o).']	N/A	N/A	[('UBERON_0000955', 'brain', 13, 'brain'), ('GO_0005739', 'mitochondrion', 19, 'mitochondrial'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 43, 'Drp-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 50, 'Fis-1'), ('PR_000012086', 'homeobox protein OTX2', 61, 'Opa-1')]
PMC5303734	2/2017	S80-PMC5303734	['with L-Carnitine supplementation, Mitochondrial Drp-1 and Pink-1 protein level was significantly increased in selc compared with the se offspring ( p< 0.01, figure1c); Opa-1 levels were normalized ( p< 0.05, figures1c,i,o).']	N/A	N/A	[('CHEBI_16857', 'L-threonine', 5, 'L-Carnitine'), ('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 48, 'Drp-1'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 58, 'Pink-1'), ('PR_000012086', 'homeobox protein OTX2', 168, 'Opa-1')]
PMC5303734	2/2017	S82-PMC5303734	['caption (fig): figure 1\n\nBrain Mitochondria protein levels of Drp-1 (a–c) , Fis-1 (d–f) , pink-1 (g–i) , Parkin (j–l) and Opa-1 (m–o) in the male Sham, se and selc dams ( n = 4) at different ages.']	N/A	N/A	[('UBERON_0000955', 'brain', 25, 'Brain'), ('GO_0005739', 'mitochondrion', 31, 'mitochondria'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 62, 'Drp-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 76, 'Fis-1'), ('PR_000000037', 'BMP receptor type-2', 94, '-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 105, 'Parkin'), ('PR_000012086', 'homeobox protein OTX2', 122, 'Opa-1'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 146, 'SHAM')]
PMC5303734	2/2017	S97-PMC5303734	['caption (fig): figure 3\n\nBrain Mitochondria protein levels of Mnsod (a–c) , Tom-20 (d–f) , oxphos Complexes i-iv (g–i) in the male Sham, se and selc dams ( n = 4) at different ages.']	N/A	N/A	[('UBERON_0000955', 'brain', 25, 'Brain'), ('GO_0005739', 'mitochondrion', 31, 'mitochondria'), ('PR_000010875', 'myoblast determination protein 1', 62, 'MnSOD'), ('PR_000016500', 'tenomodulin', 76, 'Tom-20'), ('GO_0032991', 'protein-containing complex', 98, 'Complexes'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 131, 'SHAM')]
PMC5303734	2/2017	S129-PMC5303734	['Mitophagy markers\nat p1, Mitochondrial Fission markers Drp-1, Fis-1 and Parkin were significantly decreased in the se compared to Sham offspring ( p< 0.05, Drp-1 and Parkin; p< 0.01 Fis-1; figures5a,d,j).']	N/A	N/A	[('GO_0000422', 'autophagy of mitochondrion', 0, 'Mitophagy'), ('GO_0005739', 'mitochondrion', 25, 'mitochondrial'), ('GO_0007631', 'feeding behavior', 39, 'fission'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 55, 'Drp-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 62, 'Fis-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 72, 'Parkin'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 130, 'SHAM'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 156, 'Drp-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 166, 'Parkin'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 182, 'Fis-1')]
PMC5303734	2/2017	S130-PMC5303734	['Mitochondrial Opa-1 was significantly higher in the se offspring ( p< 0.05, figure5m).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('PR_000010700', 'metallothionein-1H', 0, 'Mitochondrial'), ('PR_000012086', 'homeobox protein OTX2', 14, 'Opa-1')]
PMC5303734	2/2017	S132-PMC5303734	['at p20, Mitochondrial Drp-1 and Parkin levels were still decreased in the se offspring ( p< 0.05, figures5b,k), which were not affected by maternal L-Carnitine treatment during Gestation and Lactation (figures5b,e,h,k,n).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 8, 'mitochondrial'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 22, 'Drp-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 32, 'Parkin'), ('CHEBI_16857', 'L-threonine', 148, 'L-Carnitine'), ('GO_0007565', 'female pregnancy', 177, 'gestation'), ('GO_0007595', 'lactation', 191, 'lactation')]
PMC5303734	2/2017	S135-PMC5303734	['caption (fig): figure 5\n\nBrain Mitochondria protein levels of Drp-1 (a–c) , Fis-1 (d–f) , pink-1 (g–i) , Parkin (j–l) and Opa-1 (m–o) in the female Sham, se and selc dams ( n = 4) at different ages.']	N/A	N/A	[('UBERON_0000955', 'brain', 25, 'Brain'), ('GO_0005739', 'mitochondrion', 31, 'mitochondria'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 62, 'Drp-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 76, 'Fis-1'), ('PR_000000037', 'BMP receptor type-2', 94, '-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 105, 'Parkin'), ('PR_000012086', 'homeobox protein OTX2', 122, 'Opa-1'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 148, 'SHAM')]
PMC5303734	2/2017	S148-PMC5303734	['Mitochondrial functional markers\nthere was no significant difference in Mnsod, Tom-20 and oxphos Complexes among the three groups at p1 (figures7a,d,g).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('PR_000010875', 'myoblast determination protein 1', 72, 'MnSOD'), ('PR_000016500', 'tenomodulin', 79, 'Tom-20'), ('GO_0032991', 'protein-containing complex', 97, 'complexes')]
PMC5303734	2/2017	S153-PMC5303734	['caption (fig): figure 7\n\nBrain Mitochondria protein levels of Mnsod (a–c) , Tom-20 (d–f) , oxphos Complexes i-iv (g–i) in the female Sham, se and selc dams ( n = 4) at different ages.']	N/A	N/A	[('UBERON_0000955', 'brain', 25, 'Brain'), ('GO_0005739', 'mitochondrion', 31, 'mitochondria'), ('PR_000010875', 'myoblast determination protein 1', 62, 'MnSOD'), ('PR_000016500', 'tenomodulin', 76, 'Tom-20'), ('GO_0032991', 'protein-containing complex', 98, 'Complexes'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 133, 'SHAM')]
PMC5303734	2/2017	S181-PMC5303734	['fission can fragment damaged Mitochondrial parts to remove the dysfunctional components in the Autophagosome by Autophagy.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 29, 'mitochondrial'), ('GO_0005776', 'autophagosome', 95, 'autophagosome'), ('GO_0006914', 'autophagy', 112, 'autophagy')]
PMC5303734	2/2017	S183-PMC5303734	['the damaged Mitochondrial fragments are then tagged by Pink-1, followed by the recruitment of Parkin which ubiquitinates Outer Membrane proteins (narendra et al.,2008).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 12, 'mitochondrial'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 55, 'Pink-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 94, 'Parkin'), ('GO_0019867', 'outer membrane', 121, 'outer membrane')]
PMC5303734	2/2017	S184-PMC5303734	['through Pink-1 and Parkin, damaged Mitochondrial fragments can be eliminated (narendra et al.,2008) by Autophagy.']	N/A	N/A	[('PR_000013508', 'PX domain-containing protein kinase-like protein', 8, 'Pink-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 19, 'Parkin'), ('GO_0005739', 'mitochondrion', 35, 'mitochondrial'), ('GO_0006914', 'autophagy', 103, 'autophagy')]
PMC5325607	2/2017	S220-PMC5325607	['additionally, citrate synthase activity as a marker for Mitochondria density was not affected by the maternal diet while it was significantly higher in the offspring with rw access (fig 6b).']	N/A	N/A	[('GO_0005739', 'mitochondrion', 56, 'mitochondria')]
PMC5417583	5/2017	S58-PMC5417583	['our Metabolism runs faster with higher energy expenditure measured as calories burnt (27% more than chimps and more than that in Gorillas): this can only happen by boosting Mitochondrial function.']	N/A	N/A	[('GO_0008152', 'metabolic process', 4, 'metabolism'), ('NCBITaxon_10088', 'Mus <genus>', 129, 'gorillas'), ('GO_0005739', 'mitochondrion', 173, 'mitochondrial')]
PMC5417583	5/2017	S154-PMC5417583	['dietary Intake of Nicotinamide, Nicotinamide-riboside, and Nicotinamide mononucleotide improves Metabolic health and restores Mitochondrial function whether measured by Respiration, Membrane Potential, Atp Production Apoptosis, Autophagy, or the unfolded response with less degeneration and more active Stem Cells.358supplementation works for Genetic versions of premature Ageing and defects in Dna Repair with resulting Sirt inactivation.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_17154', 'nicotinamide', 18, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 32, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 59, 'nicotinamide'), ('GO_0008152', 'metabolic process', 96, 'metabolic'), ('GO_0005739', 'mitochondrion', 126, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 169, 'respiration'), ('GO_0045121', 'membrane raft', 182, 'membrane potential'), ('GO_0006754', 'ATP biosynthetic process', 202, 'ATP production'), ('GO_0006915', 'apoptotic process', 217, 'apoptosis'), ('GO_0006914', 'autophagy', 228, 'autophagy'), ('CL_0000034', 'stem cell', 303, 'stem cells'), ('SO_0000704', 'gene', 343, 'genetic'), ('GO_0007568', 'aging', 373, 'ageing'), ('GO_0006281', 'DNA repair', 395, 'DNA repair'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 421, 'SIRT')]
PMC5420136	5/2017	S160-PMC5420136	['reduced protein deposition in Skeletal muscle and increased fat accretion in iugr fetuses or offspring result from the abnormal Metabolic Regulation Of Intracellular Protein Turnover, Adipogenesis, and Mitochondrial biogenesis [5].']	N/A	N/A	[('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('GO_0008152', 'metabolic process', 128, 'metabolic'), ('GO_0006355', 'regulation of transcription, DNA-templated', 138, 'regulation of ... protein turnover'), ('GO_0005622', 'intracellular anatomical structure', 152, 'intracellular'), ('GO_0060612', 'adipose tissue development', 184, 'adipogenesis'), ('GO_0005739', 'mitochondrion', 202, 'mitochondrial')]
PMC5442804	9/2016	S84-PMC5442804	['the cell type composition of engrafted cells was assessed by using immunofluorescence followed by confocal microscopy analysis in coronal Brain sections (three fields per section; three slices per Mouse) using anti‐Hnuclei or anti‐Mitochondria Antibodies in combination with Antibodies against lineage‐specific markers and Nuclear counterstaining.']	N/A	N/A	[('UBERON_0000955', 'brain', 138, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 197, 'mouse'), ('GO_0005682', 'U5 snRNP', 215, 'hNuclei'), ('GO_0005739', 'mitochondrion', 231, 'mitochondria'), ('GO_0042571', 'immunoglobulin complex, circulating', 244, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 275, 'antibodies'), ('GO_0005634', 'nucleus', 323, 'nuclear')]
PMC5442804	9/2016	S319-PMC5442804	['Human cells engrafted in mld Brains were detected by means of Antibodies that specifically recognize Human Mitochondrial (hmito) and Nuclear (Hnuclei) proteins39(fig.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0000955', 'brain', 29, 'brains'), ('GO_0042571', 'immunoglobulin complex, circulating', 62, 'antibodies'), ('NCBITaxon_9606', 'Homo sapiens', 101, 'human'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('GO_0005634', 'nucleus', 133, 'nuclear'), ('GO_0005682', 'U5 snRNP', 142, 'hNuclei')]
PMC5442804	9/2016	S368-PMC5442804	['abbreviations: Ac, Anterior Commissure; arsa, Arylsulfatase a; Cb, Cerebellum; Cc, Corpus Callosum; Dapi, 4′,6‐Diamidino‐2‐Phenylindole; Gst‐Π, Glutathione s ‐transferase‐π; hfim, hippocampal fimbria; hips‐Nscs, Human Induced Pluripotent Stem Cell‐derived Neural Stem Cells; hmito, Human Mitochondrial Protein; m, months; mld, metachromatic leukodystrophy; nd, normal donor; pnd60, Postnatal day 60; Sc, Spinal Cord; Tel, Telencephalon; tx, transplanted; ut, untreated; wt, wild type.']	N/A	N/A	[('UBERON_2000468', 'anterior crista primordium', 15, 'AC'), ('UBERON_0000935', 'anterior commissure', 19, 'anterior commissure'), ('CHEBI_22649', 'arylpyrone', 46, 'arylsulfatase'), ('UBERON_0002037', 'cerebellum', 63, 'Cb'), ('UBERON_0002037', 'cerebellum', 67, 'cerebellum'), ('UBERON_0002037', 'cerebellum', 79, 'CC'), ('UBERON_0002336', 'corpus callosum', 83, 'corpus callosum'), ('CHEBI_51231', 'DAPI', 100, 'DAPI'), ('CHEBI_61268', '5-nitrosalicylate', 106, '4′,6‐diamidino‐2'), ('CHEBI_48559', 'phenylindole', 123, 'phenylindole'), ('PR_000008294', 'glutathione S-transferase A1', 137, 'GST'), ('PR_000007591', 'protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha', 141, 'π'), ('CHEBI_16856', 'glutathione', 144, 'glutathione'), ('PR_000007999', 'gap junction beta-3 protein', 144, 'glutathione'), ('CL_0000047', 'neuronal stem cell', 206, 'NSCs'), ('NCBITaxon_9606', 'Homo sapiens', 212, 'human'), ('CL_0000023', 'oocyte', 218, 'induced'), ('CL_0002248', 'pluripotent stem cell', 226, 'pluripotent stem cell'), ('CL_0000047', 'neuronal stem cell', 256, 'neural stem cells'), ('NCBITaxon_9606', 'Homo sapiens', 282, 'human'), ('GO_0005739', 'mitochondrion', 288, 'mitochondrial'), ('PR_000010505', 'MOB kinase activator 1A', 288, 'mitochondrial protein'), ('GO_0007567', 'parturition', 382, 'postnatal'), ('UBERON_0004198', 'comma-shaped body', 400, 'SC'), ('UBERON_0002240', 'spinal cord', 404, 'spinal cord'), ('PR_000016222', 'alpha-tectorin', 417, 'Tel'), ('UBERON_0001893', 'telencephalon', 422, 'telencephalon')]
PMC5485170	3/2017	S35-PMC5485170	['it is formed Intracellularly by ‘leakage’ (premature outflow) of Electrons from the Mitochondrial Respiratory Chain or from microsomal redox‐active enzymes, and their subsequent reaction with oxygen (e.g., bhattacharyya et\xa0al ,2014).']	N/A	N/A	[('GO_0005622', 'intracellular anatomical structure', 13, 'intracellularly'), ('CHEBI_16016', 'dihydroxyacetone', 65, 'electrons'), ('GO_0005739', 'mitochondrion', 84, 'mitochondrial'), ('GO_0045472', 'response to ether', 98, 'respiratory chain')]
PMC5523023	7/2017	S26-PMC5523023	['the endogenous sources of Ros are Cell Organelles (Mitochondria, Peroxisomes, Endoplasmic Reticulum), various enzymes and enzymatic Complexes (e.g., Cytochrome P450, nadph oxidases, Nitric Oxide synthase, Xanthine oxidase), Immune and non-Immune Cells (especially Phagocytes, Activated Eosinophils and Neutrophils, Monocytes and Macrophages, Airway Epithelial and Smooth Muscle Cells, Endothelium), and others (e.g., Heme proteins, reactions of metal Ions).']	N/A	N/A	[('CHEBI_8756', 'RNA (poly(A))', 26, 'ROS'), ('GO_0009986', 'cell surface', 34, 'cell organelles'), ('GO_0005739', 'mitochondrion', 51, 'mitochondria'), ('GO_0005777', 'peroxisome', 65, 'peroxisomes'), ('GO_0005783', 'endoplasmic reticulum', 78, 'endoplasmic reticulum'), ('GO_0032991', 'protein-containing complex', 132, 'complexes'), ('CHEBI_4056', 'cytochrome', 149, 'cytochrome'), ('PR_000006100', 'aromatase', 149, 'cytochrome P450'), ('CHEBI_16480', 'nitric oxide', 182, 'nitric oxide'), ('CHEBI_17957', '5-(2-hydroxyethyl)-4-methylthiazole', 205, 'xanthine'), ('CL_0000738', 'leukocyte', 224, 'immune ... immune cells'), ('UBERON_0002405', 'immune system', 224, 'immune'), ('UBERON_0002405', 'immune system', 239, 'immune'), ('CL_0000234', 'phagocyte', 264, 'phagocytes'), ('CL_0002627', 'mature astrocyte', 276, 'activated'), ('CL_0000771', 'eosinophil', 286, 'eosinophils'), ('CL_0000775', 'neutrophil', 302, 'neutrophils'), ('CL_0000576', 'monocyte', 315, 'monocytes'), ('CL_0000235', 'macrophage', 329, 'macrophages'), ('UBERON_0003209', 'blood nerve barrier', 342, 'airway epithelial'), ('CL_0000066', 'epithelial cell', 349, 'epithelial'), ('CL_0000192', 'smooth muscle cell', 364, 'smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 364, 'smooth muscle'), ('UBERON_0001986', 'endothelium', 385, 'endothelium'), ('CHEBI_30413', 'heme', 417, 'heme'), ('CHEBI_24870', 'ion', 451, 'ions')]
PMC5523023	7/2017	S50-PMC5523023	['various exogenous factors promote and amplify the inflammation and also increased the formation of Reactive Species via many mechanisms (e.g., induction of Mitochondrial dysfunction, dna Repair mechanisms damage).']	N/A	N/A	[('CHEBI_26523', 'reactive oxygen species', 99, 'reactive species'), ('GO_0008380', 'RNA splicing', 108, 'species'), ('GO_0005739', 'mitochondrion', 156, 'mitochondrial'), ('GO_0006281', 'DNA repair', 187, 'repair')]
PMC5580292	9/2017	S133-PMC5580292	['lcfas are first Transformed into Acyl Coa, then transferred into Mitochondria after combining with Carnitine where it is oxidized.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 16, 'transformed'), ('CHEBI_15347', 'acetone', 33, 'acyl CoA'), ('GO_0005739', 'mitochondrion', 65, 'mitochondria'), ('CHEBI_17126', 'carnitine', 99, 'carnitine')]
PMC5627472	10/2017	S94-PMC5627472	['Pgc1Α is the master regulator of Mitochondrial biogenesis, and Pgc1Α mrna Expression is reduced in the Skeletal muscle from subjects with type 2 diabetes [63].']	N/A	N/A	[('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 0, 'PGC1α'), ('GO_0005739', 'mitochondrion', 33, 'mitochondrial'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 63, 'PGC1α'), ('GO_0010467', 'gene expression', 74, 'expression'), ('UBERON_0004288', 'skeleton', 103, 'skeletal')]
PMC5644840	4/2014	S233-PMC5644840	['beside telomere shortening, mutations and aberrations of Mitochondrial dna (mtdna) are Ageing-related hallmarks.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 57, 'mitochondrial'), ('GO_0007568', 'aging', 87, 'ageing')]
PMC5644840	4/2014	S238-PMC5644840	['then, Mitochondrial dysfunction leads to impaired Metabolic- as well as Energetic Homeostasis and increased os which sustain a feed-forward cycle of further dna damage and Mitochondrial dysfunction.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 6, 'mitochondrial'), ('GO_0008152', 'metabolic process', 50, 'metabolic ...'), ('GO_0097009', 'energy homeostasis', 72, 'energetic homeostasis'), ('GO_0005739', 'mitochondrion', 172, 'mitochondrial')]
PMC5678092	11/2017	S43-PMC5678092	['as a Mitochondrial functional marker we chose the widely utilised citrate synthase activity.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 5, 'mitochondrial')]
PMC5678092	11/2017	S91-PMC5678092	['Mitochondrial dna copy number and quantitative rt-pcr\nMitochondrial dna copy number was measured by qpcr as previousy described26.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('GO_0005739', 'mitochondrion', 54, 'Mitochondrial')]
PMC5678092	11/2017	S93-PMC5678092	['Sybr Green qpcr (sensifast Sybr, bioline) was used to determine Mitochondrial Dna copy number.']	N/A	N/A	[('CHEBI_51461', 'SYBR Green I', 0, 'SYBR green'), ('CHEBI_87158', 'SU1498', 27, 'SYBR'), ('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 64, 'mitochondrial DNA')]
PMC5678092	11/2017	S94-PMC5678092	['two Primers were used, 36b4 for the Nuclear Genome (amplifies a Region Of the Rplp0 Gene) and cytb for the Mitochondrial Genome26.']	N/A	N/A	[('SO_0000112', 'primer', 4, 'primers'), ('GO_0005634', 'nucleus', 36, 'nuclear'), ('SO_0000630', 'upstream_AUG_codon', 36, 'nuclear'), ('SO_0001026', 'genome', 44, 'genome'), ('SO_0000842', 'gene_component_region', 64, 'region of ... gene'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 78, 'Rplp0'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('SO_0001026', 'genome', 121, 'genome26')]
PMC5678092	11/2017	S214-PMC5678092	['Mitochondrial Pyruvate carrier Mpc1 is responsible for transporting Pyruvate out of the Mitochondria for Gluconeogenesis.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('CHEBI_15361', 'pyruvate', 14, 'pyruvate'), ('GO_0097446', 'protein localization to eisosome filament', 14, 'pyruvate'), ('PR_000010205', 'cartilage matrix protein', 31, 'Mpc1'), ('CHEBI_15361', 'pyruvate', 68, 'pyruvate'), ('GO_0005739', 'mitochondrion', 88, 'mitochondria'), ('GO_0006094', 'gluconeogenesis', 105, 'gluconeogenesis')]
PMC5678092	11/2017	S297-PMC5678092	['the increases in Mitochondrial activity (cs activity) and β-oxidation ( hadh levels) would increase Fat Catabolism.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 17, 'mitochondrial'), ('GO_0006633', 'fatty acid biosynthetic process', 100, 'fat catabolism')]
PMC5678092	11/2017	S303-PMC5678092	['this excess of Nad+is expected to increase a variety of sirtuin mediated processes such as Mitochondrial function, Fatty Acid Synthesis and β-oxidation49,51,52.']	N/A	N/A	[('CHEBI_15846', 'NAD(+)', 15, 'NAD+'), ('GO_0005739', 'mitochondrion', 91, 'mitochondrial'), ('CHEBI_35366', 'fatty acid', 115, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 115, 'fatty acid synthesis')]
